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Summary
Foetal programming describes the process whereby exposure to environmental 
stimuli or insults during early development can lead to enduring change in structure 
and function in later life. This concept has found much support in terms of altered 
metabolic and cardiovascular function from a range of epidemiological and animal 
studies, but more recent work is highlighting the role that poor foetal nutrition may 
have on the development of behavioural and psychiatric problems. The biological 
mechanisms underlying nutritional programming remain uncertain, however 
compromised placental deficiency and/or foetal endocrine systems (particularly the 
IGF axis), have been considered to be of paramount importance at the nexus of this 
foetal-environmental interplay.
In the present study, two knockout mouse models of the imprinted Igf2 gene 
were used to investigate the effects of placental deficiency and foetal growth 
restriction on brain development and behaviour in later life. Total deletion of the Igf2 
gene (/g/2-Null KO) leads to complete ablation of Igf2 expression from all foetal and 
placental tissue, severe growth deficiency of both the foetus and placenta, and a 
mouse that is bom small (50% o f normal size) and remains small for life. However, 
the Igp -P0 knockout (Ig£2-P0 KO) model, where Igf2 expression is only suppressed 
in the placenta (deletion o f the P0 promoter) results in moderate foetal and placental 
growth retardation and an adult of equivalent size of normal. Intrauterine growth 
restricted mice from both Igf2 knockout models were tested on a wide range of 
behavioural batteries, and performance compared with that o f wild-type littermates. 
Since epidemiological studies of humans have commonly demonstrated linkage 
between nutritional compromise in early life, and ADHD symptoms and anxiety 
disorders in later life, behavioural tasks sensitive to these behavioural phenotypes 
were selected for the purpose o f present experiments. 7g/2-P0 KO mice displayed 
heightened levels of stress and anxiety, as indicated by greater startle responses and a 
marked increase in avoidance behaviour on several conflict-based tests of anxiety. 
Mice from both Igf2 knockout models exhibited heightened discriminative accuracy 
in the 5-choice serial reaction time task, but Igf2-?0 KO mice also showed enhanced 
impulse control. Real-time qPCR revealed differential expression of both GABA- and 
5-HT-ergic receptor subtypes in the hippocampus of Igf2-?0 KO mice, which may
correlate with the observed stress and anxiety related phenotypes. Moreover, alternate 
splicing o f the 5-HT2C receptor in the striatum could underlie the increased impulse 
control shown by Igf2-PO KO mice. While the findings of elevated anxiety levels 
among the 7g/2-P0 KO mice are in line with previous work on humans and animals, 
the heightened attentional performance and impulse control is entirely novel and 
highlight the importance of further research on the relationship between early life 
adversities and later ADHD risk.
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Chapter I
General Introduction
This thesis investigates the effects that the intrauterine environment may have on 
function in later adult life. This relationship, termed ‘foetal programming’, has been 
demonstrated to be a significant factor in a number of physiological conditions, most 
notably the metabolic syndrome, exemplified by adult onset (type-2) diabetes and 
obesity. Moreover, there is accumulating, but limited, evidence from human literature 
that this concept may also be o f relevance to psychiatric disorders and behavioural 
dysfunction (e.g. attention deficit hyperactivity disorder (ADHD) and schizophrenia); 
this evidence is based on a range o f different indices o f early growth impairments 
such as low birth weight (LBW, 2500g >) or bom small for gestational age (SGA). 
There have been numerous attempts to model these types of effects in animal models 
using different manipulations o f the foetus or maternal nutrition, with various degrees 
of success and replicability. Despite varying approaches, many of these studies have 
highlighted a key role for hormonal systems, most notably the hypothalamic-pituitary- 
adrenal (HPA) and insulin-like growth factor (IGF) axes, in mediating these 
programming pathways.
1.1 Foetal programming
The tissues and organs o f mammals and other species undergo a number of 
sensitive stages of development, known as critical periods, which are highlighted by 
phases o f rapid cellular growth, proliferation and differentiation (Rice and Baron Jr.,
2000). The critical periods vary between different organisms and programming can 
occur at different stages in life, including conception, foetal life, infancy and 
adolescence (Harding, 2004), and in terms of the development of the central nervous 
system (CNS), critical periods of growth during intrauterine life coincide with the 
stages of neuro- and glio-genesis, neuronal and glial migration, as well as synapse 
formation (Rice and Baron Jr., 2000). During these critical periods, stimuli or insults 
from the extra-foetal environment can have enduring effects on the structure, function 
or developmental schedule o f the organism, a process which has been termed,
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programming (Lucas, 1991). For instance, there is compelling evidence from 
epidemiological and animal work, demonstrating that adverse environmental factors 
acting early in foetal life, play a major role in determining a wide range of chronic 
diseases and disorders in adulthood (Barker, 1997). Moreover, whereas much of the 
earlier epidemiological observations focused on the metabolic and cardiovascular 
sequelae o f this foetal-environmental interplay (McMillen and Robinson, 2005; 
Barker, 2004), more recent work indicates that the long-term consequences of adverse 
intrauterine environment may also involve brain and behavioural functions (Schlotz 
and Phillips, 2009). Although a host o f environmental factors have been identified 
with a role in determining foetal growth rate (e.g. maternal stress and substance abuse, 
hormonal milieu and infection during pregnancy), a nutritional explanation for the 
relationship between intrauterine growth restriction (IUGR) and later disease, has 
been strongly advocated on the basis o f current evidence (Harding, 2004; Hales and 
Barker, 2001; Lucas, 1991).
Over the last 20 years, the contribution o f foetal programming to disease in 
later life has been a subject o f heightened attention, and has attracted the interest of 
geneticists, physiologists, evolutionary biologists and psychologists. Furthermore, the 
work in this field o f research has caused a major shift in the understanding o f the 
aetiology o f many common diseases. More specifically, the evidence from this work 
suggests that while most disorder are determined by genetic predisposition and/or 
postnatal environment and lifestyle, events occurring early in foetal life may also play 
a paramount role in the susceptibility for some these disorders. Unsurprisingly, gene- 
environment interplay is fundamental to the concept of programming, and in recent 
years the growing field o f nutritional epigenomics has provided an important insight 
to the possible biological mechanisms that may underlie these interactions.
1.1.1 Evidence for foetal programming from epidemiological studies
The notion that intrauterine life events and maternal well being during 
gestation may have an enduring effect for the development o f the child was generated 
on the basis o f seminal work by Rose (1964). This study indicated a link between 
early life environment and later health outcome whereby familial patterns of coronary 
heart disease correlated with the survival rate of siblings and parental mortality. 
Further studies showed that infant mortality was geographically correlated with
2
arteriosclerotic heart disease in people aged between 40-69 years (Forsdahl, 1977) and 
similar geographical relations between infant mortality and adult coronary heart 
disease were subsequently reported by Barker and Osmond (1986). More recently, 
extensive data from human epidemiological studies across diverse populations have 
indicated that aberrant foetal development influences susceptibility to metabolic and 
cardiovascular diseases. For example, in a longitudinal study, with over 36,000 men 
and women from Hertfordshire, UK, results showed that people that had either LBW 
or reduced weight beyond one year o f age, were at an increased risk o f developing 
coronary heart disease (Barker, Osmond, Winter, Margetts and Simmonds, 1989). 
This pattern has been established for other components of the metabolic syndrome, 
such as obesity, stroke, hypertension, glucose intolerance and hyperlipidemia, in a 
number o f subsequent large epidemiological studies (Leon et al., 1996; Martyn, 
Barker and Osmond, 1996; Hales, Desai, Ozanne and Crowther., 1996; Barker, 
Martyn, Osmond, Hales and Fall, 1993; Barker, et al., 1993). Consequently, Hales and 
Barker (Hales et al., 1991) formulated the foetal origins o f adult disease hypothesis 
(FOAD, also known as ‘the developmental origins of adulthood disease’ (DOAD), the 
‘thrifty phenotype hypothesis’ or the ‘Barker hypothesis’); briefly, this idea attributes 
to poor nutritional environment a causal role in the relationship between compromised 
foetal growth and subsequent metabolic and cardiovascular disease susceptibility 
(Hales and Barker, 2001 and 1992). That such a relationship exists between later 
health and early life adversity may not be surprising when considering the rate of cell 
growth and differentiation that takes place in utero and during the early neonatal 
period, amplifying the impact o f any adverse effects during these phases of life.
1,L2 Genes versus nutrition
An earlier theoretical paradigm known as the ‘thrifty genotype hypothesis’ 
was postulated by Neel (1962; cited in Prentice, 2005) based upon the aetiology of 
large babies bom to diabetic mothers and related to insulin resistance. According to 
this hypothesis, natural selection operating during the early stages of human 
evolution, could have produced a selection of genes that confer an efficient metabolic 
state and energy conservation for periods of time when food sources are scarce and 
food intake irregular. Furthermore, while such metabolic adaptation would enhance 
survival o f the organism in times of food shortage, these alterations could be
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detrimental during periods o f over-nutrition and possibly lead to diseases in 
adulthood; a process thought to underlie the current trend towards increased incidence 
of type-2 diabetes (Prentice, 2005). Consistent with this idea, mutation of the 
glucokinase gene leads to both IUGR and postnatal hyperglycaemia (Hattersley et al., 
1998) and the class III allele o f the variable number o f tandem repeat locus o f the 
insulin (INS) gene has also been associated with increased foetal growth, as well as 
with insulin resistance, diabetic hypertriglyceridemia, atherosclerosis, cardiovascular 
diseases and type 2 diabetes (Mitchell et al., 2004).
However, while the aforementioned studies suggest that genetic predisposition 
could explain the relationship between IUGR and later physiology in some cases, 
there is substantial evidence in support for the environmental programming of later 
health from twin studies or where pregnant mothers experienced severe famine. In a 
Danish twin-study investigating type 2 diabetes among discordant monozygotic twins, 
results showed that the diabetic twins had a significantly lower birth weight relative to 
normoglycemic co-twins (Poulsen, Vaag, Kyvik, Jensen and Beck-Nielsen, 1997). 
Also, in an earlier study the occurrence o f type II diabetes among first degree relatives 
was found to be greater within, than between, generations, a fact more suggestive of 
environmental than genetic influences for a nutritional origin of later disease (Beaty, 
Neel and Fajans, 1982).
An important role for environmental influences is further validated when the 
evidence from a number o f famine studies is considered. In a landmark study carried 
out by Ravelli, Stein and Susser (1976) the long-term effects of intrauterine exposure 
to maternal malnutrition in a large sample of people bom in Amsterdam at the time of 
the Dutch winter famine during the Second World War was investigated. The findings 
revealed a significantly increased prevalence for obesity among those exposed to 
under-nutrition in early gestation, than those malnourished later in pregnancy or those 
who were not malnourished at all. Moreover, subsequent findings from follow-up 
studies using the Dutch winter famine victims have reported significantly greater 
prevalence of impaired glucose tolerance (Ravelli, van der Meulen and Michaels, 
1998) and coronary heart disease (Ravelli, van der Meuelen, Osmong, Barker and 
Bleker, 1999) following famine in early gestation, whereas famine exposure during 
mid-gestation has been associated with elevated risk o f obstructive airways disease 
(Lopuhaa et al., 2000). The Dutch winter famine victims suffered from low maternal 
protein, carbohydrate and fat intake during the critical phase in development,
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suggesting that the nutritional balance of the maternal diet may have significant and 
selective effects on foetal development and programming. In fact, there is some 
evidence that the maternal intake of fruit and vegetables during pregnancy, is 
positively correlated with birth weight and glucose tolerance in the offspring (Rao et 
al., 2001; Yajnik, 2004), further demonstrating the importance of nutrients (such as 
folic acid, glucose, triglycerides, cholesterol) in normal development and subsequent 
health.
In the context of the above studies conducted in humans, as well as findings 
from animal models (see below), there is substantial evidence indicating that 
environmental agents can independently impact on gene expression and lead to 
changes in physiological and morphological phenotypes, related to metabolic and 
cardiovascular disorders. Nevertheless, it is probable that at least in some cases, 
genetic predispositions act in concert with environmental agents to bring about 
changes in later disease vulnerability. For instance, a polymorphism in the 
peroxisome-proliferator-activated receptor y2 receptor gene, which is involved in the 
development and metabolic function o f adipose tissue, has been found to modulate 
insulin resistance susceptibility o f people bom SGA (Eriksson et al., 2002). Similar 
interactions with foetal growth have been described for insulin resistance with 
polymorphisms in angiotensin-converting enzyme, plasma cell glycoprotein 1, as well 
as in vitamin D receptor genes (see Godfrey, Cameron and Hanson, 2006 for review).
1.1.3 Evidence from animal models
Human epidemiological data has gained experimental support from findings in 
a variety of animal models, in which the impact of nutritional constraints on long-term 
metabolic and cardiovascular function has been investigated (Reusens, Kalbe and 
Remade, 2004; Langley-Evans, 2004a). Surgical ligation o f one o f the uterine homs 
of a pregnant guinea pig to reduce foetal nutrition induced IUGR and subsequent 
significantly increased blood pressure when tested in young adulthood, relative to 
littermates derived from the other (intact) uterine hom (Persson and Janson, 1992). 
Elevated systolic blood pressure has also been reported in the offspring of rat dams 
that were fed protein restricted diet during gestation (Langley-Evans, Welham and 
Jackson, 1999; Langley-Evans, Gardner and Jackson, 1996; Langley-Evans and 
Jackson, 1994; Langley-Evans, Phillips and Jackson, 1994), but this cardiovascular
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vulnerability has been found to be greatest when the maternal exposure to the low- 
protein diet occurs during the last week of gestation (Langley-Evans, Welham, 
Sherman and Jackson, 1996).
Furthermore, IUGR by nutritional restriction during foetal life has also been 
demonstrated to have numerous effects on glucose metabolism and insulin action in 
later postnatal life. For example, offspring of mothers fed low-protein diet during 
gestation have been reported to have selective insulin resistance (Ozanne, Dorling, 
Want and Petry, 2000; Ozanne, Wang, Dorling and Petry, 1999), glucose intolerance 
(Hales, Desai, Ozanne and Crowther, 1996) and diabetes (Petry, Ozanne and Hales,
2001), and uterine artery ligation has been demonstrated to lead to a reduction in 
foetal pancreatic /3-cells (De Prins and Van Assche, 1998). Moreover, perturbations in 
the insulin-like growth factor (IGF) axis have been reported in foetuses that have been 
subjected to maternal malnutrition, in terms of decreased heptocyte cellular 
proliferation and insulin-like growth factor-I (IGF-I) production (El Khabatti, 
Gregoire, Remade and Reusens, 2003), and decreased pancreatic insulin-like growth 
factor-II (IGF-II) mRNA expression (Petrik, Arany, McDonald and Hill, 1998).
1.1.4 Summary
Taken together, there is clear evidence from both epidemiological data and 
animal models that intrauterine nutrition can influence adult susceptibility to 
metabolic and cardiovascular disorders, additionally; genetic background may also 
play an important role. Moreover, animal models of nutritional restriction suggest that 
the IGF axis might play a central role in modulating foetal programming o f this 
heightened disease risk. In recent years there has been a significant shift o f focus in 
the research o f foetal programming research, with an increasing number o f studies 
examining the effects o f early life environment on mental health in later life (Schlotz 
and Phillips, 2009; Connors et al, 2008; Kajantie, 2006; Breslau, 1995).
1.2 Foetal origins of mental health
1.2.1 Evidence from epidemiological studies
In case-control studies, children o f impaired foetal growth have repeatedly 
been described to have heightened risk o f cognitive deficits (Shenkin, Starr and
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Deary, 2004), anxiety-related disorders (Lundgren, Cnattingius, Jonsson and Tuvemo, 
2001; Nilson, Nyberg and Ostergren, 2001), learning disabilities (Johnson and 
Breslau, 2000) and ADHD (Breslau et al., 1996), relative to children o f normal birth 
weight. Moreover, impaired performance in tasks of executive function and 
perceptual motor skills (Taylor, Minich, Klein and Hack, 2004; Vicari, Caravale, 
Carlesimo, Casadei and Allemand, 2004; Strauss, 2000) have been reported in 
adolescents o f LBW (generally taken to be indicative of gestational compromise), but 
these adults have also been shown to have a greater vulnerability for early drug use 
(Chilcoat and Breslau, 2002).
Following up the previously reported metabolic and cardiovascular sequelae of 
maternal malnutrition during the Dutch winter famine of World War II, Susser and 
colleagues (1996) showed a two-fold increase in risk of schizophrenia in adults that 
were most severely malnourished during gestation. A similar pattern for risk of 
schizophrenia was reported in a Chinese cohort that underwent a severe famine 
several years later (St. Clair et al., 2005). In other follow-up studies of the Dutch 
famine cohort, exposure to famine during the first and second trimester was associated 
with an elevated risk for antisocial personality disorder (Neugebauer, Hoek and 
Susser, 1999), whereas those exposed to famine during the second or third trimester 
were at greater risk of being diagnosed with mood disorders in later life (Brown, van 
Os, Driessens, Hoek and Susser, 2000). Taken together, these epidemiological 
findings provide basic support for foetal programming of later psychiatric disease 
susceptibility, by changes in early nutrition.
1.2.2 Evidence from animal models
Although human epidemiological data supporting a link between early 
nutritional origin and adult psychiatric vulnerability has only begun to emerge in the 
last 15-20 years, the experimental evidence for a relationship between brain function 
and early nutritional provisioning dates back much earlier, and in fact precedes the 
research on metabolic and cardiovascular effects. During the mid 1960’s a number of 
research groups began to perform experiments in animal models to explore the effects 
o f early life malnutrition on subsequent cognitive function and behaviour (Scrimshaw, 
1967). Some of the initial findings showed that rats, piglets and puppies that were 
bom to well nourished mothers but subsequently placed on protein deficient diet
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developed motor impairments after only four days (Platt, Heard and Stewart, 1964 
and Platt, 1962, cited in Scrimshaw, 1967). Furthermore, adult rats that were weaned 
prematurely (i.e. postnatal day 15) showed a greater delay in learning, and were more 
behaviourally inhibited in a simple learning paradigm (i.e. made fewer responses), 
relative to rats that underwent weaning at the usual age of 30 days (Novakova, Faltin, 
Flandera, Hahn and Koldovsky, 1962). Since then, an extensive amount of data has 
accumulated on the behavioural consequences of suboptimal nutrition availability 
during gestation, lactation and/or early postnatal life using a number o f different 
animal models.
This research has consistently described cognitive impairments, as well as 
heightened anxiety and motivation in animals subjected to nutritional deprivation 
during lactation or pre-weaning periods (see Strupp and Levitsky, 1995 for review). In 
contrast, studies investigating the effects o f nutritional insults occurring during 
intrauterine life, on adult behaviour, have yielded contradictory results. For example, 
offspring of protein restricted rat dams showed poorer reversal learning performance 
on the water-escape version of a T-maze apparatus (Villescas, Van Marthens and 
Hammer, 1981). However, in an operant version of the task where rats had to learn a 
new stimulus-reward pairing whilst ignore a previously learned stimulus-reward 
pairing, no differences were observed at baseline configurations, and in fact, superior 
performance was observed in the prenatally malnourished group of rats when tested at 
a heightened level o f difficulty (Tonkiss and Galler, 1990). Similarly, offspring of 
protein restricted rat dams have shown impaired response acquisition on a task of 
differential reinforcement of low rate schedule (Tonkiss, Galler, Formica, Shukitt- 
Hale and Timm, 1990a). Rats that were exposed to food deprivation during gestation 
adapted less well to shifts in reinforcement schedules, when tested on a concurrent 
variable-interval paradigm (Landon et al., 2007). However, in contrast, there was no 
effect o f nutritional deprivation during foetal life on memory and learning when tested 
in the Morris water-maze and fear conditioning paradigm (Gilbert, MacPhail, 
Baldwin, Moser and Chemoff, 2010). A similar absence of impairment in the Morris 
water-maze task was noted earlier in rats that suffered intrauterine protein 
malnutrition (Tonkiss, Schultz and Galler, 1994). Thus, the effects of gestational 
malnutrition in rats on later cognitive performance are not clear cut but nonetheless a 
number of significant effects have been reported.
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A similarly confused picture emerges when the effects of foetal malnutrition 
on later stress and anxiety states are considered. Several studies have described 
heightened anxiety levels among adult rats that were exposed to either calorie or 
protein restriction during gestation when tested in ethologically based conflict tests of 
anxiety (Levay et al., 2008; Jaiswal, Upadhyay, Satyan and Bhattacharya, 1996) or in 
a test of stress responsiveness (Erhard, Boissy, Rae and Rind, 2004). Conversely, 
other studies have either not found any effect of intrauterine under-nutrition on stress­
or anxiety-related behaviour (Simitzis et al., 2008; Whatson and Smart, 1978), or have 
even demonstrated anxiolytic effects (i.e. less anxiety) on adult behaviour following 
nutritional restriction during intrauterine life (Almeida, Tonkiss and Galler, 1996a; 
Almeida, Tonkiss and Galler, 1996b). Perhaps the only relatively consistent 
behavioural effects o f intrauterine nutritional restriction have been noted in relation to 
parameters o f motivation. For example, increased lever-pressing rates in order to 
receive rewards was observed in adult rats that were bom from underfed dams (Smart, 
Dobbin, Adlard, Lynch and Sands, 1973) or from dams fed a low-protein diet during 
pregnancy (Tonkiss et al., 1990b). Similar results are obtained in a number of other 
studies employing both appetitive and aversively motivated experimental paradigms 
(see Strupp and Levitsky, 1995 for review). Overall, while there is considerable 
evidence from animal models suggesting that intrauterine malnutrition might lead to 
heightened motivation in later life, the direction and magnitude o f effects o f such 
early nutritional insults on later cognitive function and emotional state remains far 
from clear.
1.2,3 Summary
In light of findings from the human epidemiological studies, it is clear that the 
long-term effects o f impaired foetal growth are not confined to metabolic and 
cardiovascular sequelae, but may also include behavioural and psychiatric functions. 
Previous work from animal models suggests that early life nutrition might play a role 
in establishing the relationship between IUGR and later mental health. Nevertheless, 
the great discrepant findings from the animal work, suggests that the aetiology of 
developmental programming o f the CNS might be particularly heterogeneous and 
prone to postnatal environmental influences.
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1.3 Foetal programming of brain development
It has now become widely accepted that interruption of development during 
intrauterine life can result in abnormalities o f the brain (see Rice and Barone Jr.,
2000). Furthermore, nutritional inadequacy has been advocated as the principal 
nongenetic component that influences brain development (Morgane, Mokler and 
Galler, 2002), as nutrients are essential for basic developmental programmes such as; 
neuronal growth and proliferation, neuronal and glial migration, myelinisation, and 
synaptogenesis (Georgieff 2007; Morgane et al., 2002). Nutritional deficiency can 
also compromise the catalytic activities of enzymes, protein synthesis and structure 
that are critical for neuronal formation and tissue organisation (Langley-Evans, 
2004b; Morgane et al., 2002). Whereas previous research on early life malnutrition 
has described reductions in later head circumference, brain weight and cerebral cell 
number in humans (Winick, 1969), the current understanding o f the intrauterine 
effects o f nutritional inadequacy on cerebral development and function, stems mainly 
from research in animal models.
1.3.1 Foetal programming o f general brain morphology
Work with animal models using the imposition of low-protein diets during 
gestation in rats have demonstrated irreversible reductions in total brain weight, DNA 
and protein content, and in various cerebral lipid concentrations (Chase, Dabiere, 
Welch and O’Brien, 1971; Zamenhof, Van Marthens and Margolis, 1968). Other 
studies examining cerebral morphology in more detail have reported reductions in 
neuronal myelation (Bourre, Morand, Chanez, Dumond, and Flexor, 1981), dendritic 
branching of occipital pyramidal neurons (Cordero et al., 1986) and cortical thickness 
(Clark, Zamenhofj Van Marthens, Granel and Kruger, 1973) in adult rats that were 
gestationally malnourished. In addition, enlarged ventricles and reduced cortical, 
striatal and hippocampal volumes were observed in adult guinea pigs which 
experienced placental deficiency, induced by artery ligation (Mallard, Rehn, Reese, 
Tolcos and Copolov, 1999). Although there is evidence that brain weight/size is 
protected relative to the overall body weight and other organs (Ahmad and Rahman, 
1974; Tizard, 1974; Dobbin and Widdowson, 1965), some parts of the brain may be 
more susceptible to environmental insults during early life, such as the hippocampus 
(Morgane et al., 2002).
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1.3.2 Foetal programming o f hippocampal circuitry
Compelling evidence from animal models shows that the volume o f the 
hippocampus is markedly, and specifically, reduced as a result o f early life 
environmental insult and/or nutritional deficiency (Mallard et al., 1999). This has 
highlighted the neural circuitry in this area as an important target in these 
manipulations. More detailed examination of the neuronal circuitry of this brain 
region has shown reduced numbers o f pyramidal neurons in the CA1 subfield of the 
hippocampus in guinea pigs, which were IUGR as a result of uterine hom ligation of 
their dam (Mallard, Lolieger, Copolov and Reese, 2000). In rats exposed to 
intrauterine protein restriction, a significant decrease in somal size, basal dendritic 
branching and spine density in CA3 pyramidal neurons of the hippocampus (at day 
220) (Diaz-Cintra, Card-Ruiz, Corkidi and Cintra, 1994) and asymmetrical synapse 
reduction between mossy fibre granule neurons and the CA3 pyramidal neurons 
(Granados-Rojas et al., 2002) have been reported. Increases in the number o f granule 
cells in the dentate gyrus in protein malnourished rats (King et al., 2004; Nunes, 
Liptakova, Veliskova, Sperber and Moshe, 2000) highlights the fact that different sub- 
regions of the hippocampus may be differentially affected by such manipulations.
In line with the prevailing evidence of morphological differences in the 
hippocampus of rats that underwent intrauterine malnutrition, a number of studies 
have demonstrated alterations in synaptic plasticity. More specifically, changes in the 
maintenance and magnitude o f long-term potentiation (LTP). Thus, intrauterine 
protein or micronutrient (zinc) deprivation has been shown to alter both the time 
course and the magnitude of LTP in the dentate gyrus o f adult rats (Bronzino, Austin 
La France, Morgane and Galler, 1996) and elevate rates of miniature inhibitory 
synaptic currents in CA1 (Luebke, St John and Galler, 2000) and CA3 pyramidal 
neurons (Chang, Galler and Luebke, 2003). Reductions in hippocampal N-methyl-D- 
aspartate (NMDA) receptor expression, implicated in the maintenance of hippocampal 
LTP (see MacDonald, Jackson and Beazely, 2006 for review, Chowanadisai, Kelleher 
and Lonnerdal, 2005) have also been described in the rat brain following intrauterine 
zinc deficiency. Moreover, rats exposed during gestation to a diet supplemented by 
excess choline, the precursor o f the neurotransmitter acetylcholine, showed an 
attenuated LTP induction threshold in the CA1 region of the hippocampus (Pyapali, 
Turner, Williams, Meek and Swartzwelder, 1998).
11
1.3.3 Foetal programming o f hippocampal neurotransmitter systems
The morphological and electrophysio logical changes in the hippocampus 
resulting from intrauterine nutritional insults are paralleled by alterations to a number 
o f neurotransmitter systems. Electrical stimulation of cultured hippocampal slices, 
derived from the brains o f intrauterine protein malnourished rats, resulted in the long­
term increase in the efflux o f dopamine and its metabolites (i.e. 3,4—dihydroxy- 
phenylacetic acid (DOPAC) and homovanillic acid), decreased noradrenaline and its 
precursor tyrosine, and decreased serotonin (5-HT) and its metabolite 5- 
hydroxyindoleacetic acid (5-HIAA, Chen, Turiak, Galler and Volicer, 1995). 
Moreover, in vivo microdialysis studies targeted at the hippocampus of intrauterine 
malnourished rats, showed a significant decrease in 5-HT release when either exposed 
to mild electrical stimulation or when administered benzodiazepine agents, even 
though these rats had elevated basal levels o f 5-HT in comparison to well-nourished 
rats (Mokler, Galler and Morgane, 2003; Mokler, Bronzino, Galler and Morgane, 
1999).
In light o f these findings, Mokler and colleagues (2003) proposed that 
intrauterine malnutrition might invoke an altered stress response via differential 5-HT 
modulation of inhibitory GABA (Y-aminobutyric acid) intemeurons. Indeed, such 
anatomical and/or functional alterations in the 5-HTergic inputs that regulate the 
inhibitory activity o f GABA neurons, could conceivably account for the LTP 
impairment and the heightened inhibitory signalling, mentioned previously. 
Consistent with this view, chronic protein restriction during gestation in rats has been 
found to reduce both the number o f hippocampal GABAergic intemeurons (Andrade 
and Paula-Barbosa, 1996; Diaz-Cintra et al., 2007) and hippocampal GABA«i receptor 
subunit expression, while GABA^ receptor expression was found to be up-regulated 
(Steiger, Alexander, Galler, Farb and Russek, 2003), along with lower cerebral basal 
GABA efflux (Del Angel-Meza, Ramires-Cortes, Adame-Gonzalez, Gonzalez, 
Burgos, Beas-Zarate, 2002).
1.3.4 Summary
In summary, the research reviewed in this subsection indicates that 
undemutrition during intrauterine life can have enduring consequences on brain 
development and later brain morphology and neurophysiology. While the effects of
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nutritional programming encompass relatively broad alterations in brain anatomy and 
involve alterations of numerous neurotransmitter systems, there are data which 
highlight both the structural and functional vulnerability o f the hippocampal region, 
particularly in terms of the modulatory reciprocal circuitry o f the 5-HT- and 
GABAergic systems. Importantly, the findings from the animal models o f intrauterine 
malnutrition, are moreover broadly in line with results from studies of children with 
IUGR, which have described reductions in both cortical gray matter (Spencer et al., 
2008; Martinussen et al., 2005; Tolsa et al., 2004) and hippocampal volume (Isaacs et 
a l, 2000).
1.4 Programming of the placenta via functional alterations of the IGF and HPA 
axes
The placenta is the first organ to develop during mammalian embryogenesis 
and is responsible for the supply o f vital nutrients to the growing foetus (primarily 
glucose, lactate and amino acids), disposing of harmful waste materials, and 
regulating the exchange o f gases between the mother and the foetus. The placenta has 
the key role o f integrating signals from the foetus and the mother in effort to 
accommodate the maternal substrate supply to foetal demand and at the same time 
meeting its own metabolic requirements. Therefore, successful placental development 
is o f paramount importance for the optimal growth, maturation, and thus the survival 
of the embryo or foetus and concomitant formation of the adult. However, placental 
development, and in turn placental efficiency, is largely determined by nutritional 
availability (Fowden, Ward, Wooding, Forhead and Constancia, 2006). Hence, 
significantly reduced maternal concentrations (i.e. from the umbilical vein) o f some o f 
the most essential amino acids have been noted in cases o f IUGR (Cetin et al., 1996). 
The reduction in placental efficiency involves alterations in both foetal and placental 
gene expression, particularly via epigenetic modifications; such as altered DNA 
methylation, which has been shown to have repressing effects on gene transcription 
(Dolinoy, Das, Weidman and Jirtle, 2007; Gallou-Kabani and Junien, 2005). 
Importantly, in recent years there has been accumulating evidence indicating that 
early nutritional perturbation might induce foetal growth retardation and later 
physiological sequelae, by causing severe and lasting alterations in some o f the major
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components o f the endocrine system, especially in terms o f hyperactivation of the 
HP A axis, in parallel with down-regulation in the activity o f the IGF axis.
1.4.1 The IGF axis
The IGF signalling system has previously been shown to play a key role in 
foetal and placental development throughout gestation (Fowden, 2003). The IGF 
system consists o f the IGF-I and IGF-II signalling peptides, which are released from 
the foetal pancreas following exposure to glucose and amino acid stimulation (Rees, 
Wiznitzer, Le, Homko, Behrman and Martin, 1994). The mitogenic IGF-I and -II 
peptides are structurally homologous to insulin, and promote cellular differentiation, 
migration, aggregation, and inhibit apoptosis (Han and Carter, 2000). There are two 
receptors, which have unrelated structural features and binding properties: IGF type I 
and type II receptors (IGF-IR and IGF-IIR, respectively). IGF-IR mediates the 
majority o f the biological actions o f both IGF-I and IGF-II, although the insulin 
receptor also displays agonistic binding affinity for both peptides, but to a lesser 
degree. IGF-IIR functions as an antagonist to IGF-II activity. In addition to the two 
receptors, there are six IGF binding proteins (IGFBPs-1-6) that have been identified to 
date. The IGFBPs are found in both foetal plasma and tissue, and can either enhance 
or suppress IGF activity. The IGFBPs that are of the membrane-bound form (IGFBP- 
3 and -5) usually up-regulate IGF activity by chaperoning the IGFs to receptor sites 
and prolonging the half life o f activity, whereas the soluble forms of IGFBPs (IGFBP- 
1,-2 (context dependent), and -6) inhibit IGF action (O’Dell and Day, 1998).
1.4.1.1 The role o f IGF-I and IGF-II in foetal and placental growth
The IGF-I and IGF-II polypeptides are encoded by the IGF1 and the IGF2 
genes respectively, which are both expressed in foetal and placental tissue (Fowden, 
2003). Expression o f the IGF1 gene is biallelic, whereas the IGF2 gene is imprinted 
and therefore monoallelically expressed in a parent-of-origin dependent manner 
(maternally silenced/paternally expressed). In gene manipulation studies, disruption o f 
either Igfl or Igf2 gene expression in mice has been shown to result in a considerable 
deficiency in foetal growth, to approximately 60% of normal birth weight (Baker, Lin, 
Robertson and Efstratiadis, 1993; DeChiara, Robertson and Efstratiadis, 1990, 
respectively). However, a simultaneous deletion of both the Ig f genes produced far
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more severe growth retardation, to only about 30% of normal birth weight 
(Efstratiadis, 1998). A similar severity in growth retardation was observed following 
suppression o f the IGF-I receptor gene (.Igflr), notably in line with its binding 
properties for both the IGF-I and IGF-II peptides (Baker et al., 1993). Conversely, 
IGF-II up-regulation induced either by biallelic expression the o f Igf2 gene (due to 
loss o f imprinting) or by suppressing the expression of the IGF-II clearance receptor 
gene (Igf2r)y has been found to result in foetal overgrowth (Lau et al., 1994; Ludwig 
et al., 1996). Placental growth does not seem to be affected by manipulation o f Igfl or 
Ig flr  genes in mice, whereas when the Igf2 gene was either abolished from all foetal 
and placental transcripts (i.e. 7g/2-Null mice) (DeChiara et al., 1990), or a from a 
placental exclusive transcript o f the labyrinthine trophoblast (i.e. Igf2-P0 mice) 
(Constancia et al., 2002), the placenta is growth retarded by 30-40%.
An important role for the IGF axis in foetal growth regulation in humans has 
been proposed on the basis o f findings from studies in which circulating levels o f 
IGF-I were correlated with several different parameters of growth including birth 
weight, birth length, placental weight, and ponderal index (Klauwer el al., 1997; 
Osorio et al., 1996). In addition, IUGR in children bom at term has also been related 
with lowered maternal IGF-II serum levels (Holmes et al., 1997), as well as reduced 
IGF2 expression in the placenta (McMinn et al., 2006). On the other hand, foetal body 
weight at term has been positively correlated to plasma IGFBP-3, whereas an inverse 
association has been observed between foetal growth and IGFBP-1 (Kajantie et al., 
2001). Dysregulation o f IGF expressions has been implicated in several 
developmental disorders. For instance, homozygous molecular defect in the IGF I 
gene has been noted to result in severe IUGR, along with sensory-neuronal and 
mental impairments (Camacho-Hiibner, Woods, Clark and Savage, 2002). 
Furthermore, constitutive over expression of IGF2 is among the causal factors for 
Beckwith-Wiedemann syndrome (BWS), an overgrowth disorder characterised by 
macrosomia (birth weight and length >90th percentile) and cancer predisposition; 
conversely, 1GF2 down-regulation is associated with Silver-Russell syndromic 
dwarfism (Demars et al., 2010).
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1.4.1.2 Programming o f  the IGF axis
Several studies examining nutrient restriction during intrauterine life have 
demonstrated down-regulation of the IGF axis. For example, restriction in maternal 
food intake has been shown to lower foetal circulating concentrations o f IGF-I and 
IGF-II and mRNA expression o f IGF-I and IGF-II in both rats (Strauss and 
Takemoto, 1991; Stauss, Ooi, Orlowski and Rechler, 1991) and sheep (Bramfeld et 
al., 2000; Lee et al., 1997; Kind et al., 1995; Oliver, Harding, Breier and Gluckman, 
1996), whereas elevated plasma levels o f IGFBP-1 are a consequence o f reduced 
nutrient availability induced either by maternal fasting (Osborn, Fowlkes, Han and 
Freemark, 1992), dietary restriction (Strauss et al., 1991) or unilateral artery ligation 
(Price, Roog, Stiles and D’Ercole, 1992). In addition to the links between the IGF axis 
and birth size mentioned previously (Holmes et al., 1997; McMinn et al., 2006; 
Kajantie et al., 2001), hypomethylation of the IGF2 gene has been observed in the 
offspring most severely affected by the Dutch winter famine of the Second World 
War (Heijmans et al., 2008) which speculatively may reflect an epigenetic 
compensation in response to the nutritional deprivation experienced. Thus, there is 
evidence from both human and animal studies demonstrating the involvement of the 
IGF axis in intrauterine nutrition and foetal development.
1.4.2 Regulation o f the IGF system by the HP A axis
There is strong evidence from human and animal work that the HPA axis is 
highly susceptible to nutritional insults during foetal life, and might be involved in 
modulating the effects o f early nutrient restriction on IGF activity. The HPA axis 
represents a major part o f the neuroendocrine system and plays a key role in 
mediating the stress response o f the organism via excretion of glucocorticoid steroid 
hormones (Plotsky, Thrivikraman and Meany, 1993). In response to stressful stimuli, 
the hypothalamic neurons o f the paraventricular nucleus synthesize and secrete 
corticotropin releasing hormone (CRH) and arginine vasopressin (AVP), which in 
turn drive the synthesis and release o f adrenocorticotrophin hormones (ACTH) from 
the anterior lobe of the pituitary gland. Subsequently, ACTH stimulates the adrenal 
cortex to produce and release corticosteroid hormones (corticosterone in rodents, 
cortisol in humans) which then, in sufficient concentrations, provide inhibitory 
feedback signals to the hypothalamus and pituitary gland via glucocorticoid and
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mineralocorticoid receptors o f the hippocampus, thus suppressing the production of 
CRH and ACTH (Kapoor, Petropoulos and Matthews, 2008). The glucocorticoid 
hormones are essential for the successful adaptation of an organism to acute physical 
stressors by ensuring adequate glucose availability for the brain and other vital tissues. 
Nevertheless, the release of glucocorticcoid steroids requires strict regulation, since 
excess glucocorticoid secretion can lead to various detrimental effects, particularly in 
terms of heightened risk for cardiovascular disease (Reynolds et al., 2010; Walker,
2007), the metabolic syndrome or its components (Kajantie, 2006), as well as notably 
impaired hippocampal development and function (Gallagher, Reid and Ferrier, 2009; 
Brown, Rush and McEwen, 1999).
1.4.2,1 Programming o f the HPA axis
Epidemiological research assessing the relationship between the intrauterine 
environment and aberrant HPA function, have proposed alterations in corticosteroid 
secretion as one o f the key deleterious consequences of poor foetal growth, although 
some discrepancy has been noted in previous findings. For instance, while numerous 
studies reported heightened basal cortisol levels among people o f LBW (Lewitt, et. 
a l, 2000; Philips et al., 2000; Philips et al., 1998) or bom SGA (Cianfarani, Geremia, 
Scott and Germani, 2002; Houang, Morineau, Le Bouc, Fiet and Gourmelen, 1999), 
other studies have indicated lowered resting cortisol levels (Kajantie et al., 2007; Hng, 
Cheung and McLean, 2005) or following administration of the cortisol analogue 
dexamethasone (Kajantie et al., 2003; Kajantie et al., 2002). Moreover, these latter 
results are also bolstered by the fact that hypocortisolism has been demonstrated to 
underlie several stress-related conditions (see Heim, Ehlert and Hellhammer, 2000 for 
review). However, these discrepancies may be accounted for, at least in part, in terms 
of methodology and problems associated with accurate measuring of cortisol or 
grouping subjects by birth size alone. For example in a study carried out by Kajantie 
and colleagues (2006) elevated fasting cortisol concentrations in adulthood were 
observed in people bom small but early (prior to 40 weeks of gestation), whereas the 
reverse was true for individuals bom but small after 40 weeks gestation. In addition, 
three week food abstinence has previously been shown to result in a significantly 
elevated cortisol secretion in response to dexamethasone administration in human 
volunteers (Fichter and Pirke, 1986).
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Extensive work from animal models employing intrauterine interventions o f 
disrupted nutrition (as discussed previously) has demonstrated profound programming 
effects on the HPA axis. Maternal under-nutrition (only half o f the daily food intake 
o f control rat dams) during the last week of gestation increased both plasma 
corticosterone between embryonic days 19-21 and relative adrenal weight at term, and 
newborn rats displayed a reduction in ACTH circulation and lowered glucocorticiod 
and mineralocorticoid receptor expression in the hippocampus (Lesage, Blondeau, 
Grino, Breant and Dupouy, 2001). Similarly, rats subjected to a low-protein diet 
during intrauterine life showed blunted diurnal patterns of plasma ACTH 
concentrations, but also a persistent increase in glucocorticoid receptor capacity 
(Langley-Evans, Gardner and Jackson, 1996), and pigs of low birth weight have been 
shown to have a greater stimulated cortisol response and adrenal gland size, at three 
months o f age (Poore and Fowden, 2003). Transient reductions in maternal caloric 
intake in sheep also results in a significantly greater ACTH response following 
administration o f either CRH, AVP (Bloomfield et al., 2003), or insulin (Bloomfield 
et al., 2003; Edwards et al., 2001) in lambs, but these effects were not noted following 
a more prolonged exposure to calorific restriction to the ewe. However again, the 
findings from these and several other similar studies highlight that the precise 
implications of poor nutrition during intrauterine life on the function o f the HPA axis 
is largely determined by the degree and duration of the under-nutrition (see McMillen 
and Robinson, 2005 for review).
1.4.2.2 Glucocorticoid regulation o f IGF axis
During intrauterine development, there is a co-ordinated regulation of 
glucocorticoid synthesis and IGF  gene expression. This has been demonstrated in a 
number o f different ways including; the down-regulation o f IGF-II transcription in the 
liver o f neonatal rats (Levinovitz and Norstedt, 1989; Beck, et al., 1988) and the 
increased activity o f IGF-inhibiting IGFBP-1 mRNA expression (Luo, Reid and 
Murphy, 1990) following administration of dexamethasone, and a reduction in 
IGFBP-3 expression in hepatic cells exposed to dexamethasone in vitro (Villafuerte, 
Koop, Pao and Phillips, 1995). Administration of naturally occurring corticosterioids 
and thyroid hormones have also been revealed to cause hepatic reduction in IGF2 
expression (Kitraki, Philippidis and Stylianopoulou, 1992) and similar reductions in
18
IGF2 expression have been found in ovine foetal adrenal glands when maternally 
exposed to either glucocorticoids or ACTH (Lu et al., 1994). These findings are in 
line with a previous proposal that the transient release o f cortisol that usually occurs 
soon after birth might be responsible for the normal decline in IGF II transcription in 
early postnatal life (Dell, Ward, Shokrai, Madej and Engstrom, 1999; Dalle, Pradier 
and Delost, 1985). Therefore, it is possible that early life adversities (such as poor 
nutrition) could produce extensive alterations in the scale or onset o f this 
developmental reprogramming of the endocrine system, with detrimental 
consequences for the organism in later life.
1,4,3 Summary
The endocrine activities o f the IGF and the HPA axis have a central role in 
regulating foetal growth and development. These hormonal systems act as 
maturational and nutritional signals in intrauterine life, and control tissue accretion 
and differentiation in response to the prevailing environmental conditions surrounding 
the foetus (Fowden and Forehead, 2004). In particular, altered glucocorticoids 
secretion as a result o f compromised placental function, is potentially pivotal in foetal 
programming, by altering the bioavailability of key hormones, and the cellular 
expression of receptors, enzymes, ion channels, transporters, and various cytoskeletal 
proteins in the foetal tissue (Fowden and Forehead, 2004). Moreover, glucocorticoids 
can act directly on gene expression and indirectly via other hormonal systems, such as 
the IGF system. The interplay between the IGF and HPA axis is likely to be at the 
nexus in the relationship between the intrauterine environment and later health.
1.5 Towards a new approach investigating the long-term effects of foetal 
programming and IUGR bv nutritional deficiency
In view o f the current evidence, it is evident that a range of environmental 
agents can exert adverse influences upon the early developmental trajectory of the 
CNS, by inducing epigenetic alterations in gene expression that ultimately lead to 
stable and sustained changes in cognitive and behavioural endophenotypes. However 
as noted previously, whereas the developmental programming o f metabolic and 
cardiovascular complications has been well established across different species and
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varying methods of nutritional interventions, the relationship between early foetal 
environment and later psychiatric health is less clear. Indeed, whilst a large number of 
psychiatric complications have been connected with environmental adversities during 
foetal life, previous epidemiological and animal model work has remained 
unsuccessful in dissociating the varying effects o f different environmental factors on 
later cognition and behaviour, or in addressing the marked discrepancies observed 
between findings. Some o f the inconsistencies in these studies could stem from the 
heterogeneity inherent in neuronal development, composition and compensation, both 
across and within species. As such, it is currently difficult to address which of the 
later (adult) psychiatric complications, result specifically from poor intrauterine 
nutrition rather than other environmental agents.
1.5.1 Challenges o f epidemiological studies
Even though much o f the evidence associating foetal-environmental interplay 
with later psychiatric health risk is derived from epidemiological observation, most of 
these studies suffer from serious methodological challenges. The vast majority o f 
human studies have relied exclusively on measurements o f birth weight and relative 
size at gestation as indicators or surrogate markers of foetal growth and/or the 
intrauterine environment. However, the presumption that LBW or being bom SGA 
reflects adverse intrauterine environment or foetal nutritional status, is highly 
questionable. For instance, this approach provides only a transient glimpse of the 
developmental trajectory occurring during foetal life, and neglects the potential 
different growth patterns by which the foetus might have arrived at weight of birth 
(McMillen and Robinson, 2005). Moreover, the overall foetal weight and size at birth 
is an amalgam o f a number o f different environmental influences, and whilst some of 
these might have causal relations with later psychiatric disease risk, other might not 
(Simmons, 2005). In fact, it is likely that many environmental agents acting during 
intrauterine life might exacerbate later disease risk without affecting birth weight. 
More fundamentally, the usage o f birth weight and gestational size as a proxy for 
foetal growth, also fails to take into account individual differences; i.e. the fact that 
some o f the infants may have actually reached their genetic growth potential and are 
merely in the lower end of the normal growth variation, whereas others might have
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undergone foetal undemutrition and growth restriction, but still reached a birth weight 
within the normal range (McMillen and Robinson, 2005).
Another problematic issue raised concerning the interpretation of the effect of 
malnutrition on foetal growth restriction is the fact that maternal calorific and 
macronutrient intake often has relatively little impact on the birth weight of offspring, 
except at the extremes o f food intake (Gillman, 2002). This could suggest that 
maternal nutrition does not necessarily correlate with foetal nutrition, such that the 
allocation of nutritional resources might be temporarily favoured towards foetal 
requirements at the expense o f the mother. In spite of the attempts by studies using 
large famine cohorts to isolate and identify the particular sequelae o f poor intrauterine 
nutrition on later health, it has been acknowledged that there are serious limitations to 
this approach. While these individuals were likely to have been exposed to under­
nutrition during foetal life, it is difficult to rule out that any increased susceptibility to 
later psychiatric risk is in fact specifically due to the under-nutrition rather than other 
environmental factors. A famine exposed population was also likely to have been 
under serious stress, in relation to the famine, war and other accompanying hardships, 
and hence, it is possible that any observed detrimental effects on later adult 
psychiatric health was due to maternal stress rather than solely poor foetal nutrition 
(indeed, there is an abundance o f evidence linking maternal stress with psychiatric 
disorder in later life, see Rice et al., 2010 for review). Moreover, it is also difficult to 
dissociate the effects o f poor nutrition and the ingestion of other toxic substances, 
potentially used as alternative replacements o f food sources (Brown and Susser,
2008).
1,5.2 Challenges o f animal models
To substantiate the human epidemiological studies, extensive research efforts 
have concentrated on establishing animal models of foetal malnutrition and IUGR, as 
discussed in the previous sections of this chapter. Animal models provide better 
control over potential genetic and environmental confounds, improved analysis of the 
outcomes of these manipulations (in terms of pathology, neurology, and 
neurobiology), and the shorter life span o f animals allows for longitudinal studies to 
be accomplished in a much shorter time frame. Thus, placental deficiency has been 
emulated using a number o f different methodologies: uterine artery ligation (Sanders
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et al., 2004; Houdjick, Engelbregt, Poop-Snijders and Delemarre-Vd Waal, 2000), 
uterine and umbilical artery embolism (Louey, Cock and Harding, 2003; Bloomfield, 
van Zijl, Bauer, and Harding, 2002; Block, Schlafer, Wentworth, Kreitzer and 
Nathaniels, 1990), carunclectomy (Butler, Schwartz and McMillen, 2002; Rees et al.,
1998) and hypobaric hypoxia (Llanos, 2002; Gardner, Fletcher, Fowden and Giussani,
2001). These methods of inducing IUGR are very crude in nature, and could have 
severe and nonspecific morphological and physiological consequences, for both the 
foetus and the mother, and may represent the most severe examples of IUGR in the 
human population (e.g. hypoxia at birth).
A large body o f work has also been attempted utilizing more moderate means 
of affecting foetal nutritional status among rodents and sheep, involving underfeeding 
dams (e.g. access to only 50% of normal food intake), and dietary manipulation by 
reduction o f global calorific protein or iron content (Armitage, Khan, Taylor, 
Nathanielsz and Poston, 2004). However, as mentioned previously, much of this 
research has produced inconsistent findings, which may result from factors such as the 
variations in feeding regimens, dietary challenges and differences in the timing and 
duration of the maternal dietary interventions. Perhaps of greater importance is the 
fact that several studies have demonstrated that depriving dams o f regular food intake 
or subjecting them to dietary imbalance has an effect on subsequent care-taking 
behaviour up to weaning which could lead to a range o f problems for the neonates 
when adult. Thus, malnourished mother rats displayed greater amounts of exploratory 
and passive behaviour in the presence o f their offspring during the suckling period 
(Cmic, 1976: Massaro, Levitsky and Barnes, 1974; Smart and Preece, 1973) and also 
demonstrated greater latency in pup retrieval (Cmic, 1976). Moreover, malnourished 
mother rats showed greater care-taking behaviour towards their foetally malnourished 
pups, than did normally fed mother rats (Massaro, Levitsky and Barnes, 2004; Galler 
and Tonkiss, 1991). Mothering style in rats, through the pre-weaning phase has also 
been shown to have profound effects on stress reactivity, measured in terms of 
differential behaviour and altered HPA function and also inherited mothering styles 
(Champagne, 2008; Champagne et al., 2008; Caldji, Diorio and Meaney, 2000). 
Moreover, these variations in maternal caretaking behaviour have also been shown to 
influence the epigenetic status o f hippocampal glucocorticoid receptors, providing 
further evidence for the major effects that alterations in the postnatal environment 
may have on adult behaviour (Weaver et al., 2004).
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1.5.3 Summary
In light o f these findings, it difficult to conclude whether changes in cognitive 
and behavioural performance as an adult, are actually due to in utero nutritional 
deficiency rather than differential postnatal rearing environments (or other dam-pup 
or pup-pup interactions). Despite the range of experimental findings discussed in the 
previous sections relating to the use o f animal models o f poor intrauterine nutrition, 
many o f the criticisms raised against these models have been largely ignored and 
hypotheses based on the results still persist unrefined. Furthermore, with the 
importance placed upon animal work in helping to understand human conditions (a 
key component o f translational research) these limitations highlight the importance of 
the development o f more subtle and less confounded animal models o f nutritional and 
placental deficiency. One effective approach involves producing genetic models o f 
placental deficiency that would enable the circumvention of other environmental 
confounds (i.e. maternal malnutrition, stress and altered care-taking) without 
employing gross physically invasive procedures. The development of such a genetic 
model is among the main purposes of the present thesis.
1.6 Aim of the thesis: utilisation of /g/2-knockout mouse models to investigate the 
effects of placental deficiency and IUGR on brain function and behaviour
The advances in targeted mutagenesis have provided an excellent opportunity 
to investigate the foetal programming effects of placental deficiency on later health 
outcome, for instance by manipulating placental and/or foetal expression o f growth- 
regulating imprinted genes. The development of such models o f placental deficiency 
is highly relevant to simulate conditions o f foetal malnutrition in human pregnancy, 
especially in light of the recent accumulation of data indicative of dysregulated 
placental expression of imprinted genes in cases of IUGR and infants bom SGA 
(Diplas et al., 2009; Apostolidou et al., 2007; McMinn et al., 2006). Furthermore, 
while several studies have adopted knockout (KO) and transgenic mouse models to 
assay the role o f imprinted genes in foetal and placental development (Bressen et al.,
2009), to our knowledge, none of these models have been used to investigate the long­
term consequences o f placental deficiency and/or foetal growth restriction for adult 
disease risk, in the area of brain function and behaviour.
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Therefore, the main objective o f the research described in the present thesis, is 
to employ mouse models where the imprinted gene Igf2 has been deleted and 
investigate the effects of placental deficiency and/or foetal growth restriction, on 
subsequent brain function, cognitition and behaviour in adult animals. Two Ig/2-KO 
mouse models; Ig ft-PO and 7g/2-Null, will be used, which differ in terms of the tissue 
types in which Igf2 expression has been ablated. This differential pattern of 
expression is achieved by specific deletion of one of the four promoter sequences o f 
the Igf2 gene. Thus, in the Igf2-P0 KO model initially described by Constancia and 
colleagues (2002), the single placentally expressed transcript from the PO promoter is 
suppressed, whereas transcripts expressed from the foetal P1-P3 promoters remain 
intact. This results in considerable deficiency in the growth of the placenta (only 76% 
of wild-type placenta weight) throughout mid-late gestation, along with complete lack 
of placental IGF-II and decreased placental permeability. In addition, 7g/2-P0 KO 
foetuses show growth restriction and reach only 78% of wild-type weight at E l9, 
followed by postnatal compensatory growth that is completed by 3 months o f age. On 
the other hand, in the 7g/2-Null KO mouse model where transcripts from all four of 
the Igf2 promoters are disrupted, mice exhibit a more severe restriction in foetal 
growth, 40% of wild-type weight (DeChiara et al, 1990). Although, the placental 
weight is equivalently reduced as with the 7g/2-P0 KO line, the 7g/2-Null KO mice do 
not demonstrate any acceleration in early postnatal growth rate and remain small for 
life. Comparison of the different models will be of interest as the relative demands of 
the foetus and the ability o f the placenta to function normally differ. Thus, the 
placenta o f Igf2-?0 KO mice is o f reduced size, yet the foetus is not affected by the 
gene deletion and therefore has ‘normal’ demands, whereas in the 7g/2-Null KO 
model, although the placenta is smaller than wild-type, the foetus size is proportional 
and hence there is no mismatch in foetal demand and placental capacity (Angiolini et 
al., 2006).
In the present research, the performance of Igf2-KO mice when adult was 
compared to wild-type (WT) littermates on a wide variety o f behavioural tests, as 
outlined in Chapter II. Since much of the previous work in both humans and animal 
models have highlighted the relationship between early life nutrition and anxiogenic 
behaviour in later life, it was of particular interest to examine the Igf2-KO mouse 
models on behavioural tests, sensitive to stress and anxiety-related phenotypes.
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Furthermore, while there have been numerous studies reporting associations between 
low birth weight and ADHD symptoms, there has not been much experimental work 
carried out to investigate the effects o f intrauterine malnutrition on postnatal 
attentional function and impulsivity, in animal models. Therefore, behavioural tests 
developed for examination o f various behavioural aspects of working memory 
function, were also used to investigate the Igf2-KO mice on ADHD-related behaviour. 
Early postnatal growth and somatic indices will be described in Chapter III, along 
with initial behavioural characterization by behavioural batteries o f general locomotor 
activity and stress reactivity. Further assessment of stress reactivity and anxiety- 
related phenotypes between the Igf2-KO mice and WT littermates are discussed in 
Chapter IV, whilst attention-related processes and facets o f behavioural inhibition are 
the subjects o f interest in Chapter V and Chapter VI. Finally, a preliminary molecular 
assay o f some o f the key neural substrates potentially underlying observed differences 
in behavioural phenotypes will be addressed in Chapter VII.
Based on the findings presented in this chapter of significant correlations 
between intrauterine malnutrition, behavioural and cognitive dysfunction and 
neurobio logical changes, it is hypothesised that mice of the Ig/2-KO models (both the 
7g/2-P0 and /g/2-Null lines) will show significant differences in behaviour, cognition 
and neurobiology to WT littermates. Moreover, these effects may be more prevalent 
in the Igf2-?0 KO model, where there is a discrepancy in the foetal demands and 
placental ability to provide nutrition, thus increasing the level o f foetal stress. The 
findings from the current work will provide strong experimental support for the 
existence o f psychiatric sequelae o f foetal programming by placental deficiency 
and/or IUGR, and will shed important light on the discrepancy of past research in the 
field of foetal programming and suggest an alternative means of pursuing this 
important field o f research.
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Chapter II
General Materials and Methods
The purpose of this chapter is to provide descriptions o f the procedures that were 
routinely performed throughout the course of work for this thesis, and illustrations of 
the behavioural apparatus that were employed. All procedures that involved the usage 
o f live animal subjects were carried out in accordance with the requirements of the 
U.K. Animals (Scientific Procedures) Act (1986) and in line with the Home Office 
Project Licence granted to Professor Lawrence Wilkinson (PPL 80/1937). Work was 
carried out under the Home Office Personal License granted to Mikael Allan 
Mikaelsson (PIL: 30/7657).
2.1 Production of the /g/2-knockout mouse models
The 7g/2-Null KO mouse model was produced using embryonic stem (ES) cell 
knockout (KO) technology, previously described by DeChiara, and colleagues (1990). 
In brief, a replacement vector containing two selectable markers; the bacterial 
neomycin-resistance gene (neo) and the herpes simplex virus (HSV) thymidine kinase 
gene (tk), was used in order to target the Igf2 gene. These markers enabled the 
application o f a positive-negative selection protocol, using drugs G418 and 
gancyclovir (GANC), which identifies DNA recipient cells whilst reducing the 
background o f random integrants. This resulted in a significant enrichment for 
targeted clones (homologous recombinants). The targeting procedures involved 
isolating a phage X clone carrying the mouse Igf2 gene, but the fragments o f the 
cloned Igf2 gene and the transcriptionally competent neo and tk cassettes, were then 
used for the construction o f the replacement vector. The neo cassette, replacing 0.25 
kilobases (kb) o f Igf2 gene sequence in the region o f the first coding exon (E2), was 
flanked by 1.6 and 8.3 kb of murine Igf2 locus DNA, in terms o f 5 ’ and 3 ’ 
respectively. On the other hand, the tk cassette was attached at the 3 ’ end of the 8.3-kb 
fragment. Next, the linearized replacement vector DNA was introduced into recipient 
CCE ES cells by electroporation, the cell were seeded and selected on feeder layers o f 
STO fibroblasts, and the CCE.33 cells were injected into host blastocysts obtained
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from the mouse strain C57B1/6, and implanted in pseudo-pregnant 129 female mice
to produce founder mice.
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Figure 2.1: Characterization o f  the Igf2-Null mutation, as indicated by restricion 
maps o f  the WT and targeted mouse Igf2-Null alleles. (A) The position o f  five exons 
(E1.1-E4; black boxes) o f  the WT Igf 2 gene. PI and P2 are promoters from which the 
alternate 5 ' noncoding exons El. 1 and E l.2 are initiated (arrows). The position o f  the 
initiation codon (ATG), termination codon (TGA), and major polyadenylation signal 
(pA) are shown. (B) The regon o f  E2 exon represented in the E2 riboprobe is 
indicated, along with enlargement o f  the cassette segment. In the targeted gene, in 
which only the Igf2 PI promoter seems to be active, a neo cassette (J.15kb) has 
replaced exon E2 and about 0.1 kb o f the downstream intron (total o f  0.25kb). The 
cassette segment, consists o f  the coding region o f  the neo gene (stippled box) and 
regulatory sequences (open box). The latter are a mutant polyoma enhancer and the 
heipes simplex vim tk promoter that are unable to initiate transcription (crossed-out 
arrow) o f  a 9kb RNA when presented in the mutated gene. Also displayed is the 
position of the two neo riboprobes. Figure obtained from DeChiara et al., 1990.
The Igf2-PO KO model was derived by using 3.0-kb, 4.9-kb and 2.6-kb BamHl 
genomic fragments derived from the Igf2 locus o f mouse strain 129/Sv origin as 
regions o f homology, in order to generate a Cre-loxP targeting vector (Constacia et 
al., 2000). Briefly, the loxP site o f  the targeting vector, was inserted 5 ’ o f exon U2, 
whereas a loxP-flanked HS\-tk -neox cassette was inserted 3 ' o f the DMR1 region. 
The targeting vector was linearized at a unique Xho\ site outside the area o f homology 
and introduced into l-2x l07 CGR8.8 cells with a Gene Pulser at 500/zF and 230V. 
Transfected cells were plated on gelatinized dishes pre-seeded with mitomycin-treated 
STO feeder cells. Following a 24 hour period, positive selection was performed in the 
presence o f G418, and resistant clones were drawn and expanded into plates 
containing mitomycin-treated feeder cells. The neor cassette was removed by 
transiently transfecting Cre recombinase in DMR1-U2 neor cell lines with pMC-Cre. 
Finally, the DMR1-U2 neor cells were injected into host blastocyst o f the mosue strain
27
C57B1/6, and implanted in pseudo-pregnant 129 female mice to generate founder
mice.
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Figure 2.2: Characterization o f  the Igf2-P0 mutation, as displayed by the genomic 
structure o f  the Igf 2 gene in both WT's and KO alleles. The peptide coding region is 
in exon 4-6 (E4-E6, open boxes). (A) Promoters PI-P3 are transcribed in foetal and 
extraembrvonic tissues. The PO transcript is placenta-specific. All transcripts are 
spliced onto exon 4. leading to the same peptide. (B) A 5 kb BamHl genomic fragment 
was replaced by a loxP site in the PO KO allele. The deletion, which spans exon u2 
and abolishes PO transcription is 1.5kb and 2.1 kb distant from PO and PI 
transcription sites, respectively. Figure obtained from Constdncia et al., 2002.
u1 LoxP
2.2 Subjects and animal husbandry
The founder mice o f the Igf2-PO and /g/2-Null deletion lines were originally 
generated using the methodology described above (section 2.1), at the Laboratory o f 
Development and Genomic Imprinting at the Babraham Institute, Cambridge, U.K.. 
Once the subjects were certified free from all common rodent pathogens, eight male 
subjects (at three to five months o f age) were transported to the Behavioural 
Neuroscience laboratory o f  the School o f Psychology, at Cardiff University. The 
mutant alleles in both lines were transmitted paternally by a heterozygous background 
strain o f  C57BL/6*129, and the breeding stock was established by crossing the 
C57BL/6*129 male subjects carrying the Igf2 deletions, with CD1 female mice, 
resulting in offspring that were either heterozygous (/g/2-P0 or/g/2-Null KO) or wild- 
type (WT). Since the maternal allele o f the Igf2 locus is silenced due to imprinting 
regulation, it is the mutation transmitted along the paternal line that causes disruption 
in expression o f the active paternal allele, thus the imprinted Igf2 gene is expressed 
from neither paternal line (Constancia et al., 2005). Throughout this thesis, KO mice
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that lack Igf2 expression from the Igf2-PO only promoter are termed Igf2-PO KO mice, 
whereas KO mice which had Igf2 expression abolished from all four promoters are 
referred as Igf2-Null KO mice. In addition, these mice are collectively termed Igf2- 
KO mice. WT littermates from the two different lines are refered to as WT-PO and 
WT-Null mice, respectively (or collectively WT controls).
Mice were group housed (2-5 mice per cage) in environmentally enriched 
cages (i.e. with cardboard tubes, shred-mats, tissue paper) in a temperature and 
humidity controlled animal holding room (21 ± 2°C and 50 ± 10%, respectively) with 
a 12-hour light-dark cycle (lights on at 07:00 hours/lights off at 19:00 hours). Only 
subjects o f the same mutant line were housed together, but each home cage included 
at least one of each genotype (i.e. KO and WT mouse). Standard rodent laboratory 
chow and water were available at libitum unless otherwise stated. Home cages were 
cleaned and changed once a week, at approximately same time of the day and on the 
same day o f the week, in order to cause minimal disruption to the behavioural testing. 
Only male mice were tested in the present research. Experimental animals were 
regularly monitored and weighed from birth for signs o f ill health. Any mice showing 
signs o f illness were immediately assessed by a Veterinarian and, if necessary, 
withdrawn from the experiment. Sentinel mice housed in the same environment as the 
experimental cohorts were, at intervals, assessed for evidence of variety of bacterial, 
viral and helminthic pathogens using the service at Surrey Diagnostics, U.K., and 
were always found to be uninfected (Table 2.1).
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Viruses Cases Parasites Cases
Minute virus o f mice 0/1 Intestinal protozoa 0/1
Mouse hepatitis 0/1 Intestinal helminths 0/1
Pneumonia virus o f  mice 0/1 Athropods 0/1
Reovirus type III 0/1 Bacteria
Mouse encephalomyelitis 
virus
0/1 Bordet ella bronchiaseptica 0/1
Sendai virus 0/1 Campylobacter spp. 0/1
Epizootic diarrhoea o f infant 
mice
0/1 Citrobacter rodentium 0/1
Mouse parvovirus 0/1 Clostridium piliforme 0/1
Mouse norovirus 0/1 Corynebacterium kutscheri 0/1
Lymphocytic 
choriomeningitis virus
0/1 Helicobacter spp. 0/1
Hantaan virus 0/1 Helobacter hepaticus 0/1
Ectromelia virus 0/1 Helicobacter bilis 0/1
Mouse cytomegalovirus 0/1 Helicobacter rodentium 0/1
Mouse adenovirus 1 0/1 Mycoplasma pulmonis 0/1
Mouse adenovirus 2 0/1 Pasteurellacae spp. 0/1
Polyoma virus 0/1 Salmonella spp. 0/1
K virus 0/1 Strectobacillus moniliformis 0/1
Streptococcus pneumoniae 0/1
B-haemolytic Streptococci 0/1
Yersinia spp. 0/1
2.3 Standard PCR protocol
Mice were genotyped from DNA extracted from tail biopsies.
2.3.1 Tail lysis
A tail biopsy was collected from each mouse following weaning, at 
approximately four weeks o f  age. The collected tissue samples were placed in a 1.5ml 
micro-centrifuge tubes and were digested in 400/d o f lysis buffer (0.2% SDS, 50mM 
Tris: HC1 pH=8.0, lOmM EDTA, lOOmM NaCl) along with 2/d o f Proteinase K 
(Qiagen, Crawley, U.K.) with final concentration o f 0.2mg/ml, at 55°C overnight.
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2.3.2 DNA extraction
The 1.5ml micro-centrifuge tubes containing the digested tails were shaken 
briefly and spun in a centrifuge at 13,000rpm for 10 minutes to sediment debris, and 
the supernatant subsequently transferred into new micro-centrifuge tubes. Next, an 
equal volume of cold isopropanol (i.e. 400/d) was added to the obtained supernatant 
and left on ice for 20 minutes to facilitate DNA precipitation. The 1.5ml centrifuge 
tubes containing the supernatant were spun in a centrifuged again at 13,000rpm for 10 
minutes, following which the supernatant was discarded and the tubes from the 
centrifuge left upside-down on a paper towel for 30 minutes in order to allow the 
isopropanol to evaporate. A volume of 150pl of TE buffer, comprising lOmM of Tris 
(tris(hydroxymethyl)aminomethane) and lmM of EDTA (ethylenediaminetetra-acetic 
acid) (brought to pH+8 with HC1 to down-regulate the activity o f nucleases), was 
added to stabilize and protect the dissolving DNA from degradation. Only 1/xl volume 
o f the DNA sample was required for the polymerase chain reaction (PCR).
2.3.3 PCR for genotyping
To determine the genotype o f Igf2-PO KO mice, two separate PCR reactions 
were performed to identify the targeted PO (i.e. the HSV-tk-neor cassette) and WT-PO 
(i.e. the PO promoter) forms o f Igf2. Reaction mixtures were produced as per the 
protocol described in Table 2.2. The primer sequences for the Ig/2-PO gene promoter 
were obtained from Constancia et al. (2000) and are listed in Table 2.3. The reactions 
were run in a Peltier Thermal Cycler (MJ Research, U.K.), using the programme 
described in Table 2.2. Once the reaction had finished 6/ri o f 6x DNA loading buffer 
was added to each reaction and a total of 15/xl of the reaction/loading buffer mixture 
was loaded on a 1% agarose gel. Finally, 5/il o f DNA ladder (Hyperladder IV, 
Bio line, U.K.) was loaded at both sides next to the reaction samples, and the gel 
subsequently run at 100V for 60 minutes, in order to allow the DNA to separate. 
Amplicons were visualized using a UV scanner. Identification of Igf2-?0 KO mice 
was accomplished by comparison o f the resultant amplicons from each reaction. Thus, 
only Igf2-P0 KO mice will show an amplicon from reaction 1 (band at 740bp) as this 
PCR specifically identified the modification in Igf2 that caused the P0 promoter to be 
ablated whereas all mice (KO and WT) will show an amplicon from reaction 2 (band 
at 495bp). Sincer there were noticeable (and obvious) size differences at birth,
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between the growth retarded Tg/2-Null KO mice and their WT-littermates, no PCR 
reaction were required for the identification o f genotype, among mice o f the /g/2-Null 
KO line.
Mutant Igf2-PO allele WT Igf2-PO allele Program-cycle
14.6 pi of nuclease-free H2O 14.6 pi o f nuclease-free H20 1. 95°C for 15min
2.5 pi of dNTPs 
(2mM, Invitrogen, U.K.)
2.5 pi o f dNTPs 
(2mM, Invitrogen, U.K.) 2. 95°C for 30sec
2.5 pi o f lOx Taq buffer 
(Qia?en, U.K.)
2.5 pi o f lOx Taq buffer 
(Qiagen, U.K.) 3. 62.2°C for 30sec
2 pi o f MgCl2 solution (25mM) 2 pi o f MgCl2 solution (25mM) 4. 72°C for 50sec
1 pi o f primer WT forward (lOpM) 1 pi of primer WT forward (lOpM) 5. Goto step 2; 35 times
1 pi o f primer Zg/2-PO reverse 
j^lOjiM) 1 pi o f primer WT reverse (lOpM) 6 .4°C forever
1 pi o f genomic DNA 1 pi o f genomic DNA 7. End
0.4 pi o f Taq Polymerase buffer 
(Qiagen, U.K.)
0.4 pi o f Taq Polymerase buffer 
(Qiagen, U.K.)
25 ul 25 pi
Primers Primer sequence Genotype detection
WT Forward 5’-TCCTGTACCTCCT AACT ACC AC-3 ’ WT IIgf2-P0
WT Reverse 5’-CAATCTGCTCCTGCCTG-3’ WT
Igf2-P0 Reverse 5’-G AGCC AGAAGC AAACT-3 ’ Igf2-P0
2.4 Habituation to handling, test environment and procedures
2.4.1 Handling
Following weaning, at approximately four weeks of age, the mice were 
allowed to acclimatize to their new environment for at least a two week period, before 
being handled daily for two weeks (approximately 1 minute per subject per day). 
Body weight measurements were instigated during this initial handling regime.
2.4.2 Measurement o f body weight
Body weights o f all mice were recorded on a regular basis as an index o f 
general health. Weights were registered at the same time o f each day over two week 
period prior to behavioural testing (at around 17:00 hours, to coincide with the end o f
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the experimental sessions). However, during the period of behavioural testing, body 
weight measurements were reduced to a twice a week schedule.
2.4.3 Behavioural testing environment
Behavioural testing was carried out in custom-built sealed and air-conditioned 
testing rooms. Testing rooms were lit by fluorescent lights which could be dimmed to 
varying degrees. Although temperature and humidity levels were not strictly 
controlled as in the holding rooms, these parameters were generally maintained at 
around 21 ± 2°C and 50 ± 10% respectively. Rooms were thoroughly cleaned once a 
week.
2.4.4 Protocol for the water restriction schedule
Prior to testing in behavioural paradigms where liquid food reward was used 
as a reinforcer, subjects were placed on a schedule of reduced home cage water access 
(in order to enhance motivation for the reinforcer), comprising 4-hour access to water 
per day for four days, followed by 2-hour water access per day thereafter throughout 
the duration of the testing (with schedule placed at the same time each day). 
Importantly, subjects losing >20% o f their ad libitum body weight or showing clinical 
symptoms of dehydration were immediately given ad libitum water access until 
normal ad libitum body weight was reestablished. Subjects were allowed ad libitum 
access to standard laboratory chow, throughout the duration of the water deprivation 
schedule. Furthermore, in an effort to ensure the general health o f the test subjects 
was not being compromised by the water restriction schedule, general health and body 
weight was monitored on a regular basis. Any mice showing signs of dehydration, 
malnutrition or illness were immediately reported to the unit named animal care 
welfare officer (NACWO) and, if necessary, to the veterinarian.
2.4.5 Reinforcer preference test
Once the body weight o f mice had stabilized following regulated water 
consumption (generally after 10 days), subjects undergoing appetitively motivated 
behavioural tasks (i.e. 5-choice serial reaction time task and Stop-signal serial reaction 
time task), were habituated to the reinforcer (10% condensed milk solution, Nestle
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Ltd, U.K.). Briefly, the reinforcer preference test was carried out in a number of 
holding cages (285 x 130 x 120mm) with a single subject per cage, during a single 10- 
minute session per day, across a six-day period. During the first two sessions, subjects 
were allowed to habituate to the test apparatus, while general water consumption was 
measured by placing two containers (max vol.= 3ml each) containing an excess o f tap 
water o f registered weight, to the rear o f each cage. Following each test session, the 
containers were re-weighed in order to determine the total water consumption.
Over the next four sessions, one of the containers was filled with the 
condensed milk reinforcer, whereas the second container was filled with tap water. 
The locations o f the two containers within the cage were pseudo-randomly switched 
between days. As before, the containers were weighed prior to, and immediately after 
testing, in order to determine the consumption of each liquid (and thus, the total daily 
consumption), as well as the daily preference for the condensed milk. However, 
reinforcer preference was defined as the amount of reinforcer consumed in the final 
session of reinforcer preference testing, as a percentage of the total amount of liquid 
(i.e. the reinforcer and water collectively) consumed during that session. Moreover, 
the data on total volume o f liquid consumed was normalized for body weight 
differences using Kleiber’s 0.75 mass exponent (Schmidt-Nielsen, 1990).
2.4.6 Examining behavioural phenotypes: experimental control measures
In order to ensure further consistency in data collection and to avoid 
influences o f potential confounding variables, a number of precautionary measures 
were employed to provide greater experimental control. For instance, behavioural 
testing always coincided with the light phase o f the light-dark cycle o f the animal 
holding room (i.e. between 07:00 hours and 19:00 hours), and water access was 
provided immediately subsequent to any behavioural assessment. Moreover, in order 
to maintain a constant time period between the time of testing and water access 
(which might affect motivation for the liquid reinforcer), and also to minimize any 
behavioural variation due to temporal location of behavioural examination, where 
possible, individual subjects were tested at the same time each day. In addition, 
possible ‘order o f experimental run’ effects were negated by running the Igf2-KO 
mice and the WT-littermate controls in a pseudo-random order. To minimize possible
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confounds related to cage/litters, the experimental subjects were drawn from as large 
number of cages/litters as available (minimum of 10 litters/cages). Further to these 
measures, the data were routinely screened for any such effects. However, no data 
from the experiments reported in current thesis displayed any signs of systematic 
variations which could be attributed to the aforementioned factors.
2.4.7 The collective WT-control group: pooling o f WT-littermates from different 
mutant lines
Marked differences were noted across control groups of WT littermates from 
the two separate control lines, in terms o f body size, weight and somatic development 
(these data will be further elaborated upon in Chapter III). While these physical 
differences between the two WT-control groups is likely to stem from varying access 
in early postnatal nutrition (i.e. WT-Null controls potentially gain greater access to the 
maternal milk prior to weaning due to the significantly smaller body size of the Igf2- 
Null KO mice), it is uncertain whether these two groups of WT-littermate controls are 
equivalent in terms of cognitive/behavioural functions, and if not, which o f the two 
groups of WT littermates provides a more reliable or valid baseline. Therefore, it was 
decided to pool the two WT-littermate groups together into a collective WT-control 
group. This might be particularly important since postnatal environmental factors (not 
o f interest to the purpose o f present study) such as postnatal nutrition or abnormal 
behaviour o f KO littermates, might suppress potential differences between 
intrauterine growth retarded (IUGR) subjects and nonlUGR subjects due to placental 
insufficiency. In addition, pooling the WT-littermate groups together enables a more 
meaningful interpretation o f the data, as well as improves the sensitivity o f the 
analyses of variance; by increasing the n (i.e. sample size) o f the control group and 
reducing the number of group-comparison required.
However, pooling o f WT littermates into a single control group also 
introduces potential experimental confounds. For instance, the heterogeneity between 
the two groups of WT littermates per se imposes a serious issue of the legitimacy of 
pooling together WT littermates of different mutant lines into a single control group. 
Also, if mice from either group of WT littermates are abnormal due to some postnatal 
environmental factors, the mice of that control group might induce a behavioural
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difference between Igf2-KO mice and WT controls, which is not due to placental 
insufficiency induced IUGR. In an effort to address these issues, each analyses o f 
between-genotype comparison was followed-up by an independent T-test analysis 
and/or a repeated measures analysis on segregated WT-control groups (in order to 
exclude the possibility o f genotype-related interactions), and any significant 
difference revealed between subjects o f different group of genotype was further 
probed by a within-mutant line comparison (i.e. Igf2-?0 KO against WT-PO, and Igf2- 
Null KO against WT-Null). Results from each analysis o f every experiment can be 
found in the appendices o f the thesis and are cited when required.
2.5 Behavioural apparatus
The current section describes the experimental apparatus employed in this 
thesis. However, the experimental procedures in relation to the apparatus are 
described in the subsequent chapters.
2.5.1 Locomotor activity chambers
Testing o f  locomotor activity (LMA) was carried 
out in an apparatus consisting o f eight clear 
Perspex chambers (each 210 x 360 x 200mm, 
width x length x height), with embedded two 
infra-red beams crossing each cage 30mm from 
each end and 10mm from the floor o f the 
chamber. Beam breaks were recorded as an 
index o f  activity, using a computer running 
custom written BBC Basic V6 programmes with 
additional interfacing by ARACHNID 
(Cambridge Cognition Ltd, Cambridge, U.K.). 
Data were stored as the total number o f beam- 
breaks from each session, as well as the number 
o f beam-breaks made over a 5-min time-blocks 
(as used in Humby, Laird, Davies and 
Wilkinson, 1999).___________________________
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2.5.2 The Rota rod
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The Rotarod (Ugo, Basile, Italy) apparatus 
consisted o f a rotating bar (25mm diameter) and 
under the control o f a system device that allowed 
for altered rotational speed. The rotational speed 
could be set in two modes: accelerated (5- 
50rpm) over a 5-min period, or held fixed at any 
speed (between 5-50rpm). The bar was divided 
into five segments, enabling testing o f a single 
mouse within each o f the segments. A lever 
beneath each segment o f the bar was raised, 
initiating a timer. When a mouse fell from the 
bar, the lever was depressed, and the timer 
automatically stopped (as used in Carter et al.,
1999). Thus, the latency in second and the 
rotational speed (rpm) at fall could be recorded.
2.5.3 Startle chamber
The startle chamber apparatus consisted o f a 
ventilated and soundproofed SR-LAB startle 
chamber (San Diego Instruments, CA, USA) 
containing a non-restrictive Plexiglas cylinder 
(35mm in diameter) mounted, onto which a 
single mouse was placed. The Plexiglas cylinder 
was mounded on a Perspex plinth with a pressure 
sensitive piezoelectric accelerometer unit 
attached below the Plexiglas cylinder. The motor 
response o f  a subject to a white noise stimuli 
(generated from a speaker 120mm above the 
cylinder) were recorded via the piezoelectric 
accelerometer which converted flexion plinth 
vibration into electrical signals Responses were 
monitored for 50msec following the onset of the 
stimulus. A session consisted o f  exposure to 36 
acoustic stimuli, presented with a 10-sec random 
interval, against a background noise o f  70dB. 
Stimuli were presented at 120dB within each 
sessions; 4 no stimuli, 12 x pulse-alone, and 5 at 
each 2, 4, 8, 16dB prepulse amplitude. The 
duration o f each prepulse and pulse stimuli was 
0.3sec, with a 0.7-sec gap in between (as used in 
Davies et al., 2005)._________________________
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2.5.4 Elevated plus maze
The plus maze was constructed o f dulled black 
Perspex and consisted of two exposed open arms 
(175 x 78mm, length x width) and two enclosed 
arms (190 x 80 x 150mm, length x width x 
height) with an open roof. Equivalent arms were 
arranged opposite one another. The plus maze 
was positioned 300mm above the floor and 
illuminated evenly at 15 lux (mixture o f low 
level white and red light), as used in Davies et 
al., 2005.
*
The open field apparatus consisted o f a square­
shaped arena (750 x 750 mm, length x width), 
constructed o f white plastic and illuminated 
evenly at 15 lux; mixture o f low level white and 
red light (as used in Davies et al., 2005)
1 inner-square (200 x 200mm)
2 middle-square (400 x 400mm)
3 peripheral region (100mm, width)
compartments constructed o f either white or 
black Perspex (each o f 300 x 300 x 300mm, 
width x length x height). The two compartments, 
separated by a wall, were connected by a small 
square opening o f 70 x 70mm. Coarse grained 
sandpaper was placed pseudo-randomly on the 
floor on one o f the compartments to enhance 
tactile discriminability between the two 
compartments (as used in Plagge et al., 2005).
38
2.5.7 Apparatus for the 5-choice serial reaction time task (5-CSRTT) ami the Stop-signal 
serial reaction time task (SSRTT)
Behavioural analysis was performed in 9-aperture operant chambers based upon a design 
developed for use in rats and modified for use in mice in collaboration with Cambridge 
Cognition Ltd., U.K. In short, these chambers consisted o f a food magazine and an array o f 
9 apertures (10mm diameter) set into the opposite curved wall (at a distance o f 130mm). 
The magazine housed a small well in its base (to which reinforcer was delivered via a 
peristaltic pump in 0.8mm silicone tubing) and a 2.5Watt tray light. The magazine could be 
accessed from the main chamber through a clear Perspex panel hinged at the top; the raising 
o f this panel was recorded via micro-switch. Behind each aperture was a 2.5Watt light, 
which brightness could be altered through a series o f resistors, and the entrance to each 
aperture was spanned by a vertical infra-red beam. For the 5-CSRTT settings, four o f the 
nine apertures were covered with opaque plastic film (apertures 2, 4, 6 and 8 as counted 
from the left), whereas only apertures 2 and 7 were uncovered for the SSRTT settings. 
Moreover, two loudspeakers, two 2.5Watt house lights and two infra-red LEDs were set 
into the side walls o f  the chamber; the latter provided background illumination o f the 
chambers and facilitated viewing o f the mice in the chambers via an infra-red camera 
(Watac WM6, Tracksys Ltd., U.K.) located 100mm above the chamber. Each chamber was 
enclosed within a soundproofed wooden box fitted with a fan to provide adequate 
ventilation and a constant level o f background noise. Testing chambers were interfaced 
with an Acorn RISC-PC running custom written BBC BASIC V6 programmes via the 
ARACHNID system and 9-aperture box interface panels (Cambridge Cognition Ltd., U.K.), 
as described in Humby, Wilkinson and Dawson, 2005.
1 4 0 m m
1 response array (9 apertures, 10mm diameter, spanned by vertical infra-red beams and 
each containing a small light), 2 food magazine (containing tray light and food well) 
accessed via a hinged panel, 3 silicone tubing, 4 peristaltic pump, 5 reinforcer reservoir 
(10% condensed milk solution), 6 house light and 7 loudspeakers. Note that in the right 
hand photograph, four o f the nine response apertures are blocked (2, 4, 6 and 8 as counted 
from the left), as in the 5-CSRTT settings.
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2.6 Culling protocol
At the end of the experiment, or in case of illness/injury, subjects were culled 
through cervical dislocation.
2.7 Brain dissection
Cerebral tissue used for neurochemical analyses was collected from 
behaviourally naive mice (aged 6-8  months) and was dissected immediately following 
removal. Dissection was performed with a razor blade (single blade per brain) on 
metal plates pre-cooled with wet ice under the plates, as this protocol limited 
neurochemical and structural degradation during dissection, and facilitated the 
dissecting procedure by making the tissue more amenable to cutting. In order to 
ensure consistency o f dissection across animals, a standardized dissection procedure 
was employed. Thus, six brain regions were dissected from the left hemisphere of the 
brain (right hemisphere was frozen intact). These regions were the following; 
olfactory bulb, the prefrontal cortex, the striatum, hypothalamus, hippocampus, 
amygdala and cerebellum (see Figure 2.3). Although the protocol was based on 
estimation o f a brain of 11mm in length (excluding the olfactory bulbs), appropriate 
adaptations to the procedure were made accordingly for brains deviating from this 
standard.
The measurements detailed below represent distances from the anterior end o f 
the brain (excluding the olfactory bulbs). Initially, the olfactory bulbs were removed 
from the intact brain by dissecting off vertically at the nexus o f the olfactory bulbs 
and the frontal cortex. Next, the striatum, including the medial and orbitofrontal 
cortices, was dissected from a coronal slice (0.5-1.25mm, in thickness), just anterior 
to the forceps minor corpus callosum. The prefrontal dissection included the 
following structures; cingulate cortex, prelimbic cortex, infralimbic cortex, orbital 
cortex and agranular insular cortex. The striatal dissection was obtained from a 
coronal slice (2-3mm), where the anterior commisure and the lateral ventricles were 
used as landmarks. The striatum dissection included the caudate putamen, and nucleus 
accumbens. The amygdala was dissected from a coronal section (4.5-5.5mm), and was 
defined as the triangular-shaped region bordered by the corpus callosum. Hence, this 
dissection consisted of the basolateral and lateral amygdala nuclei.
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(Bregma 2.46mm)
2. S triatum  
(Bregma 1.14mm)
3. Am ygdala 
(Bregma -1.70mm)
4. H ippocam pus
(Bregma -3.28mm)
5. Cerebellum  
(Bregma -6.12mm)
6 . O lfactory bulb
7. H ypothalam us
Figure 2.3: A schematic view o f  the key cerebral regions dissected fo r  future use in 
present research. Regions 1-5 are displayed from a coronal view, whereas regions 6-7 
are viewed from a sagittal perspective The brain atlas pictures were obtained from: 
http: htvu'. Brain maps. org.
The hippocampal dissection was made from a coronal section (6-7mm), and 
obtained with relative ease due to the distinct formation o f the hippocampus, although 
care was taken to ensure that overlying cortical tissue was removed. The hippocampal 
structure consisted o f both ventral and dorsal regions. Similarly, the whole cerebellum 
was also easily removed due to the external location and ease o f identification. 
Finally, the dissected cerebral tissue was frozen on dry ice, placed into a sterile 
container and stored at -80°C for future analysis.
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2.8 Real-time aPCR methods
2.8.1 Preparation o f brain homogenates for real- time qPCR analysis
The isolation o f good quality total RNA is of paramount importance in order 
to produce high quality data of gene expression. All usual precautionary measures 
were taken to prevent degradation and/or contamination o f the RNA samples, i.e. 
tissue samples kept at -80°C immediately following dissections, and using RNA-ffee 
working surfaces and consumables.
2.8.2 Isolation o f total RNA: Trizol method
Cerebral tissue (only hippocampus, striatum and hypothalamus were processed 
for the current research, see Chapter VIII) from extracted brains was weighed using a 
microbalance, and transferred to lysing matrix tubes (FastPrep-24, MB Biomedicals, 
U.S.) containing 0.5ml o f Trizol (Tri Reagent from Sigma-Aldrich, U.K.) per gram of 
tissue. Next, the lysing matrix tubes containing the tissue/Trizol were shaken for 15, 
and then 10 seconds, and homogenised at 4°C in a FastPrep FP120 micro- 
homogenizer (MB Biomedicals, U.S.). Subsequently, the supernatant was removed 
from the matrix tubes and discarded, and 0 .2ml of chloroform was added for each 1ml 
of Trizol (added previously). Again, the tubes were shaken for 15 seconds and then 
incubated at room temperature for 2-3 minutes. The mixture was then spun in a 
centrifuge at 4000rpm at 4°C for 15 minutes, and supernatant (containing the RNA) 
was transferred to a fresh screw cap polypropylene centrifuge tube. A volume of 
0.5ml of isopropanol was next added per 1ml of Trizol, and samples were then 
incubated at room temperature for 10 minutes. The mixture was then spun in a 
centrifuge at 4000rpm at 4°C for 10 minutes, forming a gelatinous pellet, after which 
the supernatant was removed and discarded. Subsequently, the RNA pellet was 
washed in 1ml o f 75% ethanol per 1ml of Trizol in the intial preparation, vortexed and 
spun in a centrifuge at 4000rpm at 2-8°C for five minutes. The RNA pellet was next 
allowed to dry for approximately 45 minutes and then resuspended in an appropriate 
volume of DEPC-treated MilliQ water. Finally, the samples were incubated at 55°C 
for approximately 20  minutes to ensure total re-suspension.
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2.8.3 Quantification o f the RNA sample
A spectrophotometer (NanoDrop® ND-1000 UV-Vis, Wilmington, DE) was 
used to quantify the amount of RNA in each sample, by measurements o f UV 
absorption. Since RNA absorbs maximally at 260nm, the ratio of absorbance at 
260nm and 280nm (protein) was used to assay the RNA purity of a given RNA 
preparation. Pure RNA has an A260/A280 ratio of 2.1. For nucleic acid 
quantification, the Beer-Lambert equation is manipulated to give:
A x ec = ------
b
Where c is the nucleic acid concentration in ng/microlitre, A is the absorbance in AU 
(for the arbitrary absorbance units), e is the wavelength-dependent extinction 
coefficient in ng-cm/microliter and b is the path length in cm. For the nucleic acid, 
data is normalised to a 1 cm path. The generally accepted extinction coefficient for 
RNA is 40.
The spectrophotometer enabled highly accurate analyses of particularly small 
samples. Surface tension was used to hold a column o f liquid sample in place while a 
measurement was made. A small quantity o f the sample (1-2 /d) was pipetted directly 
onto a measurement pedestal, and a measurement column was then drawn between the 
ends of two optical fibres in order to establish a measurement path. The measurement 
was generally carried out within 10 seconds, while the spectrum and the analyses 
were displayed on a screen and archived, of an attached PC computer. Once a 
measurement was completed, the sample was wiped from the measurement pedestals.
2.8.4 RNeasy purification o f extracted total RNA
The RNeasy Mini Kit for RNA clean-up (Qiagen, UK) was used to purify the 
extracted RNA (binding capacity 100 fig) according to the manufacturer’s 
instructions. The total RNA sample was adjusted to 100/d with RNase free water, and 
300/d of RLT buffer was added to the sample and mixed well. Subsequently, 250/d of 
absolute ethanol was added to the RNA/RLT solution and mixed thoroughly, and then 
700/i 1 o f the sample was applied to an RNeasy mini-spin column membrane sitting in 
a collection tube. The sample was then spun in a centrifuge for 15 seconds at 
10,000 rpm, applied over to a mini-spin column membrane of the collection tube, and 
spun again for 15 seconds at 10,000rpm. Once, the RNA had been transferred into a
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new collection tube, 500/d o f buffer RPE was added and the solution then spun in a 
centrifuge for 15 seconds at 10,000rpm to wash. The same volume of buffer RPE was 
added onto the column membrane again (once the remaining buffer RPE had been 
discarded), and then spun in a centrifuge for two minutes at 13,000rpm to dry the 
RNeasy membrane. Next, the RNA spin column was placed in a new 2ml collection 
tube and spun in a centrifuge for one minute. The column was then transferred into a 
new 1.5 collection tube and 20/d of RNase-ffee water was pipetted directly onto the 
membrane and allowed to stand for one minute, after which it was spun in a 
centrifuge for a minute at 10,000rpm. This step was repeated but with only 10/d of 
RNase-ffee water this time. RNA was eluted in a total volume o f 30/d nuclease-free 
water and again was quantified by absorbance using the Nano Drop® ND-1000 UV- 
Vis Spectrophotometer machine.
2.8.5 cDNA synthesis
The synthesis o f first-strand cDNA from the toteil extracted RNA was carried 
out using Sprint™ RT Complete Products Kit (Clontech, Mountain View, U.S) in 
accordance with the accompanying Poly-dT protocol, based on the methods of 
Ausulbel et al. (1995). The extracted (and purified) total RNA in RNase-ffee water, 
was adjusted to obtain 2.5/ig o f total RNA in a final volume of 20/d, based upon the 
previous determination o f total RNA concentration. Next, the total RNA/H2O samples 
were pipetted into individual wells of the Sprint RT complete product and mixed 
thoroughly by pipetting up and down. The wells containing the RNA/H2O reactions 
were then incubated at 42°C for 60 minutes. Finally the reactions were terminated by 
heating at 70°C for 10 minutes, thus ending the synthesis of cDNA from the RNA 
reactions.
2.8.6 Quantitative PCR primer sets
The primer sets used for the real-time quantitative PCR analysis, were 
designed using customised software provided by the Babraham Institute 
Bioinformatic department, o f the Babraham Institute, Cambridge, UK. Each of the 
primer sets was designed across intron-exon boundaries, thus eliminating signals from 
contaminating genomic DNA along with the working concentrations that were 
optimised to minimise the possibility o f primer-dimer formation (Table 2.4).
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Gene Printer Primer sequence Concentration
5HT-1A Forward 5’-GACGGTCAAGAAGGTGG AAA-3’ 700nM
Reverse 5’-CACTGCGCCTGCAGTCCC-3’ 700nM
5HT-2A Forward 5 ’-GGTTTCCTTGTC AT GCCCG-3 ’ 300nM
Reverse 5’-G ACGCCGT GG AG AAG AGC-3 ’ 300nM
5HT-2C
(long) Forward 5’-CATCATGAAGATTGCCATCGTT-3’ 700nM
Reverse 5 ’-CGC AGGT AGT ATT ATTC ACG AAC ACT-3 ’ 700nM
5HT-2C
(short)) Forward 5’-ATCGCTGGACCGGAGTTTC-3* 300nM
Reverse 5’-GGGTCATTGAGC ACGC AGG-3 ’ 50nM
Gaha-(x2 Forward 5’-AGTCAGGTTGGTGCTGGCTAA-3’ 300nM
Reverse 5 ’-CCG ATT ATC AT AACC ATCC AG AAGT-3 ’ 300nM
Gaba-ctf Forward 5’-CTTCTTCAACTCCAACAGCGATT-3’ 700nM
Reverse 5’-TGTTGTAGGTCTTGGTCTCAGCA-3’ 700nM
18S Forward 5’-GT AACCCGTTG AACCCC ATT-3 ’ 300nM
18S Reverse 5’-CC ATCC AATCGGT AGT AGCG-3’ 300nM
Optimisation o f the primer sets was performed by combining different 
dilutions o f the forward primer with varying dilutions o f the appropriate reverse 
partner. Furthermore, every combination was assessed in two kinds o f reactions; the 
real-time PCR reaction using a test cDNA sample and the non-template control 
reactions (NTC). Since the NTC reactions did not contain any DNA sample, any false 
amplification signal could only originate from primer dimers. The obtained Ct values 
(see section 2.8.8 below) o f  the NTC reactions were compared to the Ct values 
obtained in the DNA-containing PCR reactions with the same primer combinations 
and those showing the greatest difference between the NTC sample and the DNA 
sample were deemed as the most optimal combination o f primer pairs for future work 
(see Table 2.4).
2.8.7 Real-time quantitative PCR
The study o f gene expression was performed using a Rotorgene 6000 RT-PCR 
machine (Corbett Research, UK), while the consumables used in the experiments 
were provided by Corbett Research and Bioline, UK. The reactions were set up in 
accordance with the protocol listed in Table 2.5, where the purpose o f stage six and 
seven in the programme is to obtain “melting curve” data, which enabled confirmation
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that only a single type o f amplicon was produced, and that no primer dimerization had 
occurred.
Reactions Program
1.4 pi of H20 1. 95°C for 10’
7.5 SensiMix 2X 2. 57°C for 0:15
0.3 Syber (50X) 3. 72 °C for 0:20
Forward primer 4. Goto Step 1; 40 times
Reverse primer 5. Ramp from 72°C to 95°C rising 1°C each step (melting curve analysis)
10 pi ofcDNA (1/10) 6. Wait for 90” o f pre-melt conditioning on first step and for 5” for each step afterwards.
7. End
21 pi
2.8.8 Real-time qPCR analysis: the 2~MCt method
Since gene expression was compared between mutant mice and their WT- 
littermate controls, a relative quantification method was selected as the appropriate 
method o f analysing the data (see Simon, 2003). Therefore, the 2‘AACt method was 
used to calculate relative changes in gene expression determined from each real-time 
quantitative PCR experiment. Derivation o f the 2'AACt equation, including 
assumptions, experimental design and validation tests have been previously described 
by Livak and Schmittgen (2001).
2.8.8.1 Selection o f  internal control
In the present study, the RNA samples were derived from dissected cerebral 
tissue o f  Igf2-P0 KO mice and their relative WT-littermate controls (see section 2.7). 
However, due to the fact that samples (i.e. the cerebral tissues) varied in size, false 
expression data could be produced by the varying concentration o f extracted RNA (or 
the converted cDNA) from each subject. Therefore, in order to normalise the qPCR 
reactions for the amount o f RNA added to the reverse transcription reaction, an 
internal gene (otherwise known as a house-keeping gene) was required to establish a 
control. Importantly, the expression of the house-keeping gene needs to be abundant 
and unaffected by genetic abnormalities or chemical treatments (Thellin et al., 1999).
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For these reasons, the 18S gene (rRNA) was selected as suitable control for the real­
time qPCR analysis (see Thellin et al., 1999).
2.8.8.2 Data analysis using the 2'AACt method
The change in expression o f the target gene, after normalization to the house­
keeping 18S rRNA, was assayed in two groups of samples; eight Igf2-PO mutants and 
eight wild-type controls. Real-time qPCR was performed on each of the 16 samples of 
cDNA, with each sample run in triplicates (in effort to minimise sampling errors). The 
Ct values (defined by the number o f cycles required for the fluorescence to cross the 
threshold, i.e. exceeding the background level) obtained from the Rotorgene 6000 RT- 
PCR software were imported into Microsoft Excel, which enabled descriptive analysis 
o f the data, and conversion to 2'AACt for subsequent analysis (see VanGuilder, Vrana 
and Freeman, 2008). The Ct values for the 18S and the target gene mRNAs were 
averaged across the triplicates for each sample, prior to performance o f the ACt 
calculation. The ACt value was calculated by subtracting average Ct values o f the 
target genes from the average Ct values o f the 18S (i.e. the control sample). Next, the 
subtraction o f the ACt values of the control samples from the ACt values of the target 
gene samples, yielded the AACt values. The negative values of this subtractions, the - 
AACt values, were then used as the exponent of 2, and represented in “corrected” 
number of cycles to threshold (see VanGuilder et al., 2008, Livak and Schmittgen, 
2001 and Chapter VII for further details), but the exponent conversion is based on the 
fact that the reaction doubles the amount of product per cycle. These values were then 
combined with the values o f relative change in the expression o f the target gene 
between the comparison groups and presented as a graph.
2.8.8.3 Statistical analysis o f  the real-time qPCR data
The final stage of the real-time qPCR analysis was to determine the threshold 
cycle or the Ct value. The Ct value was derived from a log-linear plot o f the PCR 
signal against the cycle number, which depicts the Ct value as an exponential instead 
o f a linear term. Hence, the data was converted to a linear form using 2~ACt 
(transformed data). In order to examine the statistical significance of the relative 
change, independent T-tests were performed on the transformed data.
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2.9 General data presentation and statistical methods
The data were presented as mean values ± standard error of the mean (SEM), 
calculated from the following formula;
Standard error of the mean = standard deviation of values
V number of values
All statistical analyses were carried out using SPSS 16.0 for windows (LEAD 
Technologies Inc., Apache Software Foundation, U.S.). The data were screened for 
skewed variance, kurtosis and outliers (<2.5 standard deviation) prior to statistical 
analysis, and logarithmic (by power o f 10) or arcsine transformations were applied on 
skewed data (percentage data in particular) in an effort to assure normal distribution. 
The data were analysed by either, one-sample, independent sample or paired sample 
Student’s T-test, one-way analysis o f variance (ANOVA) or repeated measures 
analysis o f variance (ANOVA), where appropriate. Post hoc pairwise comparisons 
were performed using Tukey’s HSD test, with alpha values of <0.05 regarded as 
significant. Furthermore, a one-way Kruskal-Wallis test was conducted on the data 
(Monte Carlo exact test o f 0.99% confidence level, used as it is more appropriate for 
larger sample sizes), if or when assumptions o f normality or homogeneity (Levene’s 
test) of variance were violated. Any significance in mean difference noted by the 
Kruskal-Wallis test was followed up by a Mann-Whitney test and a Bonferroni 
correction, for a post hoc comparison. Greenhouse-Geisser degrees o f freedom (df) 
corrections were applied as necessary to repeated-measures factors in relevant 
ANOVAs (nominal values for the relevant degrees o f freedom are reported), and 
Wilcoxon signed-rank test was applied as a nonparametric substitute for the repeated 
measures analysis where or if required. Moreover, in terms o f the gene expression 
data described in Chapter VII, a Benjamini Hochberg false discovery rate correction 
testing (Benjamini and Hochberg, 1995) was used to adjust p-values for false 
positives, due to multiple testing. See individual chapters for further details.
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Chapter III
Initial Developmental Characterization and Behavioural 
Phenotyping of Mice from the Igf2-P0 and Igf2-Null Knock­
out Lines
3.1 Introduction
The Igf2 gene which spans 30 kb, and comprises nine exons and four promoter 
regions (designated P0-P3, O’Dell and Day, 1998) was one of the first genes shown to 
be imprinted (DeChiara et a l, 1990). Igf2 lies on the distal region o f mouse 
chromosome 7 (corresponding to 1 lp l5 in humans, IGF2) and encodes the 67 amino 
acid monomeric plasma protein IGF-II (displays 47% animo acid sequence homology 
to insulin), which is known to play a key role in both foetal and placental 
development (Constancia et al., 2002; DeChiara et al., 1990, and Chapter I, section
1.4.1 for further details). Igf2 promotes growth via paracrine and/or autocrine actions, 
which stimulate cell proliferation, differentiation and survival (O’Dell and Day, 
1998). Expression of Igf2 becomes most widespread in foetal and placental tissue 
during mid to late gestation, and is more abundant than Igfl gene expression, in both 
rodents and humans (Fowden, 2003). In fact, plasma concentrations of IGF-II are 3-10 
fold higher than those of IGF-I during late gestation, but expression of Igf2 declines 
dramatically following birth, and in rodents the IGF-II content disappears from most 
tissues except the brain (i.e. choroid plexus, leptomeninges and potentially in the 
developing retina) by weaning (Chao and D’Amore, 2008). As a consequence, IGF-II 
is almost abolished in adult plasma. However, IGF2 expression is apparent during 
adulthood in humans, with transcripts deriving from an adult-specific promoter (de 
Pagter-Holthuizen et al., 1987).
As mentioned previously in Chapter I (section 1.6), there are several different 
transcripts o f the Igf2 gene in the mouse, expressed from the Igf2 promoters P0-P3, 
each encoding the mature IGF-II polypeptide (Constancia et al., 2005). The promoters 
P1-P3 are expressed in mesodermal, endodermal, extraembryonic tissues, whereas the 
P0 promoter is solely expressed in the labyrinthine trophoblast cell-layers o f the 
placenta (Constancia et al., 2002). Two mouse models have been generated using 
deletion o f cell-type specific promoters to separately evaluate the roles o f Igf2 in
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foetal and placental development. In mice where the labyrinthine trophoblast-specific 
Igf2-PO transcript is exclusively abated (i.e. the Igf2-PO KO model), there is a marked 
reduction in placental Igf2 mRNA, although the foetal circulation o f IGF-II is 
unaltered. In the Igf2-?Q knockout (KO) mice, overall placental weight is also reduced 
compared to wild-type (WT) from embryonic (E) day 12; however this reduction 
occurs across all placental layers proportionately, suggesting that IGF-II dependent 
growth of the labyrinthine exchange surface may regulate growth of the placenta as a 
whole (Constancia et al., 2005). Nevertheless, foetal growth in the mice remains at a 
normal growth rate until E l6 , but declines subsequently and results in intrauterine 
growth restriction (IUGR), indexed by a birth weight of average 78% that o f WT 
littermates (Constancia et al., 2002). The passive permeability of the placenta of Igf2- 
P0 KO mice is also reduced at E l9, due to decreased labyrinthine surface area and 
increased thickness of the exchange barrier.
In comparison, complete ablation of Igf2 transcripts from all four foetal and 
placental promoters (P0-P3) induced in the 7g/2-Null KO mouse model, results in 
concurrent foetal and placental growth deficiency around mid gestation (Baker et al., 
1993). Although the reduction in placental weight o f the 7g/2-Null mutant placenta is 
equivalent to that o f 7g/2-P0 up to E l4, the placenta growth restriction becomes 
subsequently more severe, and at E l6 and E l9 the 7g/2-Null KO placenta is 14-24% 
lighter in weight in comparison to Igf2-?0 placentas (Constancia et al., 2005). Hence, 
it is likely that foetal-placental expression of Igf2 from the P1-P3 promoters might be 
more involved in regulating placental growth after E l4. In a similar vein, the foetal 
growth deficiency is also far more severe among Tg/2-Null KO mice than in Igf2-?0 
KO mouse model that continue to express Ig p  in their foetal tissue, at only 
approximately 60% of WT weight at birth (DeChiara et al., 1990).
In recent years, there has been a considerable amount of research carried out 
on the function o f the Igf2 gene in foetal and placental development, particularly in 
terms o f the regulatory involvement o f lgf2 in the balance between the placental 
nutrient supply via the System A amino acid transporter, and the endocrine signalling 
of foetal nutrient requirements (Dilworth et al., 2010; Constancia et al., 2008 and 
2005). In contrast, to date there has not been any data published on the long-term 
cognitive and behavioural consequences, when this key matemal/supply- 
foetal/demand interplay is compromised by attenuated Igf2 expression. That is to say, 
there has not been any published effort made to examine emotional, cognitive, and
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other behavioural functioning o f mice from either Igf2 KO lines. Furthermore, while 
much work has focused on both foetal and placental characterization of the 7g/2-P0- 
and 7g/2-Null KO mice during intrauterine life, and basic growth pattern during early 
postnatal life, no detailed assessments have been made on the development o f early 
somatic morphology or long-term growth into adulthood. Therefore, the main 
objectives o f the present chapter were twofold; firstly, to examine the effects o f 
placental deficiency and foetal growth restriction on early body growth and 
somatic/neurological development among Igf2-KO mice relative to WT-littermate 
controls, and secondly to conduct a preliminary characterization o f the Igf2 KO mice, 
in terms o f basic motoric, sensory and emotional aspects of behaviour.
To address the first question, body weight was recorded at birth and monitored 
on alternate days across the first 100  days o f postnatal life, along with several somatic 
measurements. The somatic indices o f early postnatal development were registered, 
included the unfolding o f the ear pinna, incisor eruption, eye opening, and fur growth. 
To address the second question, behavioural analyses were carried out across a 
number of test batteries. Basic locomotion was assayed using locomotor activity 
(LMA) chambers equipped with infrared motion-detectors, whilst rotarod apparatus 
was employed to further examine locomotor ability, along with motor learning, 
balance, and motor coordination. An assessment of emotional reactivity of the mice 
was carried out with a simple responsive test to a novel foodstuff and the response and 
habituation to acoustic stimuli that induce a startle response (Li, Du, Li, Wu and Wu, 
2009). In combination with this latter assessment, prepulse inhibition (PPI), where 
the presence of a moderate stimulus prior to an exacerbated startle inducing stimulus 
attenuates the overall response to the startle stimulus will also be measured. The 
startle-PPI paradigm provides a valuable index of sensory-motor gating and reflex 
which have frequently been reported to be impaired in neuropsychological disorders 
such as; schizophrenia (Geyer, Krebs-Thomson and Swerdlov, 2001), attention deficit 
hyperactivity disorder (ADHD, Feifel, Minassian and Perry, 2008) and anxiety 
disorders (Duley, Hillman, Coombes and Janelle, 2007). The findings from this initial 
series o f experiments will provide a developmental and behavioural profile o f mice 
from both Igf2 KO lines (i.e. the Igf2-?0 and 7g/2-Null KO) and at the same time 
indicate any potential experimental confounds for future behavioural studies.
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3.2 Materials and Methods
Full methodological descriptions can be found in the relevant sub-sections o f 
the General Methods Chapter (Chapter II).
3.2.1 Subjects and animal husbandry
A subset o f mice from the total litter cohort, consisting o f mice from the Igf2- 
PO and Zg/2-Null KO lines, and WT-littermate controls (WT-PO and WT-Null mice), 
were weighed and examined on several measures of somatic development during the 
early days o f postnatal life (see Table 3.1). Behavioural testing was also carried out on 
a subset o f mice, at the age o f 3-6 months. The sample size (n) for each subset o f mice 
that were examined on somatic indices and individual behavioural tests is listed in 
Table 3.1. General housing, handling and behavioural testing conditions have been 
detailed previously in Chapter II, section 2.1.
Table 3.1: The sample size and genotype o f  each cohort-subset o f  mice assayed on 
measurements o f  somatic development. and behavioural tests.
I___________ Genotype and sample size (;i)___________ I
o c i i a v i u u i  u i
Apparatus
W eight/developmental
measurements 40 20
78
(39/39)
Locomotor activity 17 8 32(18/14)
Rotarod 19 9 37(19/18)
Acoustic startle and 
pre-pulse inhibition 21 15
48
(37/11)
Reactivity to novel 
food-substance 36 20
67
(37/30)
3.2.2 Physiological measures
3.2.2.1 Assessment o f  birth weight and somatic indices o f  development
Body weight was registered on the day o f birth, and subsequently monitored 
every alternate day for the first 100 days o f postnatal life. The somatic indices o f 
development were systematically examined by visual inspection on a daily basis until 
weaning, and consisted o f the following parameters; the day o f  ear opening (the
unfolding o f the ear pinna in both ears), incisor eruption (eruption o f the upper 
incisors), fur growth (the appearance of complete coat of dark hair, including the 
abdomen) and bilateral eye opening (visible break in eye lids and membranes 
covering the eyes).
3.2.3 Behavioural measures
3.2.3.1 Locomotor performance
Spontaneous locomotor activity was tested in a battery of eight clear Perspex 
chambers, each of 210 x 360 x 200mm (see Chapter II, section 2.5.1 for further 
details), each equipped with two infrared sensors projecting across each cage at 30mm 
from each end and 10mm from the cage floor. The total number of beam-breaks made 
within a five-minute period (block) was recorded for a two hour session (thus total o f 
24 blocks), using a computer running custom written BBC BASIC V6 programmes 
with additional interfacing by ARACHNID. Short range movements o f the subjects 
were registered as the total number o f infrared beam-breaks, whereas runs through the 
entire chamber were indicated by successive beam-breaks at the opposite end o f the 
chambers. Cages were thoroughly cleaned with 2% acetic acid between subjects. All 
animals were run in the dark between the hours 08:00 and 17:00 on three consecutive 
days in order to assess reactivity to novelty (indexed by the any change in 
performance upon repeated exposure to the test apparatus), with each animal run at a 
similar time on each day.
3.2.3.2 Balance and motor coordination
Mice were tested on the Rotarod apparatus (as previously described in Chapter 
II, section 2.5.2) in order to provide a more sensitive assessment of various aspects of 
motor function, such as; motor learning, balance and coordination. Subjects were 
tested on the rotarod across five consecutive trials, during which subjects were placed 
on the rotating rod of the apparatus which steadily accelerated in velocity from 5- 
50rpm throughout the entire session. The latency of subjects to fall from the rod was 
registered by the automatic system, as well as the velocity level o f the rod-rotation at 
the time of fall. Each trial lasted for maximum of 4 minutes. An inter-trial interval o f 
at least 30 minutes was provided to allow for recuperation. Following five consecutive 
trials, the performance of subjects on the rotarod apparatus was tested further over
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two trials o f 60 seconds each (with a 2 -minute inter-trial interval) where the rotarod 
velocity was fixed at 35 and 45rpm. This further assessed balance and motor 
coordination while controlling for possible differences in stamina. The values for the 
five training sessions, latency to fall and rotational speed were averaged to produce 
single scores for each subject. Similarly, the latencies to fall for each of the sessions in 
the fixed configuration were also averaged together.
3.2.3.3 Acoustic startle and prepulse inhibition
In order to assay the integrity o f sensory-motor circuitry, sensory-motor gating 
and gross auditory capability, mice were tested for acoustic startle and prepulse 
inhibition (PPI, see Chapter II, section 2.3.3 for apparatus description). Subjects were 
acclimatised to the startle chamber over a five minute period prior to testing, with a 
background white noise o f 70dB. Subsequently, mice were subjected to three pulses 
o f white noise at 120dB, followed by five blocks of six trials; each block consisting of 
two pulse-alone trials (120dB), and four trials in which a prepulse of 0.3 seconds 
duration was presented (pulse + prepulse trial) 0.7 seconds prior to the onset of the 
startle stimulus (one of each pre-pulse volume level of 2, 4, 8 or 16dB above 
background, presented pseudo-randomly). Additionally, four consecutive readings 
were taken without a stimulus presentation in order to account for movement 
unrelated to the startle response.
The data were corrected for locomotion in the absence of a stimulus by 
deduction of the average startle response at the four no-pulse trials from each pulse- 
alone or pulse+prepulse trial. Furthermore, as the response to a startle pulse was 
determined by the piezoelectric effect of the flexion at the base o f the animal 
enclosure, all startle responses were normalised to body weight using Kleiber’s 0.75 
mass exponent (Schmidt-Nielsen, 1990). The startle responses to pulse-alone trials 
were calculated by averaging the responses to stimuli presentations 3-12, whilst the 
first two presentations were analyzed separately to provide measures o f the stimulus 
response to a novel stimulus. The four presentations o f each pulse+prepulse trials 
combination (at 2, 4, 8, 16dB prepulse amplitude above background) were averaged 
together and the following calculation was used to determine the prepulse inhibition 
(PPI):
54
% prepulse inhibition = 100 x (pulse-alone trial -  pulse+prepulse trial)
(pulse-alone trial)
3.2.3.4 Assessment o f reactivity to a novelfoodstuff
The reactivity to a novel foodstuff was assessed in mice following a period of 
24-hour water restriction as described previously (see Chapter II, section 2.4.4), using 
a 10% condensed milk solution. The test o f food neophobia (a choice between water 
and the 10% condensed milk solution) was carried out within the reinforcer 
preference/habituation testing, which was implemented prior to conditioned 
behavioural paradigms. Moreover, the liquid consumption data were adjusted for 
body weight differences, using Kleiber’s 0.75 mass exponent. Further details o f this 
procedure are described in Chapter II, section 2.4.5.
3.2.4 Statistical analysis
The data were subjected to either one-way analysis of variance (ANOVA) for 
a genotype (between-subject) comparison o f performance for the entire experimental 
session, or a two-way repeated measures ANOVA to examine the effect of genotype 
on either performance o f subjects across time (i.e. experimental blocks or days) or 
between different levels o f the behavioural tests (such as concentration levels o f 
natural rewards during preference tests), as well as possible interactions. Any 
interactions observed, were followed-up by an additional one-way ANOVA or 
repeated measures ANOVA between the individual levels of the within-subject factor, 
if or where required. Finally, data from the separate WT-lines were pooled together 
for analysis in order to increase the statistical power and for reasons mentioned 
previously (in Chapter II, section 2.4.7). However, every analysis o f physiological and 
behavioural parameters was carried out separately by T-test between the WT-P0 and 
WT-Null mice, to ensure behavioural homogeneity between the WT-lines. The results 
o f these analyses are presented in Appendix I.
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3.3 Results
3.3.1 Physiological results
3.3.1.1 Neonatal health
The genotype o f all mice was determined by standard PCR analysis (see 
Chapter II, section 2.3), along with registered birth weight. All o f the subjects were 
monitored continuously throughout the duration o f their lives for general health and 
wellbeing, by researchers and animal technicians. No indications o f observable health 
problems were noticed in the Igf2-PO and /g/2-Null gene KO mice. There were some 
incidents o f neonatal mortality in the earliest days o f postnatal life following birth (i.e. 
first 1 -3 days), but these cases were few. Furthermore, since the Igf2 gene mutation is 
inherited to offspring in a Mendelian manner, it is likely that the notably fewer births 
o f /g/2-Null KO mice relative to their WT littermates reflect intrauterine mortality and 
re-absorption (although this may also have occurred in few cases with the Igf2-PO KO 
mice). In addition, it is possible that maternal cannablisation o f the smalles pubs could 
also occurred in some cases.
Mutation line Ig/2-PO line Igf2-Null line
Genotype KO WT KO WT
Number of 
births 58 65 30 56
All o f the mice displayed some degree of stress when initially handled, such 
as; vocalisation, faecal deposition and urination, although there was no discernible 
difference between the genotypes with regard to these behaviours. Moreover, the 
majority o f mice became accustomed to handling after few days and did not exhibit 
any further observable signs o f distress. No obvious difference in habituation to 
handling was observed across genotypes.
3.3.1.2 Early postnatal body weight and somatic indices o f  development
Mice o f both Igf2-KO lines had significantly lower birth weights, than the 
WT-littermate controls (one-way ANOVA; F2,i35= 147.76, p< 0.001). The/g/2-P0 KO 
mice exhibited a -25%  reduction in birth weight relative to that o f WT controls (post
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hoc test; Fi,n6= 91.78, p< 0.001), whereas the 7g/2-Null KO mice were growth 
restricted by -45% (post hoc test; Fi,96= 265.40, p< 0.001). The notable difference in 
growth retardation between the Igf2-KO mice were also found to be statistically 
significant (post hoc test; Fi,58= 65.72, p< 0.001). The overall growth rate across the 
first 100 days o f postnatal life, was in addition, found to be greater among mice o f the 
Igf2-KO lines than o f WT controls (Figure 3.1 A, onew-way ANOVA; F2,i35= 18.45, 
p< 0.001). Dividing the first 100 days o f growth into four equal phases for further 
analysis, showed that Igfi-PO KO mice underwent a period of accelerated weight gain 
relative to WT controls and 7g/2-Null KO mice, between postnatal days 25-50 (Figure 
3.IB, between-subject test; Fi,i35= 10.07, p< 0.001, post hoc tests; Fij 16=19.74, p< 
0.001). However, a repeated measures comparison between days 51-75 and 76-100 
showed no difference in growth rate between 7g/2-P0 KO and the other groups of 
mice (Fi,i35= 0.13, n.s.). In comparison, the 7g/2-Null mice only displayed a 
significant growth spurt during the first 25 days of postnatal life (Figure 3.IB, 
between-subject effect; F2,i35= 6.65, p< 0.001, post hoc test; Fi,96= 13.19,/?= 0.001), 
following which growth rate was equivalent to that of WT controls (repeated 
measures analysis; Fi,96= 3.39, n.s.).
By postnatal day 100, the body weight of 7g/2-P0 KO mice was still 
significantly reduced in comparison to WT controls (one-way ANOVA; F 1,135= 
182.63, p< 0.001, post hoc test: F ij 16=21.08, p< 0.001), but this difference reflected 
only a -7%  reduction compared to the -25% difference at birth, suggesting a 
significant period of accelerated catch-up growth. The body weight of the 7g/2-Null 
KO mice was still markedly lower than WT controls (post hoc test: Fi,96== 365.07, p< 
0.001), a reduction o f -38%, comparable to the -45% difference at birth, suggesting 
an absence o f catch-up growth during these first 100 days of life. Body weights from 
older mice (-400 days old) showed similar proportions of weight differences between 
the genotype groups (data not shown).
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Figure 3,1: Body weight over first 100 days of postnatal life. (A) Growth curves o f  
early body weight over the first 100 days o f postnatal life across mice o f  different 
genotypes. (B) Curves o f  early growth rate, in terms o f  percentage body weight 
increase, over first 100 days o f  postnatal life, across mice o f  different genotypes . Data 
are presented as mean values along with SEM. __ _____ __
*Period o f  heightened growth rate in Igf2-P0 KO mice, significant at p<0.05.
To gauge a measure o f early somatic developmental, four physiological 
parameters were examined (Figure 3.2). No differences were noted for any o f these 
somatic indices between the lgf2-P0 KO mice and the WT controls (ear opening (one­
way ANOVA): F2,i35= 57.23, p< 0.001, post hoc test: Fi,n6= 0.15, n.s., incisor 
eruption: F2,i35= 26.80, p< 0.001, post hoc test: Fi,n6= 0.26, n.s., fur growth: F2,i35= 
24.04, p< 0.001, post hoc test: F i.iup 2.93, n.s., and eye opening: F2,i35= 10.28, p< 
0.001, post hoc test: Fifn6= 1.15, n.s.). However, the Zg/2-Null KO mice showed a 
significant delay in indices o f  early postnatal development o f between 1-2 days, on all 
four o f the somatic parameters (Figure 3.2); ear opening: F2,i35= 57.23, p< 0.001, 
incisor eruption: F2,i35= 26.80, p< 0.001, fur growth: F2,i35= 24.04, p< 0.001, and eye 
opening: F2,i35= 10.30,/?< 0.001.
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Wild-type littermates 
Igf2-P0 KO 
Igf2-Null KO
E a r  In c iso r F u r E ye
o p e n in g  e ru p tio n  g row th  o p e n in g
Figure 3.2: Development o f  a number o f  somatic indices 
across mice o f  different genotypes. Data are presented as 
mean values along with SEM.
*Significant at p  <0.05.
Analysis o f early postnatal body weight, growth rate and somatic development 
was performed on the separate groups o f the WT-littermate controls (i.e. WT-PO and 
WT-Null controls, see Appendices 1.1 and 1.2). Although, body weight was found to 
be equivalent between the WT-PO littermate controls and the WT-Null controls at 
birth, the WT-Null controls were found to have a notably higher body weight, by that 
o f -7% , at postnatal day 100 (WT-PO (g): 39.35 ± 0.37, WT-Null: 42.40 ± 0.45). 
Thus, a differential postnatal growth pattern was noted over the first 100 days o f life 
between the two WT-control groups where the WT-control mice o f the 7g/2-P0 
mutant line showed an elevated growth rate between postnatal days 25-50 and the 
WT-Null control littermates displayed greater postnatal weight gain during the first 25 
days o f  postnatal life (see Appendix 1.1). Due to these differences between the WT 
littermates o f  different control lines, it was important to carry out separate 
comparisons between the mice o f each o f the 7g/2-KO lines with WT littermates from 
their own mutant line (see Table 3.2). However, these separate analyses did not 
reduce the pattern o f effects reported previously; indeed they showed that Igf2-P0 KO 
mice achieved full catch-up to their WT controls and enhanced the difference reported 
for the Igf2 KO mice. A one-way ANOVA, involving separate WT-littermate control 
group comparison, reported that both Igf2-?0 and Tg/2-Null KO mice had significantly
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lower birth weight relative to their own littermate-controls ^ 3,134= 100.12, p< 0 .001 ; 
post hoc tests: F ij7= 57.28, p< 0.001 and Fi,57= 240.99, p< 0.001, respectfully), 
however only the /g/2-Null KO mice were found to lower body weight at postnatal 
day 100 relative to their comparative WT littermates (approximately 40% lower 
weight, F3,i34= 145.20, p< 0.001; post hoc test: Fi,57= 416.47, p< 0.001). Therefore, 
these findings show that the Igf2-P0 KO mice demonstrated a full compensatory 
growth in relations to their own WT-littermate controls, as the body weights between 
the two groups o f mice were not found to be significantly different postnatal day 100 
(post hoc test: F ij7= 4.00, n.s.).
M utation line l£f2- P0 line /g/2-Null line
Genotype KO WT KO WT
Birth weight 
<B>
1.60 ±0.07 2.08 ± 0.02 0.96 ± 0.03 2.17 ±0.04
Weigt at day
1 0 0 (g) 38.00 ±0.54 39.35 ±0.37 25.40 ± 0.86 42.39 ± 0.45
Furthermore, a separate analysis o f somatic development between the two 
WT-control groups, revealed a significant delay in ear opening and incisor eruption 
among the littermates o f the WT-Null control group, relative to the WT-PO control 
groups (see Appendix 1.2). In addition, similar results to the between-genotype 
comparison described previously were obtained when the Igft-KO  mice were 
individually compared to their own WT-littermate controls, thus Igf2-?0 KO mice did 
not differ from their WT controls as before (ear unfolding: F ij7= 0.72, n.s.; incisor 
eruption: Fi,77= 0.99, n.s.; fur growth: F ij7= 2.17, n.s.; eye opening: Fi,77= 0.13, n.s., 
respectfully). However, the Tg/2-Null KO mice showed greater latency in the 
unfolding o f  ear pinna (/g/2-Null KO: 5.80 ±0.14 day, WT-Null: 4.23 ±0 .12  day, 
post hoc test: Fi,58= 72.13,p< 0.001), incisor eruption (/g/2-Null KO: 9.90 ± 0.26 day, 
WT-Null: 8.18 ± 0.17 day, Fi,58= 27.93, p< 0.001), fur growth (/g/2-Null KO: 10.40 
± 0.23 day, WT-Null: 8.36 ± 0 .1 7  day, Fi,58= 39.62, p< 0.001) and bilateral eye 
opening (7g/2-Null KO (day): 16.40 ± 0.23 day, WT-Null: 14.92 ± 0.22 day, Fi,58= 
9 .95 , p< 0 .01) relative to their own littermate-controls.
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3.3.2 Behavioural results
3.3.2.1 Locomotor performance
Locomotor activity performance was assessed with repeated measures analysis 
over three days, with separate 2-hour sessions each day. Igf2-PO KO mice and the WT 
controls exhibited equivalent levels o f  locomotion throughout each session (between- 
subject test: Fi,47= 3.17,/?< 0.05, post hoc test: Fit38), although the level o f  locomotion 
was highest during the first session, but declined over the subsequent sessions (within- 
subject effect; ¥2 2 = 10., p< 0 .001) as the mice acclimatised to the activity chambers. 
In addition, ambulation was also noted be greatest at the beginning o f each session but 
steadily reduced throughout the session blocks (see figure 3.3, Session 1 (within- 
subject test): F7,403= 50.05, p< 0.001, Session 2: Fn,6io= 23.23, p< 0.001, Session 3: 
F1 o,566= 14.53, p< 0.001). In contrast, mice o f the/g/2-Null KO line showed an overall 
reduction in locomotion across all three sessions in comparison to WT controls 
(Figure 3.4A, repeated-measures analysis (between-subject test): post hoc test: Fi^8= 
5.79,p< 0.05).
•  WT-littermates 
Igf2-P0 KO 
Igf2-Null KO
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Figure 3.3: Performance on LMA within a session. The number o f  beam-breaks 
made across blocks (5-min duration) throughout the first session, between mice o f  
different genotypes. Data are presented as mean values along with SEM.
The number o f consecutive beam-breaks at opposite ends o f the chamber 
(termed runs) did not differ between genotype (Figure 3.4B, F2,54= 2.16, n.s.) and was 
accordingly greatest during the first session but readily reduced subsequently across
the next sessions (Session 1: F9,488= 56.75, p< 0.001; Session 2: F9,487= 33.68, p< 
0.001; Session 3: F9,506= 22.90, p< 0.001, respectively). An analysis o f locomotor 
activity performance was carried out between the WT-control lines, and the results 
summarised in Appendix 1.3. No difference was found between the WT-PO mice and 
WT-Null control mice on either total beam-breaks or runs, across sessions.
WT -littermates 
Igf2-P0 KO 
Igf2-Null KO
1s* session 2nd session 3rd session 1st session 2nd session 3rd session
Figure 3.4: Performance on LMA across experimental sessions. (A) The number o f  
beam-breaks made across the three daily sessions, between mice o f  different genotypes. 
(B) The number o f  two consecutive beam-break made at opposite ends (runs), across 
the three daily session, between mice o f  different genotypes. Data are presented as 
mean values along with SEM.
*Significant at p  <0.05.
3.3.2.2 Balance and motor control
Mice were given five trials on the rotarod (5-50rpm in 4mins), where subjects 
o f each genotype groups displayed a relatively high degree o f motor competence. All 
subjects showed improved performance on the rotarod test across the five sessions as 
reflected by increased latency to fall from the rotating bar (Figure 3.5A, within- 
subject test; F4^n=  28.40, p< 0.001) and heightened rotation-speed at the time o f fall 
(Figure 3.5B, within-subject test; F3^ h= 25.33,p< 0.001). No significant difference in 
performance was found between the Igf2-?0 KO mice and WT-control littermates 
(post hoc test (see ANOVA result below); Fi,54= 1.07, n.s. and Fj,54= 1.13, n.s), for 
latency and rotational speed, respectively). However, mice o f the /g/2-Null KO line 
exhibited a greater latency on average to fall from the rod across all five sessions 
(between-subject test; F2,62= 3.60, p< 0.05), although a post hoc comparison only 
found this to be significant relative to the Igf2-P0 KO mice (Fi^7= 7.14, p< 0.05). 
Accordingly, the 7g/2-Null KO mice were also shown to fall from the rod at greater
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rotation velocities on average (between-subject effect; F2,62= 3.81, p< 0.05, post hoc 
test; Fi<27= 4.79, p< 0.05), but again this was only significant when compared to KO 
mice o f the lgf2-P0 line.
WT-littefmates 
IgO-PO KO 
IgC-Null KO
T ria ls T  ria ls
Figure 3.5: Performance on the rotarod across five trials with over increasing rotation 
velocity. (A) The latency of subjects from different groups o f  genotype, to fa ll o f  the rod 
over the five consecutive trials. (B) The velocity level o f  rod rotation at the time o f  fa ll 
over the five consecutive trials, across mice o f  different genotypes. Data are presented 
as mean values along with SEM.
Conversely, there were no differences revealed between the different groups o f 
mice when subjects were assessed exclusively with one-way ANOVA, either at a 
rotation velocity o f 35rpm (Figure 3.6A, F2,62= 1 47, n.s.) or at 45rpm (Figure 3.6B, 
F2,62= 2.30, n.s.). Furthermore, a repeated measures analysis o f rotarod performance 
between the separate WT-control lines showed that WT-controls o f the Igf2-P0 line 
stayed on the rod for a longer period o f time than WT-Null control mice, before 
falling (see Appendix 1.4 for summary o f results). Similarly, the WT-PO controls fell 
from the rod at a significantly greater rotation velocity, than the control mice o f the 
7g/2-Null line. However, this was perhaps not surprising considering the increased 
body weight and size o f the WT-Null control mice.
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Figure 3.6: Performance on the rotarod across at fixed rotation velocity. (A) The 
latency o f  subjects from  different groups o f  genotype, to fa ll o f  the rod at a rotation 
velocity? level o f  35 rpm. (B) The latency of subjects from different groups o f  genotype, 
to fa ll o f  the rod at a rotation velocity level o f  45rpm. Data are presented as mean 
values along with SEM.
3.3.2.3 Acoustic startle and prepulse inhibition
The effects o f auditory acoustic stimuli inducing a startle response and a 
measure o f sensory-motor gating were tested in lgf2-KO and WT-control mice. 
Sensory-motor gating was examined by presentation o f a range o f prepulse stimuli 
prior to the startle stimuli, inducing a phenomenon known as prepulse inhibition 
(PPI), whereby the amount o f startle reflex behaviour is attenuated (Li et al., 2009). 
PPI is characterized as a form o f low level perceptual gating. The amount o f 
movement induced by the startle stimuli (startle reflex) was determined by the 
piezoelectric response to the flexion in the base o f the chamber in which the mice 
were placed. Due to the differing body weight of the different genotype models under 
test, most notably that o f the /g/2-Null KO mice, the reported values for startle reflex 
(in arbitrary startle units) were normalised to (body weight)0 75 (see section 3.2.3.3).
Mice o f all genotypes demonstrated a startle response to the 120dB stimulus 
(Figure 3.7 A). However, the magnitude o f the startle response to the acoustic stimulus 
(pulse alone) was found to be significantly elevated for Igf2-P0 KO mice (one-way 
ANOVA; F2,8i= 8.67, p< 0.001), relative to /^/2-Null KO mice (post hoc test: Fi,34=
7.02, n.s.) and WT-control littermates (post hoc test: Fij67= 17.08, p< 0.001). This 
effect was still present on trials where the startle stimulus was preceded by prepulse 
stimuli at 2, 4 and 8 dB above background (70dB) (interaction: Fi,gi= 33.04, p<0.001), 
but failed to reach significance at a prepulse level o f  16dB above background,
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possibly due to floor effects {post hoc comparison relative to; WT controls: 
Fi,6 7 = 5 .61, n.s. and 7g/2-Null KO mice: F|,34= 5 . 61, n.s.). No differences were 
observed between 7g/2-Null KO mice and WT controls for either pulse alone or 
prepulse trials {post hoc test; Fi,61=0.39, n.s.).
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Figure 3.7: Startle reactivity and PPI. (A) The amplitude o f  startle response emitted 
by mice o f  different genotypes (after adjustment fo r  body weight), across vatying sound 
levels o f  the prepulse stimulus (B) The degree o f  prepulse inhibition (in terms o f  
percentage) across varying sound levels o f  the prepulse stimulus, between mice o f  
different genotypes. Data are presented as mean values along with SEM.
All mice demonstrated a pattern o f reduced startle responses as the amplitude 
o f the prepulse increased (Figure 3.7A, within-subject test; F2,i40= 52.57, p< 0.001), a 
trajectory that did not differ between the different genotypes (between-subject test; 
Fi,8i= 33.04, p< 0.001). However, as noted, the heightened startle response o f the 
IgP~P0 KO mice persisted through this manipulation (see above). Calculation o f PPI, 
the degree with which the startle response is reduced by the prepulse, showed a 
general increase with increasing amplitudes of the prepulse stimuli (Figure 3.7B, 
within-subject test; F,3^43= 33. 34, p< 0.001) for all groups o f mice (between-subject 
test; F2,8i= 1.33, n.s.). However, closer examination o f the data showed that Igf2-P0 
KO mice did not exhibit PPI when the prepulse was 2dB above background (Student’s 
paired-sample) T-test; f(20)= 0.94, n.s.) in contrast to the 7g/2-Null KO and WT- 
control mice which both showed significant PPI (£(14)= 3.54, p= 0.005) and /(47)= 
4.57, p= 0.001, respectively), suggesting a degree o f altered sensory-motor gating in 
IgP-PO KO mice.
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There was a significant difference noted between the separate WT-littermate 
control groups in acoustic startle response following presentation o f pulse-alone 
stimuli (as summarized in Appendix 1.5). This was in terms of greater magnitude o f 
response for WT-control mice of the Igf2-PO mutant line, however, this response was 
still significantly different from Igf2-?0 KO mice (one-way ANOVA; F3,go= 7.10, p< 
0.001, post hoc test: Fi,3o= 12.13, p< 0.005) and was not observed in trials where a 
prepulse stimulus was presented prior to the acoustic stimulus. Moreover, there were 
no differences in the amount of PPI between the two groups of control mice.
3.3.2.4 Assessment o f  reactivity to a novel foodstuff
Number o f studies has demonstrated associations between early life nutrition 
and stress reactivity in later life. Habituation of the mice to the novel milk reinforcer 
( 10%), to be used for appetitive conditioning paradigms, provided an opportunity to 
examine response to novel foodstuff by the mice. All subjects showed a linear 
increase in total liquid consumption across six habituation sessions (Figure 3.8A, 
within-subject test; F,4,533= 114. 24, p< 0.001), following a Kleiber’s 0.75 mass 
exponent method for adjustment o f body weight. However, no difference was found 
in consumption between genotype groups (between-subject test; F,2,i20= 2.15, n.s.). 
Importantly, a one-sample T-test showed that all subjects displayed equivalent 
consumption of water across the two containers during the first two sessions (7g/2-P0 
KO mice; Session 1: t(35)= -0.55, n.s., Session 2: Dayl: t{35)= -0.72, n.s.; /g/2-Null 
KO mice; Session 1: t(\2)= -1.26, n.s., Session 2: t(\2)= -0.95, n.s.; WT controls; 
Session 1: t(66)= -0.05, n.s., Session 2: t{66 )= -0.28, n.s.), indicating that the subjects 
did not make any discrimination in their water consumption between the locations of 
the containers.
Furthermore, although the WT controls showed a significant preference for 
condensed milk from the first session of preference testing between condensed milk 
and water (i.e. relative to 50%, Session 3, t(66)= 3.21, p< 0.002), the mice of the Igf2 
KO lines did not display milk preference until the second session o f preference testing 
(Session 4; Igf2-?0 KO: t(35)= 22.24, p< 0.001, Igf2-Null KO: t{\9)= 4.54, p< 0.001). 
Also o f interest, a repeated measures analysis reported a significantly lower 
preference for the novel milk solution among Igf2-P0 KO mice during Session 3 
(Figure 3.8B, one-way ANOVA; Vxno= 4.67, p< 0.02), in comparison to milk
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preference o f the WT-control littermates (post hoc test: F^ioi = 4.67, p< 0.011), albeit 
this difference did not persist in Session 4 (one-way ANOVA: F2,i20= 1.47, n.s.) or in 
subsequent sessions (Session 5: F2,i20= 0.21, n.s.; Session 6: F2,i20= 1.27, n.s.).
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Figure 3.8: Food neophobia and habituation. (A) The total volume o f liquid consumed, 
between mice o f  different genotype groups, across sessions (after adjustment fo r  
bodyweight). (B) The preference fo r  the novel foodstuff (10% condensed milk) between 
mice o f  different genotypes, across sessions. Data are presented as mean values along 
with SEM.
In contrast, the Tg/2-Null KO mice did not demonstrate any difference in the 
condensed milk preference from WT controls (post hoc test; Fi,85= 0.63, n.s.) or Igf2- 
P0 KO mice (post hoc test Fi,54= 2.37, n.s.) during the first preference session, or 
subsequent sessions (F2,i20= 0.45, n.s.). Finally, a separate analysis o f condensed milk 
preference and the total volume o f liquid consumed between the littermates o f the two 
control-lines did not shown any difference on either parameter, as summarized in 
Appendix 1.6.
3.4 Discussion
This initial series o f experiments investigated the early growth characteristics, 
development and sensory/motor behaviour o f Igf2 KO mice. In the present study, both 
deletion o f the Igf2 gene o f the sole placental specific transcript (Igf2-?0) and 
complete deletion o f all o f  the foetal and placental transcripts (7g/2-Null), resulted in 
considerable foetal growth deficiency in mice consistent with previous findings 
(Constancia et al., 2002; DeChiara et al., 1990). The Igf2-P0 KO mice displayed
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moderate IUGR, in terms of reduction o f birth weight to 75% that of WT littermates, 
followed by an early compensatory weight gain between postnatal days 25-75, leading 
to less than 7% difference in adult body weight by postnatal day 100. However, when 
Igf2-P0 KO mice were compared solely to their own WT littermates (i.e. from the 
same dam), results demonstrated a full compensatory growth during the early 
postnatal life as the body weight of the two groups were found to be equivalent on day 
100. In comparison, /g/2-Null KO mice were found to have undergone more severe 
IUGR and were only 55% that o f WT weight at birth. While the /g/2-Null KO mice 
did demonstrate some acceleration in early postnatal growth rate, this weight gain 
occurred immediately following birth and did not persist beyond day 25, and they 
were still significantly lighter in weight than WT controls at 100 days o f age.
The growth retardation o f the /g/2-Null KO mice was found to be slightly less 
profound on average to an earlier study by DeChiara and colleagues (1990) (or 
approximately 60% of wild-type birth weight). In addition, no difference was noticed 
in early postnatal growth rate between the /g/2-Null mice and WT littermates in that 
study, suggesting that the early catch-up growth might be a physiological response to 
the imbalance between the nutritional supply and demand rather than due to the 
growth restriction as such. The /g/2-Null KO mice were also found to be delayed on 
all four morphological measurements o f somatic development (i.e. unfolding of ear 
pinna, incisor eruption, bilateral eye opening and fur growth), however this was not 
the case for mice of the Igf2-?0 KO line.
One o f the main findings from the behavioural experiments, was that the Igf2- 
P0 KO mice displayed significantly elevated startle responses in the startle and PPI 
paradigm (i.e. relative to the WT littermates) and greater neophobic response to novel 
food-stuff, evidence of heightened stress reactivity/anxiety-related behaviour 
(Rodriges-Fomells, Riba, Gironell, Kulisevsky and Barbanoj, 1999; Zhu et al., 2006, 
respectively). In addition, the Ig/2-?0 KO mice also failed to show PPI at prepulse 
amplitude level of 2dB, possibly as a consequence of a mild impairment in sensory- 
motor gating. In contrast, the 7g/2-Null KO mice did not show any differences from 
WT-littermate performance on either the startle and PPI paradigm, or the food 
neophobia test. These results are particularly noteworthy, considering the fact that PPI 
has been demonstrated to be attenuated in several different anxiety-related disorders 
(Duley et al., 2007), and similar increases in stress responses and anxiety-related 
behaviour have also been described in a number of animal models, using alternative
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means of inducing intrauterine malnutrition (i.e. reduction in maternal food intake or 
dietary manipulations) (Levay et al., 2008; Erhard et al., 2004; Jaiswal, 1996), 
epidemiological studies of people bom with low birth weight (LBW) or small for 
gestational age (SGA, see Chapter IV, section 4.1 for further discussion of this 
evidence) and studies showing the association between IUGR and hyperactivation of 
the hypothalamic-adrenal-pituitary (HPA) axis in both animals and humans (see 
Chapter IV, section 4.4). Moreover, as previously mentioned in section 3.1, impaired 
sensory gating has also been shown to be a common feature in ADHD and 
schizophrenia, highlighting that further behavioural investigation is warranted, as 
behavioural tests sensitive to ADHD and schizophrenic related impairments could 
perhaps enable further dissociation o f effects in Igf2-V0 KO mice with respect to Igf2- 
Null KO and WT controls (see also section 1.2.1).
It is possible that the reluctance o f the 7g/2-P0 KO mice to consume the 
condensed milk might have stemmed from developmental alterations in either 
motivational or sensory properties. What undermines the feasibility o f such 
explanations however is the fact that the Igf2-P0 KO mice only showed this reduced 
milk preference during the first day of being provided with milk-water option, 
whereas by the second day the preference for the condensed milk was 
indistinguishable from that o f WT littermates and 7g/2-Null KO mice. Nevertheless, in 
order to provide further support for an anxiogenic explanation for this difference and 
for the other behavioural phenotypes found, further investigation o f anxiety-related 
behaviour among the 7g/2-P0 KO mice would be of relevance.
There were no differences found between Ig/2-PO KO mice and WT controls 
in measures of LMA or motor coordination, as tested on the rotarod. When tested on 
the LMA chambers, the 7g/2-Null KO mice showed a general decrease in ambulation 
(in terms of fewer beam-breaks), but this reduction was only found to be significant 
during the first session of testing. On the other hand, the 7g/2-Null mice also exhibited 
an improved overall performance on the rotarod apparatus, indicated by greater 
latency o f the 7g/2-Null KO mice to fall from the rotating rod, as well as heightened 
rotational speed at the time o f fall. While the improved rotarod performance could 
easily be attributed to the relatively smaller body size o f the 7g/2-Null KO mice (i.e. 
due to smaller body/rod size ratio, similar pattern o f effects shown by chromosome X 
imprinting centre (IC) deletion mice, also of small size relative to controls, Relkovic 
et al., 2010), the reason behind the decreased ambulation on the LMA chambers is
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less clear. This reduction in LMA could reflect impaired motor ability by /g/2-Null 
KO mice, however motivational or emotional aspects must also be taken into 
consideration. The role o f stress or anxiety-related properties underlying this 
reduction in LMA could possibly be excluded with further examination on test- 
batteries of anxiety-related behaviour.
A key aspect in analysing data from these studies, concerns the equivalence of 
the two groups of WT-control mice. Although of equivalent background strain, age, 
and husbandry, the differences observed could make grouping of the data problematic. 
Notable differences were observed in both postnatal growth trend and somatic 
development, across the segregated WT-littermate control groups, where littermate 
controls from the /g/2-Null mutant line reached a slightly greater body weight at day 
100 and also displayed a delay on the somatic indices of ear pinna unfolding and 
incisor eruption. Since the birth weight o f the two WT-control groups was found to be 
the same, it is plausible that these marked differences in early postnatal development 
reflect variations in the early postnatal environment (although disparity in intrauterine 
environment should not be excluded). This may have arisen from differential access to 
early postnatal nutrition, as the WT-Null controls are likely have gained greater access 
to the maternal milk due to weaker competition from their much smaller KO 
littermates. Alternatively, other early life environmental factors could have attributed 
to the differential postnatal development of the WT-littermate controls, such as 
difference in maternal or KO littermate behaviour towards the two WT-littermate 
groups. Perhaps more importantly, the WT littermates of the Igf2-P0 line produced 
greater startle response during the acoustic startle and PPI paradigm, when the 
prepulse stimulus was absent, although direct comparison with Igf2-P0 KO mice did 
not affect the significance in this case. The WT-PO controls also demonstrated a 
superior overall performance on the rotarod apparatus in comparison with WT-Null 
littermates, however this difference is likely to be attributed to greater body weight 
(and size) of the WT-Null mice (in terms of potential increase in body-rod size ratio).
As mentioned earlier in Chapter II (section 2.2.7), the aforementioned 
differences between the segregated WT-littermate control groups raises a serious 
concern regarding the methodological validity of pooling the two WT-control 
littermate groups. This is because any variations between the pooled WT-control 
groups (particularly in terms o f behaviour) could significantly distort the results from 
a between-genotype comparison when using a single collective WT-control group as
70
baseline. Firstly, an irregularly large variation between the two WT-control groups 
will undoubtedly increase the within-group variance of the collective WT-control 
group, and thus reduce the sensitivity of a given statistical test to identify difference in 
variation between groups. Secondly, due to the fact that littermates from one of the 
WT-control groups might differ in one or more ways from what constitutes ‘normal’ 
behaviour for mice o f this particular background strain generated in the absence o f an 
genetically modified littermates (e.g. due to unfavourable prenatal or postnatal 
environmental influences), it is possible that the behavioural data from one (or both) 
of these groups of mice could skew the comparative WT-control baseline from what 
presumably is ‘normal’ WT behaviour (i.e. if the skewness goes in opposite direction 
from the variance o f the Igf2 KO mouse models). Hence, any apparent difference in 
behaviour observed among KO mice o f either Igf2 mouse models could in fact be 
false, as the baseline does not accurately represent normal WT behaviour. However, 
although the WT littermates from Igf2-PO control group are more likely to correspond 
to normal WT mice than WT-Null control mice (by observation, in relation to body 
weight and somatic development), this is difficult to conclude with certainty. In spite 
of the fact that the two different groups of WT-littermates were found to be 
significantly different for some measures, it is also plausible that this between-group 
difference might lie within the range o f what could constitute normal variation in both 
physical and behavioural properties o f regular WT mice. Furthermore, carrying out a 
comparative analysis o f behaviour between mice of the Igf2 KO mouse models and 
WT littermates using two segregated WT-control groups instead of a single collective 
WT-control group would make data interpretation both lengthy and perhaps at times 
confusing. As such, the approach of using two segregated WT-control groups could 
produce behavioural differences which are irrelevant to the purpose of the current 
thesis. Therefore, in order to confront the compromised methodological validity of 
employing a pooled WT-control group, it is crucial to ensure that for any difference 
observed between mice o f either one or both of the Igf2 KO models, and the collective 
WT-control group, there is no difference is found between the segregated WT-control 
groups on that parameter. Moreover, it would also be relevant to carry out individual 
comparison across mice of a give Igf2 KO group and WT littermates from separate 
control groups (particularly the WT group of the same breeding line), for any 
difference obtained between the Igf2 KO mice and the collective WT controls, in 
effort to evaluate the strength and the nature of this difference. Conceivably, this
71
would enable a reliable and valid inference o f any behavioural difference as a result of 
placental deficiency and IUGR, rather than irregularity o f WT-littermate behaviour. 
This will be further addressed in the general discussion in Chapter VIII.
The findings from the present study provide for the first time evidence for 
compromised brain development and behaviour among mice of the Igf2-PO KO 
model, as indicated by the marked differences in stress and anxiety-related 
phenotypes. Although, there was a notable difference found among the 7g/2-Null KO 
mice on behavioural tests involved with competence of locomotor activity, balance 
and motor coordination, it remains unclear whether this is due to differences in early 
brain development or in other physical/morphological aspects related to their small 
size. Furthermore, it is important to note that the differential behavioural profile 
described between the Igf2-?0 and Zg/2-Null KO mice, may reflect dissociation 
between consequences o f nutrient deficiency (due to compromised placental function) 
and growth restriction, in intrauterine life (see Chapter I, section 1.6). As such, it is 
conceivable that the heightened stress/anxiety-related behaviour might be a result o f 
foetal malnutrition, rather than IUGR. However, this topic will be subjected to further 
discussion in the General Discussion (Chapter VIII, section 8.3). The studies 
described in the present chapter are the first to describe the adaptation of a genetic 
model to mimic and investigate the long term deleterious consequences of adverse 
intrauterine environment, on brain development and behaviour. Still, further research 
into the cognitive functions and behaviour of the Igf2 KO mouse models, is essential, 
in order to gain further converging (and thus stronger) evidence for heightened stress 
and anxiety among these mice, as well as to establish a broader characterization of 
their cognitive and behavioural domains.
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3.4.1 Summary o f key results from Chapter HI
• KO mice of both Igf2-PO and 7g/2-Null lines showed considerable IUGR as 
indicated by the lowered birth weight, although this growth deficiency was 
found to be more severe in 7g/2-Null KO mice.
• 7g/2-P0 KO mice showed a considerable compensatory weight gain during 
early postnatal life (day 25-50), and displayed normal development across all 
somatic indices.
• 7g/2-Null KO mice showed a transient growth spurt in the first few days 
following birth (day 0-25) and were delayed on all measurements of somatic 
development and remained growth impaired throughout life.
• Zg/2-Null KO mice showed an overall reduction in ambulation in the LMA 
chambers relative to Igf2-?0 KO mice and WT controls, although a significant 
difference was only obtained on the first session. In contrast, no difference 
was found between 7g/2-P0 KO mice and WT controls.
• Zg/2-Null KO mice displayed an overall improvement in motor co-ordination 
and balance on the rotarod apparatus relative to the Igf2-PO KO mice, as 
indicated by greater latency to fall from the rod and a greater rotation velocity 
at the time o f fall.
• Igf2-P0 KO mice showed significantly greater startle amplitude in response to 
acoustic stimuli than Tg/2-Null KO and WT controls. This effect still persisted 
during trials when the startle stimulus was preceded by prepulse stimuli at 2, 4 
and 8 dB above background, but not at 16dB.
• Igf2-P0 KO mice showed a mild impairment in PPI during trials when the PPI 
was 2dB above background.
• Igf2-P0 KO mice showed a significantly reduced preference for a novel
foodstuff during the first day of testing relative to /g/2-Null KO and WT
controls.
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Chapter IV
Investigating Stress/Anxiety-Related Behaviour in Mice of the 
Igf2-P0 and Igf2-Null Knockout Lines: Elevated Plus-Maze, 
Open Field and Free-Exploratory Paradigm
4.1 Introduction
Pathological anxiety is the most prevalent psychiatric disorder in the general 
population, with lifetime prevalence approximating 29% (Kessler et al., 2005). In 
recent years, there has been emerging evidence indicating that early life factors might 
play a role in the risk o f developing stress and anxiety-related disorders in later life. 
Studies have shown different relationships between birth weight and measures of 
stress and anxiety, such as an inverse correlation between birth weight and stress 
susceptibility (Nilsson et al., 2001) or an inverted ‘IT function, whereby individuals at 
both the lower and higher ends o f the birth weight distribution were at greater risk of 
having anxiety-related symptoms in adulthood (Alati et al., 2009). Moreover, these 
patterns have been replicated in studies o f low birth weight (LBW) children that were 
bom full-term (Gustafsson, Josefsson, Selling and Sydsjo, 2009; Wiles, Peters, Leon 
and Lewis, 2005; Cheung, Khoo, Karlberg and Machin, 2002). The associations of 
foetal growth with later anxiety were shown to persist, when adjusted for 
socioeconomic status in order to control for effects of continuing postnatal adversity 
(Cheung et al., 2002; Wiles et al, 2005; Nilsson et al., 2001). Physiological 
differences have also been found, such as higher resting heart rates and elevated 
urinary catecholamine levels among children that have been growth retarded from 
early childhood, relative to nonstunted counterparts (Femald and Grantham- 
McGregor, 2002; Femald and Grantham-McGregor, 1998). However, a key issue is 
the association between measures of foetal growth or birth weight as accurate 
predictors of an adverse foetal environment, as discussed in Chapter I (section 1.5.1). 
Thus, results from the epidemiological studies may only represent summary indices of 
successful foetal and infant development, which itself is not causally related to the 
long-term effect on behaviour and mental health (Schlotz and Philips, 2009; Gillman, 
2002). Therefore, it still remains unclear whether the associations reported in these
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studies reflect foetal under-nutrition, or other factors that contribute to impaired foetal 
growth and later risk of anxiety-related disorders.
The notion of early nutritional origins affecting adult stress/anxiety-related 
behaviour has also gained some support from work utilising animal models, although 
the overall findings from this line o f research are ambiguous, and in some regards 
contradictory. Adult rats exposed to under-nutrition during gestation or lactation 
showed heightened anxiety when assessed using two common rodent paradigms 
purported to assay anxiety, the elevated plus maze and the open field test (see below 
for test details) (Jaiswal et al., 1996; Levey et al., 2008). Pain thresholds and 
emotional reactivity has also been found to be elevated in rats (Smart et al., 1973; 
Levitsky and Barnes, 1970) and pigs (Barnes, Moore and Pind, 1970), which had 
received inadequate nutrition during early postnatal life. In further support of the 
behavioural results in rodents, adult sheep showed enhanced emotional reactivity 
when exposed to restraint or novel stimuli, when their mothers received a protein 
restricted diet during early gestation (Erhard et al., 2004).
In contrast, several other studies have been unsuccessful in demonstrating a 
link between early nutritional deficits and stress- or anxiety-related behaviour in 
adulthood. In rats, one such study demonstrated that the imposition o f a protein- 
calorie restricted diet during gestation did not produce any difference on anxiety/stress 
related parameters when tested on the open field (Villescas et al., 1981), and some 
studies have even noted a reduction in anxiety among rats that were malnourished in 
utero (Almeida et al., 1996a; Almeida et al., 1996b). Additionally, a number o f 
studies have also reported anxiolytic effects of early postnatal under-nutrition 
(Fran^olin-Silva, Hemandes, Fukuda, Valadares and Almeida, 2006; Almeida, Garcia 
and De Oliveira, 1993; Almeida, De Oliveira and Graeff, 1991; Brioni and Orsingher, 
1988), but the results o f Erhard et al. (2004) in juvenile lambs could not be replicated 
(Simitzis et al., 2008).
There are a number of possible explanations that could either individually, or 
in combination, account for some o f the spurious and contradicting results that have 
arisen from the animal work. Firstly, the different procedures employed to induce 
malnutrition, and secondly, the severity of the nutritional manipulation, may yield 
very different outcomes in adult assessments of stress and anxiety. Third, animal 
studies have involved the use o f nutritional manipulation during different stages of 
development, both during gestation and in the early neonatal time, which may lead to
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profound differences in neurobiological and behavioural phenotypes in later life. 
Finally, and perhaps o f fundamental importance, some of the aforementioned animal 
studies may have been prone to methodological limitations, for reasons such as; lack 
of standardized tools for investigating stress/anxiety-related phenotypes, or 
insufficient efforts to control for possible confounds. For instance, it is difficult to 
conclude whether the behavioural differences observed are in fact a result of foetal 
under-nutrition, or rather due to differences in maternal care-taking as result of 
maternal food restriction, as has been previously discussed (see Chapter I, section
1.5.2, for more detailed discussion). These variations in experimental methodology 
and control make a clear interpretation of the findings from animal models 
particularly difficult, and suggest that the current experimental evidence for a causal 
relationship between intrauterine nutrition and later risk of anxiety disorders is 
relatively weak.
In Chapter III, mice of the intrauterine growth restricted (IUGR) Igf2-?0 KO 
line displayed a greater startle response to acoustic stimuli, as well as a reluctance to 
consume a novel food. As discussed, these finding might suggest heightened anxiety 
in adulthood, as a result o f placental insufficiency-induced IUGR. Nevertheless, 
further evidence is warranted in order to provide better support for this notion. 
Therefore, to extend the findings of Chapter III, the main aim o f this chapter was to 
explicitly investigate the impact of placental deficiency and IUGR on anxiety-related 
behaviour among mice o f the Ig/2-KO lines. Thus, a number of unconditioned conflict 
tests o f anxiety-related behaviour (termed approach-avoidance conflict tests) were 
carried out on the Igf2-KO mice and WT-littermate controls: the elevated plus maze 
(EPM), open field (OF) and the free-exploratory paradigm (FEP). These paradigms of 
anxiety-related behaviour are based on the natural conflict observed in rodents 
between the drive to explore a new environment and the tendency to avoid a 
potentially dangerous region (Ramos, 2008), and have been shown to be reasonably 
sensitive to classical, anxiety-reducing, benzodiazepine drugs (see Lister, 1990 for 
review; Belzung and Berton, 1997). The EPM is the most widely used test of anxiety- 
related behaviour in animal models (Carobrez and Bertoglio, 2005; File, Lippa, Beer, 
Lippa, 2004) and involves assaying the aversion of rodents to open space and height. 
The maze has four arms where two opposing arms are enclosed by high walls and the 
other two have no sides. An index of anxiety is determined by measuring the 
accumulated time and frequency of entries by subjects onto the open arms of the maze
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relative to the enclosed arms. The OF, another commonly used test of anxiety-related 
behaviour, is a large and brightly lit open arena from which escape is obstructed by 
high walls. Rodents with high levels o f anxiety usually spend more time close to the 
peripheral walls o f the arena (thigmotaxis) whereas those of low anxiety levels will 
freely explore the arena, frequently entering the central region. The FEP assesses 
anxiety in terms of the response of an animal to a novel environment (neophobia). 
Subjects are habituated to one side of a two compartment place preference apparatus 
before being allowed to explore the other, novel, side. Rodents with high anxiety 
levels usually spend lesser time in the novel compartment relative to non-anxious 
rodents (Teixeira-Silva et al., 2009).
Due to the heterogeneity of anxiety (Unick, Snowden and Hastings, 2009), it is 
essential that multiple tests o f anxiety-related behaviour are used in order to broadly 
assess the different psycho-physiological states that might be reflected by these tests. 
In addition to the bidirectional sensitivity o f anxiolytic/anxiogenic drug manipulations 
on behaviour, these ethologically based conflict tests of anxiety provide the 
advantages of not requiring lengthy training procedures, the use of food/water 
deprivation or the conditioning of aversive stimuli (Rodgers, Cao, Dalvi and Holmes,
1997). Furthermore, since these tests do not involve a conditioning procedure, there is 
no (or at least less) reliance on memory or attention and confounding effects of 
activity can be taken into account.
The collective results from these tests of anxiety-related behaviour could 
provide further evidence for the putative anxiogenic effects o f foetal malnutrition and 
growth deficiency, on mice of the 7g/2-P0 knockout (KO) line. Although the 
reviewed literature does not provide a clear hypothesis as to the direction of altered 
anxiety that might be expected to be demonstrated by Igf2-?0 KO mice relative to 
Igf2-Null and wild-type (WT) mice, the evidence to date (including that from Chapter 
III) does suggest that Igf2-?0 KO mice may show some specific anxiety-related 
effects.
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4.2 Materials and Methods
Full methodological descriptions can be found in the relevant sub-sections o f 
the General Methods Chapter (Chapter II).
4.2.1 Subjects and animal husbandry
Two cohorts o f age-matched (8 to 12 months old at the onset o f testing) adult 
male mice (generated in the Behavioural Neuroscience Laboratory at Cardiff 
University) were used in this series o f experiments (see Table 3.1). The first cohort o f 
mice was subjected to testing on the EPM and OF. The EPM preceded testing in the 
OF and a number o f mice were removed from the study for a number o f different 
reasons including, tissue collection and illness. A second group o f mice was tested on 
the FEP. Mice were obtained from a crossbreeding o f background strain o f 
C57BL/6*129 (carrying either the mutant Igf2-PO allele or the /g/2-Null allele) with 
CD1 female (as previously described in Chapter II). The mice were housed in 
littermates groups o f  two to five animals per cage, under temperature- and humidity- 
controlled conditions, with a 12-hour light: 12-hour dark cycle (lights on at 07:30). 
All subjects had ad libitum access to standard laboratory chow and water and were 
weighed on regular basis. The body weight o f each mouse was monitored regularly 
for indication o f health status (see Chapter II, section 2.4.2). All experimental 
procedures were conducted under licenses issued by the Home Office (U.K.) in 
compliance with the Animals (Scientific Procedures) Act 1986 and local ethics 
committee.
Table 4.1: The sample size and genotype o f  each cohort-subset o f  mice assayed on 
ethologically-based conflict tests o f  anxiety: EPM, OF and FEP.
I__________ Genotype and sample size (n)__________ Incnaviourai
Apparatus
Elevated plus maze 21 14 47(23/24)
Open field arena 17 11 42(18/24)
Free exploratory 
paradigm 18 9 40(22/18)
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4.2.2 Behavioural methods
4.2.2.1 General methods
Each of the test methods used to assess anxiety involved individual testing of 
mice; hence the apparatus was cleaned thoroughly with a 2% acetic acid solution 
between subjects, to remove odours possibly left by the previous subject. All testing 
took place between the hours o f 10:00 and 17:00, with equal distribution of testing for 
subjects of different genotypes throughout the day, and prior to testing mice were 
habituated to the test room for at least 20 minutes. The test room was illuminated by a 
dim light and care was taken to minimise physical disturbance or excessive noise. 
Data for the EPM, OF and FEP were collected using EthoVision Observer software 
(Version 3.0.15, Noldus Information Technology, Netherlands) with specific virtual 
arena and zone configurations for each piece of apparatus (see below). The 
EthoVision tracking system performs calculations over a series o f frames (12 
frames/sec) to derive a set o f quantitative descriptors about the movement of subjects, 
and variables such as duration and entries into the arms were determined by the 
EthoVison programme in terms of location of the greater body-proportion of subjects. 
Tracking of the subject was calibrated for each piece of apparatus prior to testing 
using non-experimental mice o f the same body size and fur colour as the experimental 
subjects. Data were analysed as total values for each session and in 1 -minute intervals 
to assess performance within a session. Each session was also recorded using DVD 
HD recorders (Sony Corp, U.K.) for further analysis if required.
4.2.2.2 The elevated plus maze paradigm
In order to assay the innate aversion of both lines of Igf2-KO mice to open 
space and height, relative to WT-littermate controls, the subjects were placed at the 
centre o f the EPM (as previously described in Chapter II, section 2.3.4) facing one of 
the exposed open arms and allowed to explore the maze over a single session of 10 
minutes. The maze was illuminated by a single 60 Watt lamp, located 75cm above the 
central region of the maze. To optimize data analysis, the different parts of the EPM 
was divided into 5 virtual zones representing the 2 open arms, 2 closed arms and the 
middle section from which all arms originated, using the EthoVision Observer 
software. Data from the 2 open arms was combined to generate a single open arm 
value and a similar cumulative closed arm value was also produced. Therefore the
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following data were collected for each cumulative zone: accumulated time, latency o f 
first entry, frequency o f entries, duration o f movement, average velocity and distance 
moved. In addition, the following parameters were manually scored: number o f rears 
(defined as standing on hind feet only), number of stretch attend postures (SAP, 
defined as an animal keeping its hindquarters in the closed arms but stretching 
forwards onto an open arm) and number of head dips from the open arms (looking 
over the edge of an open arm). Data were expressed for the total session and in 1- 
minute time intervals (or blocks). The main parameters used as indices of anxiety- 
related behaviour were the proportion of time spent exploring the open arms (relative 
to the time spent on both open and closed arms), the number of entries onto the open 
arms and the latency of first entry onto the open arms. Other potential indicators of 
anxiety states included; the number o f head dips on the unprotected open arms, the 
number o f rears and SAPs. The parameters used as measurements of locomotor 
activity were; the total duration of movement, the average velocity of locomotion, as 
well as the distance moved.
4.2,2.3 The open field  paradigm
Mice of the lgf2-KO lines were tested on the OF, a white square shaped 
Perspex arena enclosed by high walls (see chapter II, section 2.3.5 for further details 
of the apparatus), along with WT-control littermates, in an effort to investigate 
possible differences across the subjects in their aversion to unprotected open areas. 
The maze was illuminated by a single 100 Watt lamp, located 75cm directly above the 
central region. At the start of the 20-minute test, the mice were placed, facing the 
wall, at the edge of the arena at a point equidistant along the wall. The key measure o f 
anxiety-related behaviour in the OF is the proportion of time in the central part of the 
arena relative to the more peripheral areas, thus the EthoVision tracking software 
programme was applied to subdivide the arena into two virtual concentric squares 
with dimensions of 200*200mm (‘inner-square’)/ 400*400mm (‘middle-square’) and 
remainder peripheral area (‘outer region’). The following tracking parameters were 
calculated for each of the designated regions o f the arena and the arena as a whole: 
accumulated time, latency of first entry, frequency of entries, duration of movement, 
average velocity and distance moved. Data were expressed for the total session and in 
2-minute time intervals. The main parameters used as indices of anxiety-related
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behaviour were the proportion of time spent exploring the central regions (relative to 
the total time spent in the arena), the frequency o f entries into the inner-square and the 
latency to first entry into the inner-square. The parameters used as measurements of 
locomotor activity were; total duration of movement, the average velocity of 
locomotion, the distance moved and the number crossings of quadrant lines.
4,2.2.4 The free-exploratory paradigm
The Igf2-KO mice and WT-controls were tested on the FEP in order to provide 
an alternative measurement o f potential differences in anxiety-related behaviour 
among the mice. In the FEP, the level o f aversion among mice to novel environment 
is examined, by allowing the subjects to freely explore an environment that contains 
both familiar and novel parts. The chamber was illuminated by a single 100 Watt 
lamp, located 75cm above the central region. Subjects were placed, in the centre 
facing away from the communicating door, o f one of two possible compartments o f 
the FEP apparatus (as previously described in Chapter II); a white coloured 
compartment with smooth floor surface or a black coloured compartment with a 
coarse-grained floor surface (i.e. coarse sandpaper); the colours and textures o f the 
two compartments was varied to enhance discriminability of the two environments. 
The chamber used for each subject was counter-balanced between genotypes. Subjects 
were allowed to move freely within the selected compartment for a 45-minute 
habituation session and the communicating door to the other compartment was 
blocked, preventing access. Following the habituation session, the mouse was 
removed from the apparatus and placed in a holding cage whilst both of the chambers 
were thoroughly cleaned with 2% acetic acid solution. The communicating door was 
opened and the mouse was replaced into the centre of the habituated chamber, facing 
away from the doorway and allowed to freely explore the entire apparatus, i.e. both 
the familiar and the novel compartment, for a 10 minute (free exploration) test 
session. In addition to the cleaning with 2% acetic acid solution between subjects as 
mentioned previously, the sandpaper on the floor of the black compartment was 
replaced between each subject. EthoVision tracking was performed during both the 
habituation and exploration phases of the experiment. The FEP chamber was 
subdivided into four virtual equal regions, designated as novel near and far, familiar 
near and far, where distance was determined by proximity to the communicating door.
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Thus, each region had a span o f 150 mm. This subdivision has the advantage of 
increasing the sensitivity o f the obtained measurement, as more anxiogenic subjects 
may be more reluctant to enter the more distal part of the novel chamber, remaining 
close to the compartment entrance (i.e. in the proximal part). Thus, the following 
parameters for each region were calculated: accumulated time, latency of first entry, 
frequency of entries, duration of movement, average velocity and distance moved. 
Data were expressed for the total session and in 1-minute time intervals. The main 
parameters used as indices o f anxiety-related behaviour were: exploration preference 
for the novel compartment (relative to the familiar compartment), number of entries 
into the novel compartment and the latency o f first entry to the novel compartment. 
These same parameters were also exclusively calculated for the distal part of the novel 
compartment. In order to assess the locomotor activity o f subjects, the parameters; the 
total duration o f movement, the average velocity of locomotion and the distance 
moved, were analysed for the whole apparatus.
4.2.3 Statistical analyses
The data were subjected to either one-way analysis of variance (ANOVA) for 
a genotype (between-subject) comparison of performance for the entire experimental 
session, or a two-way repeated measures ANOVA to examine the effect o f genotype 
on performance of subjects, on minute-to-minute basis (i.e. minute blocks), as well as 
to investigate possible interaction across genotype groups in behaviour over time. 
Moreover, any interactions observed, were foliowed-up by an additional one-way 
ANOVA or repeated measures ANOVA between the individual levels o f the within- 
subject factor, if or where required. Any significant difference between genotypes on 
parameters of anxiety-related behaviours, across behavioural batteries and within 
cohort, was folio wed-up by correlation analysis (Pearsons r). A one sample T-test 
comparative analysis was carried out to establish regional preference, relative to 50% 
rate. Finally, data from the separate WT-lines were clustered together for analysis 
where no significant differences between the two groups were observed (see 
Appendix II), in order to increase the statistical power and for reasons mentioned 
previously (in Chapter II, section 2.4.7).
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4.3 Results
4.3,1 The elevated plus maze paradigm
Analysis o f  the data collected from the digital video tracking system showed 
that, as expected, subjects o f all genotypes spent a significantly greater time during 
the EPM session in the protected closed arms and the middle area (~70% o f total test 
time, see figure 4.1) than on the exposed open arms; lgf2-PO KO mice (one-sample T- 
test): f(18)= 15.33, /?<0.001, r= 0.96; /g/2-Null KO mice: 413)= 10.43, /?<0.001, r= 
0.95; WT controls: 443)= 15.01, /?<0.001, r= 0.70, and a within-subject analysis 
indicated a greater amount time spent on the open arms at both the onset o f the 
experimental session and towards the end of the session, F9,657= 4.22, /?<0.01 (see 
Figure 4.1 A). Moreover, KO mice o f  the Igf2-?0 line showed a significantly lower 
amount o f time on the exposed open arms relative to the enclosed arms (one-way 
ANOVA; F2,73= 5.71, /?<0.01) in comparison to KO mice o f the Igf2-Null line and 
WT controls (post hoc tests; Fi,3o= 6.84, /t<0.05 and Fi,6i= 10.27, p<0.0\ , 
respectively), as shown in Figure 4 .IB. There was a slight reduction in the number o f 
entries onto the exposed open arms as the session progressed (Figure 4.2A, within- 
subject test: F7,5i2= 5.68, /?<0.001). Although the Igf2-P0 KO mice made on average 
fewer entries onto the open arms during the EPM session than subjects o f other 
genotype groups (Figure 4.2B), this was not found to be significant (one-way
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Figure 4.1: Time spent on the open arms during the EPM. (A) The total amount o f  time 
spent on open arms between subjects o f  different genotypes, over the course o f  the 10 
minute session. (B) The percentage o f  time spent on the open arms, between genotypes. 
Data are presented as mean values along with SEM.
*Significant at p<0.05.
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ANOVA; F2,73= 1.61, n.s.).
No difference was found between subjects o f different genotypes for the 
latency o f  the first entry onto the exposed open arms (7g/2-P0 KO: 15.0 ± 4.8; Igf2- 
Null KO; 12.1 ± 1.8; WT controls: 10.0 ± 1.4, F2,65= 1.04, n.s., one-way ANOVA; 
F2,73= 1.01, n.s.). While a one-way ANOVA reported a significant difference between 
groups o f different genotype in the number o f rears (one-way ANOVA; F2,65= 3.35, 
/?<0.05), suggestive o f fewer rearing among the Igf2-P0 KO mice (7g/2-P0 KO: 153.1 
± 18.2; /g/2-Null KO; 220.6 ± 29.5; WT controls: 204.2 ± 14.4), a post hoc 
comparison did not show this difference to be significant (F2,73= 5.41, n.s.). No 
significant differences were found in either the number of head dips (7g/2-P0 KO:
56.4 ± 6.4; 7g/2-Null KO; 71.1 ± 4.5; WT controls: 67.2 ± 3.6, F2,65= 1.04, n.s.) nor 
stretch attends (7g/2-P0 KO: 22.6 ± 5.4; Igf2-Null KO; 23.9 ± 3.7; WT controls: 25.0 
± 1.3, one-way ANOVA; F2,65= 1 04, n.s. and F2,65= 0.20, n.s., respectfully) between 
genotypes.
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Figure 4.2: Number o f  entries made into the open arms during the EPM. (A) The 
frequency o f  entries made onto the open arms betw een subjects o f  different genotypes, 
over the course o f  the 10 minute session. (B) The total frequency o f  entries onto open 
arms, between subjects o f  different genotype. Data are presented as mean values along 
with SEM.
Furthermore, the results did not show any evidence o f differences in 
locomotor activity between different genotypes. The total distance moved and time 
spent moving on the maze, during the session was equivalent across subjects (one­
way ANOVA; F2,73= 0.01, n.s. and F2,73= 2.54, n.s., respectively) and the averaged 
velocity (cm/sec) o f locomotion was also not significantly different (F2,73= 0.01, n.s.).
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A separate analysis o f behavioural parameters between the WT controls o f the 
different KO lines did not reveal any overall difference in the amount of time spent on 
the open arms or in the frequency of open arm entries, the WT littermates of the Igf2- 
Null KO line displayed elevated levels of activity on all three indices of locomotion 
(see Appendix 2.1).
4,3,2 The open field  paradigm
The area o f the OF was subdivided into three virtual regions using the Noldus 
video tracking software; outer, middle and inner. All o f the subjects demonstrated 
thigmotaxic behaviour, concentrating the majority o f their ambulation in the 
peripheral (outer) region near the walls of the OF, in contrast to the central region 
composed of the middle-square; Igf2-P0 KO mice (one-sample T-test): *(16)=-22.95, 
/K0.001, r=0.99; /g/2-Null KO mice: /(10)=-22.82, /?<0.001, r=0.99; WT controls: 
?(41)=-47.93, /?<0.001, ^=0.99. Overall, there were no differences observed between 
subjects o f different genotype in the percentage of time spent within the either inner- 
square (one-way ANOVA; F2,67=0.21, n.s.) or middle-square (F2,67=0.17, n.s.), 
relative to the overall session duration (i.e. time spent in the entire arena, Figure 4.3A) 
and there was no difference found between genotypes for the frequency of inner- 
square entries (F2,67=0.88, n.s.) or middle-square entries (F2,67=0.56, n.s.), as shown in 
Figure 4.3B. Additionally, subdividing the 20-minute session into 10 equally sized 
blocks also did not yield significant differences between the different groups of mice 
(or interaction) for the time spent in or entries to the middle region of the maze 
(Figure 4.4A, within-subject test; F2,67=0.18, n.s., and Figure 4.4B, F2,67=0.58, n.s., 
respectively) but showed that there was a steady increase in both the time spent in the 
central region (i.e. the inner-square) (Figure 4.4A, F6,3 9 0 = 1 0.92, /?<0.001) and the 
frequency of entries into the more central regions of the maze (Figure 4.4B, 
F6,420= 13.77, /><0.001), as the experiment progressed during the first 8-10 minutes. 
However, the number o f entries into the central region began to slowly decline 
towards the latter half o f the experimental session.
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Figure 4.3: Two o f  the main indices o f  anxiety-related behaviour during an OF session. 
(A) The percentage o f  time spent in the inner- and middle square relative to time spent in 
the entire arena, between subjects o f  different genotype. (B) Frequency o f  entries into the 
inner-square and middle square, between subjects o f  different genotype. Data are 
presented as mean values along with SEM.
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Figure 4.4: Two o f  the main indices o f  anxiety-related behaviour across 2-minute blocks 
throughout the OF session. (A) The time spent in the inner-square, between subjects o f  
different genotype. (B) Frequency o f  entries into the inner square, between subjects o f  
different genotype. Data are presented as mean values along with SEM.
Mice o f the IgP-PO KO line displayed a significantly greater latency to enter 
the inner-square for the first time (Figure 4.5, one-way ANOVA; F2,67= 4.31,/?<0.05), 
relative to WT-littermate controls (post hoc test; Fif57= 8.10, /?<0.05), but this 
difference was not significant in comparison with /g/2-Null KO mice (post hoc test; 
Fi,26= 4.46, n.s.) and between /g/2-Null KO mice and the WT controls (post hoc test; 
Fi,5i= 0.00, n.s.). In addition, there were no significant differences between mice o f
8 6
the different genotypes in general parameters of locomotor activity, in terms o f the 
total amount o f distance moved during the session (one-way ANOVA; F2,67=0.41, 
n.s.), the amount o f time spent moving (one-way ANOVA; F2,67= 1.17, n.s.) or in the 
average velocity o f locomotion (one-way ANOVA; F2,67= 0.40, n.s.). An analysis 
between the different WT-control subjects from each KO line did not reveal any 
variation in performance during the OF test, as summarized in Appendix 2.2.
WT Igf2-P0 Igf2-Null
Figure 4.5: The latency o f  firs t entry into the central region 
o f  the OF arena (inner-square). between subjects o f  different 
genotype. Data are presented as mean values along with 
SEM.
*Significant at p  <0.05.
4.3.3 Comparison o f  elevated plus-maze and open fie ld  performance
A correlation analysis (pearson’s r) was carried out on a subset o f subjects that 
were included in the behavioural analysis in both the EPM and OF paradigms; Igf2-P0 
KO mice (/?): 17, /g/2-Null KO mice (n): 10 and WT controls (n): 37 (of which WT- 
P0 (n): 20 and WT-Null (n): 17). The results showed a moderate and significant 
negative relationship between percentage o f time spent on the exposed open arm on 
the elevated plus maze and latency o f first entry into the central region o f the open 
field arena (inner-square), or r=-0.38, (one-tailed) /?<0.001, respectively. Furthermore, 
when the data were examined separately for each genotype, the results showed that 
this association was only significant for mice o f the Igf2-P0 KO line, at r= -0.52, p  
(one-tailed)<0.05 (/g/2-Null KO: r= -0.18,/? (one-tailed)=n.s.; WT controls: r=-0.22,
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p  (one-tailed)= n.s.). Therefore, this significant correlation between separate measures 
of behaviour from two independent paradigms further supports the idea of increased 
levels o f anxiety in the 7g/2-P0 KO line o f mice.
4.3.4 The free-exploratory paradigm
A second group of mice were assessed for performance in the FEP, where 
exploration between habituated and novel compartments was compared. All subjects 
exhibited greater preference to explore the novel compartment during the 15 minute 
test of free-exploration (Figure 4.6A), although this novelty preference was only 
found to be significant for Igf2-PO KO mice and WT-littermate control subjects (one- 
sample T-test; f(18)= 4.25, /?<0.001, r= 0.99 and f(39)= 7.60, /?<0.001, r= 0.99, 
respectively). The absence of a significant effect on novelty exploration by mice of 
the 7g/2-Null KO line (f(8)= 1.75, n.s.) might be a result of the low n (9) in this group 
and, hence, leading to insufficient statistical power. However, mice of the 7g/2-P0 
KO line exhibited a significantly lower preference for the novel compartment during 
the free-exploratoiy session when compared with WT controls (Figure 4.6A, one-way 
ANOVA; F2,65= 4.54, p<0.05, post hoc test: Fi,57= 7.55, /?<0.05). Moreover, while 
there was no difference observed in latency of first entry into the novel compartment 
across subjects (one-way ANOVA; F2,65= 0.06, n.s.), the latency to enter distal part of 
the novel compartment was significantly increased among Igf2-?0 KO mice (Figure 
4.6B, one-way ANOVA; F2,65= 4.20, /?<0.05, post hoc test: Fi,57= 7.75,/?<0.05).
Conversely, there was no difference found in the proportion of time spent in 
the distal part of the novel compartment between subjects of the different genotypes 
(one-way ANOVA; F2,65= 0.24, n.s.), the number of entries made into the novel 
compartment (one-way ANOVA; F2,65= 0.82, n.s.) or into the distal part of the novel 
compartment (one-way ANOVA; F2,65= 2.21, n.s.). As expected, a repeated measures 
analysis indicated that the number of entries into the novel compartment declined 
rapidly for all subjects as the experimental session progressed (Figure 4.7A, within- 
subject test; F9,585= 26.98, /?<0.001), whereas preference for the novel compartment 
remained relatively stable across the session (Figure 4.7B, within-subject test; F5i304= 
1.77, n.s.). There were no significant effects of the different genotypes on measures of 
locomotor performance during the exploratory session in terms of distance moved, as 
reported by a one-way ANOVA (F2,65= 1.96, n.s.), the amount of time spent moving
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(F2,65= 1.46, n.s.) or the average velocity o f locomotion (F2,65= 0.90, n.s.). Also, no 
difference was observed between WT controls o f the different mutant lines, as shown 
in Appendix 2.3.
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Figure 4.6: Behavioural measures in the FEP. (A) The percentage o f  time spent in the 
novel compartment relative to time spent in the familiar compartment, across subjects o f  
different genotype. (B) Latency o f  first entry into the distal part o f  the novel 
compartment, between subjects o f  different genotype. Data are presented as mean values 
along with SEM.
*Significant at p  <0.05.
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Figure 4.7: Two o f  the main indices o f anxiety-related behaviour across 2-minute blocks 
throughout the FEP session. (A) The time spent in the novel compartment, between 
subjects o f  different genotype. (B) Frequency o f  entries into the novel compartment, 
between subjects o f  different genotype. Data are presented as mean values along with 
SEM.
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4.4. Discussion
The converging findings of this series of experiments provide evidence for an 
enduring alteration in stress and anxiety-related behaviour, as a consequence o f IUGR 
by placental insufficiency, and builds upon the results found in the previous chapter. 
Mice o f the Igf2-P0 KO line displayed heightened levels in anxiety-related behaviours 
in the EPM, OF and FEP. The Igf2-PO KO mice showed greater aversion for the 
exposed open arms of the EPM as reflected by the significant decrease in the 
proportion o f time spent on the open arms relative to the enclosed arms, whereas these 
mice also showed greater reluctance to explore the central region o f the OF arena (as 
indicated by the increased latency o f first entry to the region). Furthermore, a similar 
pattern of findings were produced when a separate cohort of mice were assessed in the 
FEP, where the Igf2-PO KO mice displayed a reduced preference for the novel 
chamber in comparison with WT controls (suggested by a lower proportion of time 
spent in the novel compartment) and showed greater reluctance to explore the distal 
part of the novel compartment. Mice of the Tg/2-Null KO line did not show any 
significant difference on any o f the conflict tests of anxiety-related behaviour. 
Moreover, the fact that the Igf2-PO KO mice did not exhibit any differences on any of 
the measures o f locomotor aspects provides strong support that the behavioural 
differences observed on these conflict tests were likely to be due to alterations in 
anxiety (or stress) levels, rather than because of variations in locomotor activity. The 
findings of these series of experiments also provide further support for a behavioural 
dissociation between the Igf2-KO lines, as mentioned in Chapter III (section 3.4).
The collective results from this series of experiments are in line with the 
extensive human epidemiological data, which infer the possible importance of 
intrauterine environment in the aetiology of adult stress or anxiety-related disorders 
(see section 4.1). The present work is also consistent with a number of studies using 
animal models that suggests an essential role for nutritional programming in particular 
(see section 4.1). Moreover, these data may be of relevance to research examining the 
effects of IUGR on the hypothalamic-adrenal-pituitary (HPA) axis and appears to be 
consistent with the evidence of later anxiogenic consequences of intrauterine 
malnutrition, which has emerged from the human and animal work (see Chapter I, 
section 1.4.2.1 for review). In fact, hyperactivation of the HPA axis, implicitly linked 
via the actions o f cortisol in stress responses and anxiety (see Weber, 1998 for
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review), has also been proposed as the nexus in mediating early life adversities with 
metabolic and cardiovascular sequelae in later life (McMillen and Robinson, 2005). 
Several studies have demonstrated raised levels of plasma cortisol in adulthood, 
among individuals o f LBW (Lewitt, et. al., 2000; Philips et al., 2000; Philips et al.,
1998) or bom SGA (Cianfarani et al., 2002; Houang et al., 1999). Consistent with the 
human studies, exposure of foetal rats to maternal under-nutrition has also been 
shown to result in elevated plasma corticosterone levels during early postnatal life 
(Navarrette et al., 2007; Lesage et al., 2001). Similarly, plasma corticoid levels were 
found to be elevated in lambs bom to ewes that had been briefly exposed to moderate 
under-nutrition during late gestation (Edwards and McMillen, 2001), although 
opposing effects have also been observed with more prolonged nutritional restrictions 
in sheep (Bispham et al., 2003). In this context, the current findings highlight the 
importance o f investigating HP A functionality in Igf2-P0 KO mice (see section 8.7).
The limbic system (incorporating the amygdala and hippocampus) has been 
implicated as one o f the key neuroanatomical substrates underlying anxiety and fear 
related behaviours (Engin and Dallas, 2007; Bannerman, et al., 2004). Further, while 
amygdala lesions have been shown to distinctively impact upon the fear response 
during fear-conditioning tasks, lesions to the hippocampus are noted to particularly 
exert effects on unconditioned ethologically based tests of anxiety (see Bannerman et 
al., 2004 for review) such as those presented here. For instance, a marked reduction in 
anxiety-related behaviour was observed in tests of social interaction and the 
successive allays apparatus (a modified version of the EPM), following selective 
lesions to either dorsal or ventral parts of the hippocampus, whereas ventral 
hippocampal lesions have also been found to result in anxiolytic effects on the EPM 
and light-dark test (McHugh, Deacon, Rawlins and Bannerman, 2004; Kjelstrup et al., 
2002). Similar anxiolytic effects have been reported, when preceded by electrical 
stimulation o f the hippocampus (Dringenberg, Levine and Memard, 2008). Moreover, 
pronounced over-secretions o f adrenocortioctrophine and corticosterone have been 
noted among rats in response to acute restraint stress, as well as heightened basal 
corticosterone levels, following hippocampal lesions (Feldman and Weidenfeld, 
1995).
Although a number o f neurotransmitter systems have been implicated in the 
control of stress and anxiety-related behaviour (e.g. cholesystokinin, noradrenaline 
and glutamate), the GAB A- and serotonergic (5-HTergic) systems are generally
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thought to have the major role (Millan, 2003; Clement and Chapouthier, 1998). 
Moreover, it is notable that the anxiety-modulating receptor subtypes of the GABA- 
and serotonergic systems have enriched expression in the hippocampus (Mehta and 
Ticku, 1999; Hoeyer et al., 1994, respectively). A number of micro-infusion studies 
have demonstrated a reduction in anxiety-related behaviour on various conflict tests of 
anxiety, following hippocampal injections of direct or indirect benzodiazepine acting 
GABAa receptor agonists (Rezayat, RoohBakhsh, Zarrindast, Massoudi and 
Djahanguiri, 2005; Menard and Treit, 2001; Gonzalez, Ouagazzal and File, 1998). On 
the other hand, the functional role of the 5-HT system in stress- and anxiety-related 
behaviour is less clear, where some studies have reported intra-hippocampal injection 
of 5-HTia agonists to have anxiolytic effects on the elevated plus maze (Menard and 
Treit, 1998; Kotwoski, Plaznik and Stefanski, 1989) or no differences on anxiety- 
related performance (Files, Gonzalez and Andrews, 1996; Belcheva, Belcheva, Petkov 
and Petkov, 1994). Moreover, an anxiogenic effect of 5-HTia agonists on subsequent 
testing of social interaction has even been recorded (Andrew, Hoggs, Gonzalez and 
File, 1994), with a reduction in anxiogenic behaviour on the elevated T-maze, 
following injection of SR46349B, a selective 5-HT2A antagonist (Mora, Netto and 
Graeff, 1997). Unfortunately, the reasons for these paradoxical findings are not 
entirely certain but they still highlight a significant involvement of hippocampal 5-HT 
systems in modulating stress- and anxiety-related behaviours.
Therefore, the early developmental vulnerability of the hippocampus, 
illustrated in previous research (see Chapter I for review), may suggest this neural 
circuitry plays a role in the mediation of the anxiety-related phenotypes observed 
among the Igf2-P0 KO mice. Further, the results from the aforementioned 
neurophysio logical investigations of stress and anxiety-related disorders, also suggest 
that either GAB A- and/or 5-HTergic neurotransmitter pathways might be affected by 
altered developmental trajectories from the early life nutritional insult. In order to 
provide further evidence for this possibility, a neurobiological assessment of the Igf2- 
P0 KO mice in relations to their WT-littermates, is required (see Chapter VIII).
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4.4.1 Summary o f key results from Chapter IV
• Igf2-PO KO mice spent proportionally less time on the open arms of the EPM, 
relative to /g/2-Null KO mice and WT controls.
• Zg/2-PO KO mice displayed greater latency to enter the exposed open region of 
the OF arena, than /g/2-Null KO mice and WT controls.
• In the FEP, the Igf2-PO KO spent significantly less time in the novel 
compartment of test apparatus and showed greater latency to enter the distal 
part o f the novel compartment, when compared to /g/2-Null KO mice and WT 
controls.
• /g/2-Null KO did not show any difference from WT controls on any of the 
conflict tests of anxiety.
• No difference was found between the Ig/2-KO mice and WT controls, on any 
of the parameters indexing locomotor competence, during the EPM, OF and 
FEP.
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Chapter V
Investigating Attentional Function and Behavioural Inhibition 
in Igf2-P0 and Igf2-Null Knockout lines: 5-Choice Serial 
Reaction Time Task
5.1 Introduction
Attention deficit-hyperactivity disorder (ADHD, DSM-IV-TR, 2000) is one o f the 
many neuropsychiatric disorders that have been associated with intrauterine life 
events (Breslau, 1995). ADHD is an early-onset pathophysiologically heterogeneous 
disorder, highlighted by poor sustained attention, hyperactivity and impulsivity. It is 
one of the most commonly diagnosed behavioural disorders in children and 
adolescents, with prevalence varying between 5-10% of children (Linnet et al., 2003), 
and diagnosis being approximately four times more common in males than females 
(Cuffe, Moore and McKeown, 2005). Findings from family-gene, twin, adoption and 
segregation analysis studies indicate that ADHD is a highly heritable neuropsychiatric 
disorder (see Franke, Neale and Faraone, 2009 for review). However, despite 
extensive efforts from recent candidate-gene association and genome wide linkage 
research, no major genes have been identified for ADHD (main candidate genes 
explain about 1% of the variance of phenotypes), and individual gene variants have 
only displayed modest effects (Plomp, Engerland and Durston, 2009). Moreover, 
according to data from monozygous twin studies the concordance of ADHD is 
estimated to be about 0.76 (Faraone and Biederman, 2005; Thapar, Holmes, Poulton 
and Harrington, 1999), which suggests that the aetiology of ADHD is also likely to 
include environmental factors or perhaps more likely, as a result from the interplay 
between genetic and environmental risk factors.
In the last decade, there has been an increased interest in the notion that 
ADHD susceptibility could be partially related to a suboptimal foetal environment. In 
this regard, a number o f case-control studies have consistently reported higher rates of 
hyperactivity and inattention among children of low birth weight (LBW) in 
comparison to normal birth weight children, based on assessments by parents and 
teachers (Indredavik, Heyerdahl, Kulseng and Brubakk, 2005; Zubrick et al., 2000:
94
Breslau et al., 1996; McCormick, Workman-Daniels and Brooks-Gunn, 1996). 
Moreover, children bom at term with birth weights ranging between 1500-2499g had 
a 90% increased risk of being diagnosed with ADHD (Linnet et al., 2006), but in 
parallel, children with ADHD were shown to be three times more likely to have been 
bom with LBW relative to nonADHD children (Mick, Biederman, Faraone, Sayer and 
Kleinman, 2002). Similar findings have also been demonstrated in studies where 
weight and size at birth were adjusted for gestational age (Schlotz, Jones, Godfrey and 
Philips, 2008; Lahti et al., 2006; Indredavik et al, 2005).
Although these retrospective epidemiological studies support the notion that 
part of the susceptibility for ADHD can be attributed to early life events, the exact 
implications of these findings are difficult to interpret. One issue is that foetal weight 
and size (even in at-term births) do not necessarily represent surrogate measures for 
foetal growth. Another issue concerns the fact that birth weight and size is a 
consequence o f many factors, both genetic and environmental. Some of these 
environmental factors may be related to ADHD susceptibility, whereas others may 
not. Alternatively, intrauterine growth retardation (IUGR) per se might affect ADHD 
susceptibility, regardless o f the nature o f its causal determinants. While suboptimal 
nutrition supply to the growing foetus has been advocated as one of the key 
programming stimuli that underlie the relationship between IUGR and later life 
disorders (Gallou-Kabani and Junien, 2005; Harding, 2004; Barker, 1997), other 
environmental factors such as maternal alcohol use, smoking and stress, have also 
been implicated (see Kramer, 1987 for review). In fact, in previous epidemiological 
studies, ADHD symptoms have been positively correlated with maternal alcohol use 
(Mick et al., 2002; Streissguth, Sampson and Barr, 1989), smoking (Mick et al., 2002; 
Milberger, Biederman, Faraone and Jones, 1998) and stress (O’Connor, Heron, 
Golding, Beveridge and Glover, 2002; McIntosh, Mulkins, and Dean, 1995), 
independently o f birth weight; importantly, there have not been any studies showing 
such relationship between intrauterine malnutrition and ADHD susceptibility.
Therefore, the main objective of this chapter is to investigate whether 
intrauterine malnutrition and foetal growth retardation in genetic model system, affect 
attentional function and impulsivity (in terms of response inhibition), in later life. In 
this study, aspects o f attentional function and impulsivity were compared between 
mice o f both Ig/2-KO lines and wild-type (WT) littermates, using the 5-choice serial 
reaction time task (5-CSRTT). The 5-CSRTT is a widely used test of attentional
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performance in rodents (Higgins and Breysse, 2008), and has been considered to be an 
analogue of the continuous performance task (CPT), which examines attentional 
functions in humans (Robbins, 2002). In the 5-CSRTT, subjects are required to 
respond as accurately and as rapidly as possible to a brief visual stimulus which is 
randomly presented in one of five spatial locations, in order to receive a reinforcer. 
Since accurate responding requires attention on both temporal and spatial domains by 
the subject, this task provides considerable parametric flexibility and potential 
independent assessment of the spatial and temporal component of attention (e.g. 
between selective and sustained attention) (Bushnell, 1998). Furthermore, although 
discriminative accuracy performance can be confounded by other sensory, motor or 
motivational processes, these interpretations can be disambiguated to some extent, by 
considering the overall behavioural profile of the results (see Robbins, 2002 for 
review). While the 5-CSRTT was primarily developed to examine attentional 
functions in rodents, aspects of response inhibitory control are also indexed by the 
number o f premature responses, occurring inappropriately during the interval between 
trials and prior to the presentation of the visual stimulus. Other measurement of 
behavioural phenotypes provided by the task, include; motivation (latency to collect 
the reinforcer , the effects o f ad libitum feeding prior to test, number of trials and 
reaction times) and locomotor activity (as indexed by beam-breaks crossing the 
operant chamber and reaction times). Moreover, a number of task manipulations may 
be introduced during the course of this task, in order to tax dissociable aspects of 
behaviour.
5.2 Materials and Methods
Full methodological descriptions can be found in the relevant sub-sections of 
the General Methods Chapter (Chapter II).
5.2.1 Subjects and animal husbandry
A cohort of 95 male mice (generated from the Behavioural Neuroscience 
Laboratory at Cardiff University), aged 13-16 weeks at the onset of experiment, were 
subjected to testing on the 5-CSRTT (see Table 5.1). The mice were obtained from a 
crossbreeding of background strain of C57BL/6*129 (carrying either the mutant Igf2-
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PO allele or the /g/2-Null allele) with CD1 female, as previously described in Chapter 
II, section 2.1.
Table 5.1: The sample size and genotype o f  the total litter cohort w hich began 
and completed the 5-CSRTT.
I______  Genotype and sample size (/?)__________I
Status
Number of subjects to 
begin the 5-CSRTT 29 16
50
(30/20)
Number of subjects to 
complete the 5-CSRTT 22 13
37
(25/12)
Mice were housed in littermate groups o f two to five animals per cage, under 
temperature- and humidity-controlled conditions, with a 12-hour light: 12-hour dark 
cycle (lights on at 07:30 hours). All subjects had access to standard laboratory chow 
and water ad libitum, unless otherwise mentioned. From the onset o f the experiment, 
mice were maintained on a regime o f regulated access to water in the home cage (as 
detailed in section 2.4.4). Initially, for 4-hours/day (for 2 days) before reduction to 2- 
hours/day for the duration o f behavioural testing. Upon stabilization o f body weight 
under this regime, mice began habituation o f the rein forcer followed by testing on the 
5-CSRTT. Throughout this period, body weight was monitored regularly, and any 
mice losing more than 10% of normal body weight (measured during ad libitum 
water) were returned to ad libitum water. All experimental procedures were 
conducted under licenses issued by the Home Office (U.K.) in compliance with the 
Animals (Scientific Procedures) Act 1986 and local ethics committee.
5.2.2 Behavioural methods
5.2.2.1 Reinforcer habituation and preference testing
Habituation to the condensed milk solution (10%) reinforcer was carried out 
for all subjects across six daily sessions o f 10 minutes. For the first two days, mice 
were presented with two bowls o f water during, while in the following four sessions 
the mice were presented with one bowl o f water and one bowl o f condensed milk 
solution. For each session, the volume o f each liquid consumed was recorded and total 
liquid consumption, and condensed milk preference was calculated in terms o f  as the
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condensed milk consumed/total volume of liquid consumed (see Chapter II, 2.4.5 for 
further details). Due to the weight differences between the 7g/2-P0 KO, 7g/2-Null KO 
and WT-control mice, the volumes consumed were normalised for body weight using 
Kleiber’s 0.75 mass exponent (Schmidt-Nielsen, 1990).
5.2.2.2 5-choice serial reaction time task (5-CSRTT)
The experimental work for the 5-CSRTT task was carried out in nine-aperture 
operant chambers, previously modified for use in mice (Humby et al., 1999) with four 
of the nine apertures, apertures 2, 4, 6 and 8, in the response array blocked (see 
Chapter II, section 2.5.7). Aspects of attentional functions and impulsivity were 
examined by measurement o f discriminative accuracy and the number of premature 
nose-pokes respectively, but other parameters of interest included; omissions, trial 
numbers, correct reaction time (correct RT), magazine latency (MagLat). The mice 
performed one 20-minute session per day with a maximum of 100 trials per session. 
See Chapter II, section 2.3 for further details.
5.2.2.2.1 Initial behavioural shaping
Shaping was carried out over eight consecutive daily sessions (of 20-minute 
duration each) in order to habituate the mice to the chambers and train them to obtain 
the condensed milk reinforcer from the food magazines. All of the apertures in the 
response array were covered with a transparent plastic film, throughout these shaping 
sessions. In the first three sessions, the door to the food magazine panel was wedged 
open to enable easy access to the reinforcer, and reinforcer delivery (50 deliveries of 
40pl each, 30-second intervals) was accompanied by an illumination o f the tray light 
in the food magazine. On the fourth and fifth sessions, the magazine panel was 
released which constrained the mice to push the panel open (termed ‘panel-push’) in 
order to gain access to the reinforcer. Any mice which failed to learn this procedure 
were given additional shaping sessions to overcome this obstacle. In the sessions 
seven and eight, the structure of the task was altered such that the delivery of the 
reinforcer was under the control o f the subjects (i.e. by emitting a conditioned 
response). Thus, a panel push initiated the onset of a 10-second light stimulus 
(presented pseudo-randomly at each of the five stimulus positions in the nose poke
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array) along with the delivery of the reinforcer 1 second prior to light stimulus offset, 
thus allowing the mice to associate the stimulus offset with delivery of the reinforcer. 
The tray light illuminated concomitantly with the reinforcer delivery and remained 
until the subject made another panel-push, initiating the next trial. The final two 
shaping sessions lasted for 20 minutes or upon reaching 100 trials (which ever 
occurred first), and apart from the nose-poke component, constituted the basic trial 
design of the 5-CSRTT.
5.2.2.2.2 5-CSRTT: trial design
From session nine, the transparent plastic film covering the apertures in the 
response array was removed allowing subjects to make nose poke responses to the 
stimuli. Each session lasted for 20 minutes or upon reaching 100 trials, which ever 
occurred first, and at the beginning of each session the first trial was initiated by a 
panel-push and commenced with a 5-second inter-trial interval (ITI), followed by a 
stimulus presentation in one of the five apertures of the response array. The sequence 
of the light stimulus presentation was predetermined by a pseudo-random schedule, 
by which there were four presentations at each o f the five apertures within a block of 
20 trials (thus five blocks within a session). Subjects were required to respond with a 
nose-poke in the illuminated aperture within the duration of the stimulus presentation 
and a 5-second limited hold period. If the mice emitted a response in the correct 
aperture within this time period, reinforcer (20pl condensed milk) was dispensed in 
the food magazine along with an illumination of the tray light (see Figure 5.1). The 
next trial was initiated by the collection o f the reinforcer (i.e. panel-push) and the 
subsequent exiting of the food magazine.
Alternatively, if mice responded with a nose-poke in any of the four non­
illuminated apertures (incorrect response) or failed to make a response within the 
defined response period (omission), a 5-second time-out period was implemented with 
the onset of the house lights. Similarly, a premature response during the ITI also 
resulted in a 5-second time-out period. However, the time-out period could be 
cancelled by a panel-push, which started a new trial.
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r  Time-out(house light switched on for 5sec) No noseJ  Premat
___________ ■— — — | Incorre
StirmJus presentation 
ane* Push (duration: 32-0.8sec)
m  ■------------------------------------ ,
Delivery of reinforcer (20pl) 
along with tray lightFigure 5.1: Schemata o f  the possible sequences o f  events during a 5-CSRTT trial. 
Trials were initiated by a panel push, with an inter-trial interval (ITI, 5-sec at 
baseline) followed by brief stimulus presentation (0.8-sec at baseline) at one o f  five 
possible apertures in the nine-hole array. I f  subjects made a correct response, 
reinforcer is delivered in the food  magazine behind the panel, and the next trial 
begins. Alternatively, i f  the subject fails to make a response, makes an incorrect 
response or responds too early, a 5-sec time-out period is signalled by the house 
light.___________________________________________________________________
5.2.2.2.3 5-CSRTT: training to baseline performance
At the outset o f 5-CSRTT sessions, the length of the stimulus presentation was 
set at 32 seconds to facilitate learning, although this duration was gradually reduced to 
a baseline duration o f 0.8 second in the following stages; 32 second, 16sec, 8sec, 4sec, 
2sec, 1.8sec, 1.6sec, M sec, M sec, l.Osec and 0.8sec. The stimulus duration was 
reduced for each individual subject on attaining pre-established performance criteria 
across three consecutive sessions, which was confined to; >80% accuracy, <20% 
omission and >20 trials per session. No other parameters were altered during the 
acquisition o f baseline performance.
5.2.2.2.4 5-CSRTT: behavioural manipulations
Once subjects had reached stable baseline performance at a stimulus duration 
o f 0.8 second, defined by the same criteria as described above, a variety o f 
behavioural manipulations designed to measure dissociable aspects o f attentional 
load, impulsivity and motivation, were undertaken. Each manipulation was 
implemented following two consecutive days o f stable criterion performance. The
100
order o f manipulations is listed in Table 5.2. During manipulation sessions, the 
various parameters were presented pseudo-randomly and interpolated within baseline 
stimuli conditions. The initial two manipulations were designed to increase attentional 
load by disrupting the temporal predictability of the stimulus presentation by 
decreasing or increasing the ITI, albeit the second manipulation also taxed response 
control by prolonging the period for the awaited stimulus. Manipulations three and 
four also assessed attentional load, by reducing or increasing the stimulus duration 
and thus making the stimuli more or less discriminable. In manipulations five, mice 
were given ad libitum access to the 10% condensed milk (i.e. the reinforcer), 
respectively, 20 minutes prior to a baseline session, in order to assay the effects o f 
reductions in primary motivation. Furthermore, the final manipulation (7) involved 
the imposition o f a short burst o f a distracting white noise (lOOdB), o f 0.5 second 
length, at varying times within the 5-second ITI prior to the stimulus onset, in order 
examine aspects o f selective attention.
Manipulation Parameters Main effect on behaviour
(1) Short inter-trial 
interval
ITI: 5sec (baseline), 4sec, 3sec, 2sec Increase attentional load
(2) Long inter-trial 
interval
ITI: 5sec (baseline), 6sec, 7sec, 8sec Increase attentional load 
Reduce impulse control
(3) Short stimulus 
duration
Stimulus Duration: 0.8sec (baseline), 
0.6sec, 0.4sec, 0.2sec
Increase attentional load
(4) Long stimulus duration Stimulus Duration: 0.8sec (baseline), 
1.2sec, 1.6sec, 2sec
Reduce attentional load
(5) A d lib condensed milk 
access 20min prior to test
None Reduce motivation
(6) White noise distracter 
(lOOdB) for 0.5sec
Presentation o f distractor: None 
(baseline), at beginning o f trial, at 
2.5sec into ITI, coincident with stimulus 
presentation
Increase attentional load
5.2.2.2.5 1-choice serial reaction time task (J-CSRTT)
Upon completion o f  the final manipulation session in the 5-CSRTT the task 
protocol was modified such that stimulus presentation was limited to the central 
aperture only as a further assessment o f alteration in attentional load. Altering stimuli 
presentation in this way, thus tested the extent to which any effects on discriminative
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accuracy in 5-CSRTT were related to attentional effects. During the 1 -CSRTT, the ITI 
was randomly varied within a baseline session (duration 4-seccond, 4.5-sec, 5-sec and 
5.5-sec) to add a degree o f temporal unpredictability. This was done in effort to 
ensure that the mice were reacting to the actual stimulus presentation, rather than 
merely timing their responses. In other respects, all protocol parameters remained in 
the same settings as in the 5-CSRTT.
5.2.2.2.6 Behavioural measures
Task acquisition of the 5-CSRTT was determined by the number of sessions 
required for each subject to reach baseline performance within the limits of the criteria 
outlined in section 5.2.2.2.3, and the number o f sessions taken at each training level 
(i.e. level o f stimulus duration). A number of different behavioural measures were 
recorded for each session, in order to establish a relatively broad behavioural profile 
of the /g/2-KO lines. The primary indices of attentional function were the percentage 
of discriminative response accuracy (i.e. correct responses/(correct + incorrect 
responses)) and the percentage of omissions, (number of omitted trials/total completed 
trials) reflecting possible failures o f detection and/or motivational or motor deficits. 
The number o f premature nose-pokes was used as an index of response control and 
among other measures o f interest were; total number of completed trials, correct RT 
(i.e. latency to respond to the correct aperture after stimulus presentation), latency to 
collect the reinforcer following a correct response, duration of eating (i.e. magazine 
latency, defined as the time the food magazine door (panel-push) was held open on 
the initial visit o f the subject after a correct response), and the number of nose-pokes, 
panel-pushes and beam-breaks per trial.
5.2,3 Statistical analysis
The data were either subjected to one-way analysis of variance (ANOVA) for 
a genotype (between-subject) comparison of performance, or a two-way repeated 
measures ANOVA to examine the effects of stimulus duration levels and levels of 
behavioural manipulations (both defined as within-factors) on performance within 
genotypes, as well as possible interactions. Moreover, any interactions observed, were 
foliowed-up by an additional one-way ANOVA or repeated measures ANOVA 
between the individual levels o f the within-subject factor. The genotype of subjects
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was defined as between-subject factor throughout the entire analysis, whereas specific 
within-subject factors were used in each analysis. Thus for the reinforcer habituation 
the following factor was used: the number of habituation session during reinforcer 
habituation, for 5-CSRTT acquisition the training stage, (defined by the stimulus 
duration), and the level of manipulation within 5-CSRTT manipulation sessions. A 
repeated measures analysis was also carried out in order to compare performance 
between the 5-CSRTT and 1-CSRTT. Finally, data from the separate WT-lines were 
clustered together for analysis see Appendix III (unless otherwise stated) in order to 
increase the statistical power and for reasons previously mentioned (in Chapter II).
5.3. Results
5.3.1 Reinforcer habituation and preference testing
Analysis o f the milk reinforcer preference and total volume consumption of 
the mice was only carried out on subjects that completed the 5-CSRTT (Figure 5.2). 
The preference of subjects for the condensed milk reinforcer increased rapidly 
throughout the four habituation sessions (Figure 5.2A, within-subject test; F3^o9= 
159.47, /?<0.001) with no significant differences between the different genotype 
groups (between-subject test; F2,69= 1.35, n.s). By the final habituation session, mice 
of all three genotypes had displayed a strong preference (>85%) for the condensed 
milk reinforcer. Furthermore, there was a steady increase in the total volume of liquid 
consumed over the course of the reinforcer habituation among all subjects (see Figure 
5.2B, within-subject test; F4^7o= 54.78, /?<0.001). There were no differences in the 
total volumes of liquid consumed between the different genotypes o f mice after the 
volume-consumption data had been corrected for differences in bodyweight (F2,69= 
2.06, n.s.). Comparison between the two WT-control mutant lines (i.e. WT-PO 
littermates and WT-Null littermates) did not reveal any difference in the preference 
for the milk reinforcer or in the overall volume of liquid consumed (see Appendix 
3.1).
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Figure 5.2: Reinforcer habituation. Subjects w ere only presented with w ater during 
the first two days o f  reinforcer habituation, but in the following four days an option 
between water and condensed milk (10%) was present. (A) Subjects established a 
relatively strong preference for the condensed milk reinforcer by day four, reaching 
levels >85%. (B) Total liquid consumption (water and condensed milk combined), 
normalised fo r  body weight o f  the subjects, gradually increased over the course o f  the 
reinforcer habituation sessions. For subject N  see methods section 5.2.1. Data are 
presented as mean±SEM. _ ________ ____
5.3.2 5-CSRTT acquisition
Although, all o f  the subjects successfully acquired the 5-CSRTT procedure 
and reached baseline performance, only 76% o f mice completed both 5-CSRTT and 
1-CSRTT (including all the manipulations, see table 5.1). The total number o f 
sessions required to reach stable baseline performance (~75 sessions) was equivalent 
between genotypes (one-way ANOVA; F2,69= 0.63, n.s.) and there was no difference 
between the groups o f mice in the number o f sessions required to complete each stage 
o f training (Figure 5.3, between-subject test; F2,69= 1-30, n.s.). The large number o f 
sessions required by the subjects to reach criteria at the 32-second stimulus duration 
(SD) level provided an index o f the learning o f the 5-CSRTT trial procedure and once 
having acquired the trial procedure, mice progressed relatively rapidly across the next 
few SD levels. However, once the stimulus duration decreased below 4 seconds the 
number sessions required to progress to subsequent levels, began to increase (within- 
subject test; F6,4io= 9.05, /?<0.001). A separate analysis o f WT-control lines (i.e. 
between WT-P0 and WT-Null control lines), did not show any differences in 5- 
CSRTT acquisition (one-way ANOVA; Fi,35= 0.37, n.s.).
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Figure 5.3: 5-CSRTT acquisition, in terms o f the number o f  sessions that were 
required fo r  subjects to reach criteria, at each o f the stimulus duration (SD) levels. 
Data are presented as mean±SEM.
The discriminative response accuracy of subjects showed a gradual overall 
increase during the 5-CSRTT acquisition phase (Figure 5.4A, within-subject test; 
Fg,56o= 4.62, p<0.001), but began to decline as the stimulus duration approached the 
baseline (0.8-sec) level. More importantly, mice o f the Igf2-PO KO line displayed a 
significantly heightened discriminative accuracy during the acquisition phase relative 
to WT controls (between-subject test; F2,69= 3.96, /K0.05; post hoc tests: Fij57= 6.83, 
/?<0.05), but no such difference was noted between Tg/2-Null KO mice and WT- 
controls (Fi,48= 1.81, n.s.). The rate o f omissions increased steadily among subjects as 
the SD level reduced during the acquisition phase, reflecting the rising attentional 
demands o f the task (Figure 5.4B, within-subject test; F6,448= 71.46, p<0.001), 
although the analysis did not reveal any difference across genotypes (between-subject 
test; F2,69= 1-18, n.s.).
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Figure 5.4: Performance of subjects on major behavioural measures at the different 
SD levels during 5-CSRTT acquisition. Data taken from final session at each level, and 
shows response accuracy (A), number o f  completed trials (B), omitted trials (C) and 
correct response latency (D). Data are presented as mean±SEM.
Although the number o f completed trials at each training stage was not 
consistent, Igf2-P0 KO and WT-control mice showed a significant increase in the 
number o f trials through the middle stages o f training (interaction between genotype 
and training stage, Fi5,532= 1.74, /?<0.05), but all groups o f mice were performing an 
equivalent number or trials by the time the acquisition phase had been completed 
(Figure 5.4C, one-way ANOVA at SD of 0.8sec; F2,69= 0.61, n.s.). Furthermore, the 
correct reaction time decreased during the course of acquisition (Figure 5.4D, within- 
subject test; F2,ii9= 255.60, /?<0.001) as the stimulus duration decreased. No main 
effect o f genotype was observed (between-subject test; F2,69= 1.47, n.s.) but there was 
a significant interaction between genotype group and training stage (F3,n9= 5.44, 
p<0.001) which indicated a lower correct RT among Igf2-?0 KO mice at the initial 
acquisition stage (i.e. SD= 32-sec). No difference was found between the two WT-
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control groups on any of the behavioural measures during the 5-CSRTT acquisition 
phase (see Appendix 5.2).
5.3.3 5-CSRTT baseline performance
The pattern of behaviour observed during acquisition was recapitulated once 
baseline performance has stabilised (Figure 5.4 and Table 5.3), with heightened 
discriminative response accuracy among mice of the Igf2-PO KO line relative to WT- 
littermate controls (Figure 5.5A, one-way ANOVA; F2,69= 4.48,/?<0.05,/?osf hoc test: 
Fi,57= 6.89, p<0.05), though no significant difference was found between the Igf2- 
Null KO mice and the WT controls (post hoc test; Fi,48= 4.79, n.s.). In contrast, 
analysis did not reveal any difference across genotypes in the rate of omitted 
responses (Figure 5.5B, one-way ANOVA; F2,69= 0.19, n.s.) or in the latency to 
respond to the correct aperture after stimulus presentation was the same across 
genotypes (Figure 5.5C, one-way ANOVA; F2,69= 0.35, n.s.). Significantly fewer 
premature nose-pokes were made on average by mice of the Ig/2-PO KO line, in 
comparison to WT controls (Figure 5.5D, one-way ANOVA; F2,69= 3.22, p<0.05, post 
hoc test: Fi,57= 5.61,/?<0.05). Zg/2-Null KO mice also tended to emit fewer premature 
responses than WT controls, albeit this difference did not yield significance (post hoc 
test: F 1,48=4.68,/?= 0.085).
Assessment of other behavioural measures (see Table 5.3) showed that there 
was no evidence o f difference in the number of trials initiated between genotypes 
(one-way ANOVA; F2,69= 0.09, n.s.), however, Igf2-Null KO mice showed a 
considerably lengthened latency to collect the reinforcer following a correct response 
(Kruskall-Wallis test; H2= 7.42, /?<0.05), relative to Igf2-P0 KO mice (post hoc test: 
U= 73, p<0.05, r=-0.40) and WT controls (post hoc test: U= 147, /?<0.05, r=-0.29). 
No genotype difference was found on other behavioural measures by one-way 
ANOVAs; duration o f eating: F2,69= 0.33, n.s., nose-pokes/trial: F2,69= 1.92, n.s., and 
panel-pushes/trial: F2,69= 0.07, n.s. A comparative analysis of the two WT-control 
lines did not show any difference on any the behavioural measures at baseline 
performance (see Appendix 3.3).
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Figure 5.5; 5-CSRTT baseline performance. Response accuracy (A), omitted trials 
(B). correct reaction time (C) and the number o f premature responses (D) from a 
baseline session following tw o consecutive sessions at criterion performance. Data are 
presented as mean±SEM.
*Significant at p  <0.05.
Table 5.3: 5-CSRTT performance at baseline level following two 
consecutive baseline sessions at criterion performance.
Behavioural Param eters Mean ± SE I
Trial num ber 55.8 ±5.1 52.8 ±6.7 55.7 ±3.4
Magazine latency (sec) 4.5 ± 2.8 *11.0 ± 4.0 2.2 ± 0.6
Duration of eating (sec) 2.5 ± 0.2 2.3 ± 0.5 2.6 ± 0.2
Prem ature nose-pokes 1.8 ±0.5 2.2 ±0.8 3.6 ± 0.5
Nose-pokes per trial 1.2 ±0.1 1.3 ±0.1 1.6 ±0.2
Panel-pushes per trial 1.8 ±0.2 1.6 ±0.1 1.6 ±0.1
*Significant at p  <0.05.
When the data were sub-divided by the location of the stimulus presentation 
the findings showed the anticipated pattern o f responses across all groups o f mice
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(data not shown). That is the attentional components of behaviour were found to be 
enhanced in trials where the stimulus was presented in the central or near centre 
apertures, relative to trials where stimulus presentation occurred in the peripheral 
apertures. These results along with the consistent performance pattern of the correct 
RT, suggest that the subjects adopted, as anticipated, a scanning and response strategy 
by using the central position as a point of reference. No difference was found in the 
pattern of responses between individual WT lines (see Appendix 3.4).
5.3.4 5-CSRTT baseline manipulations
5.3.4.1 Effects o f altering ITI length
Interpolating variable ITI durations had a considerable effect on the inhibitory 
response control o f subjects (Figure 5.6). The discriminative response accuracy was 
not affected by the altering ITI lengths (Figure 5.6A, decreased-ITI session (within- 
subject test): F2,i63= 1 00, n.s.; increased-ITI session (within-subject test): F3^o7= 1.56, 
n.s.), although a heightened accuracy was found among mice of both Igf2-KO lines 
(relative to WT controls) during the increased-ITI session (between-subject test; F2,69= 
7.17, /?<0.001, post hoc tests; Igf2-?0 KO: FU7= 9.77, /?<0.001; /g/2-Null KO: Fi,48= 
9.02, /K0.001). There were no genotype differences in the amount of omitted trials 
(Figure 5.6B) when the ITI durations were reduced (between-subject test; F2,69= 1.57, 
n.s.) or increased (between-subject test; F2,69= 0.39, n.s), but there was an increase in 
rates of omissions by all groups as the ITI was lengthened (within-subject test; F3>207= 
5.69, p<0.001). A main effect of genotype was reported for both ITI sessions in the 
number of premature nose-pokes (Figure 5.6C, between-subject tests; decreased-ITI 
session: F2,69= 3.71, p<0.05; increased-ITI sessio: F2,69= 5.59,/?<0.01), indicating a 
greater response inhibition among Igf2-?0 KO mice relative to the WT controls. This 
effect was against a general background of reduction in premature nose-pokes in the 
decreased-ITI session (within-subject test; F2,i25= 16.73, /?<0.001) and an increase in 
the increased-ITI session (within-subject test; F3,i86= 22.23, /?<0.001).
The number o f trials initiated did not differ during sessions where the ITI was 
altered (within-subject tests; decreased-ITI: F3^07= 2.36, n.s.; increased-ITI: F3^07= 
0.66, n.s.), nor was there any difference found between genotype groups (between- 
subject test; decreased-ITI: F2,69= 1.34, n.s.; increased-ITI: F2,69= 0.37, n.s.) and 
correct RT was not affected by altering ITI lengths (within-subject tests; decreased-
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Figure 5.6: The effects o f  altering the inter-trial interval (ITI), on 5-CSRTT 
performance. Mice were presented w ith sessions where ITI was randomly varied 
between trials. The figure shows performance in terms o f  response accuracy (A), 
omitted trials (B) and the number o f  premature nose-pokes (C), at each ITI 
duration. Data are presented as mean values±SEM.
ITI session: F3,i86= 0.68, n.s.; increased-ITI session: F2,i72= 1-79, n.s.). An analysis 
conducted on behavioural performance between the separate WT-control lines, did not 
reveal any significant difference (see Appendix 3.5).
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53.4.2 Effect o f altering SD length
An overall reduction in discriminative response accuracy was shown in 
sessions where the SD was reduced (Figure 5.1 A, within-subject test; F2,i2o= 20.08, 
/?<0.001), however there was no main effect found across genotypes (between-subject 
test; F2,69= 1.97, n.s.). Response accuracy was not affected by increasing the stimulus 
duration (within-subject test; F3,207= 1.03, n.s.), nor was there any difference between 
genotypes (between-subject test; F2,69= 2.03, n.s.). In parallel with the effect on 
response accuracy, shortening the stimulus duration induced an increase in omission 
rates (Figure 5.7B, within-subject test; F3^07= 25.92, p<0.001), and a significant main 
effect was found between genotypes (between-subject test; F2,69= 3.43, /?<0.05) at 
shortening-SD sessions, indicating fewer omissions by /g/2-Null KO mice relative to 
WT counterparts, although a post hoc comparison failed to verify this effect (Fii48= 
3.76, n.s.). Increasing the stimulus duration induced a decrease in omitted trials 
(within-subject test; F3,207= 6.57, /?<0.001), but showed no genotype-related 
differences (between-subject test; F2,69= 0.07, n.s.). Repeated measures analysis did 
not reveal any effect of SD length on the number of premature nose-pokes (Figure 
5.7C) within shortening-SD sessions (within-subject test; F3^o7= 0.64, n.s.), or 
lengthening-SD sessions (within-subject test; F3^07= 2.58, n.s.). Furthermore, in 
common with baseline results (see previous), /g/2-P0 KO mice made overall 
significantly fewer premature responses than WT controls during both shortening-SD 
sessions (between-subject effect; F2,69= 3.54, p<0.05; post hoc test: Fi,57= 6.74, 
/?<0.05) and lengthening-SD sessions (between-subject test; F2,69= 3.91, p<0.05; post 
hoc test: Fi,57= 6.57,/?<0.05).
Alteration o f the stimulus duration did not have any effect on the number of 
trials initiated, during either shortening-SD (within-subject test; F3^o7= 0.57, n.s.) or 
lengthening-SD sessions (within-subject test; F2,no= 1.07, n.s.) and there were no 
differences between genotypes (between-subject tests; shortening-SD: F2,69= 0.15, n.s, 
lengthening-SD: F2,69= 2.37, n.s). Correct reaction latencies were also not affected by 
altering SD during shortening-SD sessions (within-subject test; F2,i57= 0.18, n.s.) or 
lengthening-SD sessions (within-subject test; F3^07= 2.25, n.s.), and there were no 
differences noted between genotypes on correct RT in either o f the SD-altering 
sessions (between-subject tests; shortening-SD: F2,69= 5.82, n.s.; lengthening-SD:
1 1 1
1*2,69 0.56, n.s.). No difference was found between WT-PO mice and WT-Null mice 
for any measures, as shown in Appendix 3.6.
At reduced SD At lengthened SD
A
>*o
5
oo
CO
0co
co
Q.
CO0
OH
B
100 
90 
80 
70 
60 
50
60 
40 
20
C „
2.0
co
0M
R 15
1
CO
g  1.0 
£
3  0.5
COE
0£  o.o
-0.5
co
'co
CO
EO
’ WT-littermates 
Igf2-P0 line 
Igf2-Null line
0.2sec 0.4sec 0.6sec 0.8sec 0.8sec 1.2sec 1.4sec 1.6sec
 1---------- 1---------- 1---------- 1---------- 1---------- 1---------- 1---------- 1---
0.2sec 0.4sec 0.6sec 0.8sec 0.8sec 1.2sec 1.4sec 1.6sec
0.2sec 0.4sec 0.6sec 0.8sec 0.8sec 1.2sec 1.4sec 1.6sec
Figure 5.7: The effects o f  altering the stimulus duration (SD) on 5-CSRTT 
performance. Mice were presented with sessions where SD was randomly varied 
between trials. The figure shows performance in terms o f  response accuracy (A), 
omitted trials (B) and the number o f  premature nose-pokes (C) at each SD level. 
Data are presented as mean values±SEM..
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5.3.4.3 Effects o f  ad libitum reinforcer access prior to 5-CSRTT testing
Ad libitum access to the condensed milk reinforcer 20 minutes prior to testing 
significantly reduced the number o f trials initiated (Figure 5.8A, one-way ANOVA; 
Fi,69= 138.64, p<0.001) and increased omission rates (Figure 5.8B, one-way ANOVA; 
Fi,69= 34.69, /K0.001). In contrast, ad libitum reinforcer access did not affect the 
response accuracy (Figure 5.8C, one-way ANOVA; Fi,69= 2.29, n.s.), correct RT 
(Figure 5.8D, one-way ANOVA; F],69= 1.63, n.s.) or magazine latency (one-way 
ANOVA; Fi,69= 0.00, n.s.).
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Figure 5.8: The effects o f  ad libitum condensed milk access 20 minutes prior to 5- 
CSRTT testing, on key performance parameters. Graphs show the number o f  trials 
initiated (A), omitted trials (B), response accuracy (C) and correct RT (D). Data 
are presented as means±SEM.
However, no main effects of genotype were found on these or other 
behavioural measures (between-subject tests; trials: F2,69= 0.05, n.s., omissions: F2,69= 
0.26, n.s., response accuracy: F2,69= 0.85, n.s., correct reaction time: F2,69= 2.05, n.s.), 
the latency to collect the reinforcer was significantly greater among 7g/2-Null KO
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mice (26.58 ± 8.92 sec, Kruskall-Wallis; H2= 16.45, /K0.001) relative to Igf2-PO KO 
mice (3.96 ± 2.49 sec, post hoc test: U= 33, /?<0.001, r=-0.63) and WT controls (4.92 
± 2.29 sec, post hoc test: U= 99, /?<0.01, a^-0.44). A comparative analysis o f 5- 
CSRTT performance during these sessions between the WT-PO and WT-Null controls 
did not reveal any difference (see Appendix 3.7).
5.3.4.4 Effects o f lOOdB white noise distractor induction
A lOOdB white noise distractor stimulus was interpolated at various intervals 
within the ITI (at the onset o f ITI, at 2.5sec into the ITI and at the offset o f ITI), in 
order to assess stimulus detection under distracting conditions. There was a decreased 
response accuracy at trials when the distractor stimulus was implemented coincident 
with the onset o f the stimulus (Figure 5.9A, within-subject test; F3,i8i= 19.35, 
p<0.001). Overall, Ig/2-PO KO mice exhibited a higher rate o f response accuracy in 
comparison with WT controls during this session (between-subject test; F2,69= 3.35, 
/?<0.05) and a repeated measures analysis reported a significant interaction between 
the genotype and presence o f the distractor, indicating that the response accuracy o f 
/g/2-Null mice and WT controls was particularly susceptible to the white noise
stimulus (F5,i8i= 2.39, /?<0.05).
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Figure 5.9: Effects o f  interpolating a white noise distracter on 5-CSRTT 
performance. Brief (0.5-sec) lOOdB hursts o f  white noise were presented 
pseudorandomly on trials at different positions in a trial: at the onset o f  the ITI. . 
midway (2.5sec) into the ITI and coinciding with the light stimulus presentation 
(5sec, offset o f  the ITI), relative to other trials when no distracter occurred. Graphs 
show response accuracy (A) and correct RT (B). Data are presented as mean 
values±SEM.
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Furthermore, there was a significant increase in correct RT by Zg/2-Null KO 
mice in trials where the white noise stimulus was presented coincident with the 
stimulus (Figure 5.9B, interaction: F3,98= 8.03, /K0.001). In contrast, no difference 
was found in correct RT when the white noise stimulus was presented earlier during 
the ITI. Furthermore, the introduction o f the white noise stimulus did not have any 
significant effect in the rate o f omissions (within-subject test; F2,i36= 1.16, n.s.), or in 
the number o f trials initiated (within-subject test; F3^ o7= 0.85, n.s.). In addition, a 
separate analysis o f 5-CSRTT performance during sessions o f white noise distraction 
did not show any difference between the two WT-control lines, as shown in Appendix 
3.8.
5.3.5 1-CSRTT baseline performance
Presenting the light stimulus in just the central aperture o f the response array, 
reduced the attentional demand o f the task, by excluding the requirement o f divided 
attention. In support o f this, the Ig/2-KO mice, as well as the WT controls, showed an 
overall improvement in discriminative response accuracy at baseline in the 1 -CSRTT 
relative to 5-CSRTT baseline (within-subject test; Fi,69= 79.97, /?<0.001), although the 
repeated-measures analysis reported a significant interaction, indicating that the 
improvement was relatively greater among WT controls (F2,69= 6.95,/?<0.01). In fact,
Table 5.4: Behavioural measures o f  1-CSRTT performance at baseline 
level following two consecutive baseline sessions o f  criterion performance.
Mean ± SE
D v iiit ▼ lu u i <ii r a i i i u i c i c n
Accuracy (%) 95.3 ± 0.5 94.4 ± 1.0 94.1 ±0.6
Omission (%) 17.5 ±0.8 *22.4 ±2.1 19.0 ±0.9
Premature nose-pokes 2.5 ± 0.3 ^1.4 ± 0.2 2.8 ± 0.3
Trial number 61.7 ±2.9 *49.4 ±3.3 59.6 ± 2.4
Correct RT (sec) 0.67 ± 0.02 0.72 ± 0.04 0.70 ± 0.03
Magazine latency (sec) 4.2 ± 1.8 8.7 ±3.0 2.6 ± 0.7
Duration of eating (sec) 2.7 ± 0.2 2.2 ± 0.5 2.9 ± 0.2
Nose-pokes per trial 1.2 ±0.1 1.3 ±0.1 1.6 ±0.2
Panel pushes per trial 1.8 ±0.2 1.6 ± 0.1 1.6 ± 0.1
only.
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no difference was found in response accuracy across genotypes at baseline sessions 
during the 1-CSRTT (one-way ANOVA; F2,69= 0.95, n.s.), as shown in Table 5.4.
In a similar vein, a significant reduction was observed across all genotypes in 
the rate of omissions during baseline performance at the 1-CSRTT (within-subject 
test; F2,69= 21.36, /?<0.001), relative to 5-CSRTT performance. However, /g/2-Null 
KO mice showed higher rates o f omissions at 1-CSRTT baseline session, than Igf2-PO 
KO mice and WT controls (one-way ANOVA; F2,69= 21.36, /?<0.001). There was a 
significant increase in the number of premature nose-pokes emitted (within-subject 
test; Fi,69= 4.93, /?=<0.05), and in the number of trials initiated (within-subject test; 
Fi,69= 5.77, p<0.05), was demonstrated across all genotypes at baseline performance 
during the 1-CSRTT relative to 5-CSRTT baseline performance, while correct RT 
was reduced (within-subject test;Fi ,69=20.85, /?<0.01). Also of importance, /g/2-Null 
KO mice made fewer premature nose-pokes than Igf2-P0 KO mice and WT controls 
at 1-CSRTT baseline (one-way ANOVA; F2,69=4.69, p<0.05), and initiated fewer 
trials than KO mice of the Igf2-P0 line (post hoc test: Fi^3= 6.30, p<0.05). There was 
no difference however, in correct RT between genotypes (F2,69= 0.56, n.s.). One-way 
ANOVAs (and Kruskall-Wallis test) did not reveal any difference between genotypes 
on other behavioural parameters; magazine latancy: H2=5.16, n.s., eating duration: 
F2,69-  0.56, n.s., nose-pokes/trial: F2,69= 1.48, n.s., and panel-push/trial: F2,69= 0.46, 
n.s.. Moreover, no difference was found on any of the behavioural parameters 
between the separate WT lines, see Appendix 5.9.
5.4. Discussion
The present study provides new data into the issue of long-term developmental 
effects of IUGR due to foetal under-nutrition on cognition and behaviour later in life. 
The 5-CSRTT was successfully completed by the vast majority of mice, and enabled 
an extensive analysis of performance along multiple behavioural parameters and 
across genotypes. Moreover, the introduction of task manipulations affected 
dissociable aspects of 5-CSRTT performance, in the anticipated manner (see Humby 
et al., 1999). The key results from this study were that mice of both Igfi-KO  lines 
exhibited enhanced response accuracy and impulse control during different stages of 
5-CSRTT performance. This effect was more consistent in Igf2-P0 KO mice which 
demonstrated heightened response accuracy during acquisition of the 5-CSRTT, at
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baseline, under task conditions where the ITI was increased, and were less distracted 
by the induction of an auditory stimulus coincident with stimulus presentation. In 
terms of impulse control, Ig/2-FO KO mice were also found to have fewer premature 
nose-pokes at baseline and during sessions o f increased ITI, indictive of enhances 
behavioural inhibition (i.e. less impulsiveness).
In comparison, mice o f the 7g/2-Null KO line only displayed improved 
response accuracy relative to WT-controls under conditions where the ITI was 
increased, but were also found to have reduced rate of omission in sessions in which 
the SD was shortened. 7g/2-Null KO mice did not show differences in impulse control 
but they did demonstrate patterns o f behaviour that implied a reduction in levels of 
motivation, such as fewer trials initiated and greater reaction times during 5-CSRTT 
acquisition (albeit the difference in reaction time could also be due a locomotor 
component) and greater latency to collect the reinforcer at baseline. This was 
particularly true during the simplified 1-CSRTT, where the 7g/2-Null KO mice 
initiated a lower number o f trials, made fewer premature responses, and showed 
higher rates o f omission at baseline. However, the possible reduction in motivation by 
7g/2-Null KO mice is not necessarily surprising as they have much smaller body sizes 
and lower body weight (see Chapter III), and thus it is likely that these mice 
experience satiety earlier than the other mice (cf. drink lower volumes of solution 
during reinforcer preference test, prior to statistical normalisation). As mentioned in 
the preceding chapters, the comparison of performance between the Ig/2-KO lines 
may provide some information into the distinguishing contributions of foetal nutrient 
deficiency and growth restriction, to psychiatric disease risk in later life. The fact that 
subjects of both Igf2-KO mouse models demonstrated heightened attentional 
performance in the present experiment, suggests that the neural substrates underlying 
this behavioural phenotype are either more susceptible to nutritional insults (relative 
to the behavioural phenotypes observed solely in Igf2-P0 KO mice) or the result of 
IUGR. By contrast, the enhanced impulse control among Igf2-P0 KO mice might be 
implicated particularly with foetal nutritional deficiency, and perhaps neurobio logical 
linked with the heightened stress/anxiety-related phenotypes reported in chapters III 
and IV. This will be discussed further in the General Discussion (Chapter VIII).
As highlighted in the introduction o f this chapter, a number of epidemiological 
studies have previously reported a relationship between IUGR and the risk of ADHD 
(Schlotz, Jones, Godfrey and Philips, 2008; Lahti et al., 2006; Linnet, 2006; Hawdon,
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Hey, Kolvin, and Fundutis, 1990), while other studies o f humans have indicated 
association of nutritional deficiency in early life and ADHD symptoms (Arnold and 
DiSilvestro, 2005; Arnold et al., 2005; Bilici et al., 2004; Brophy, 1986). Attentional 
problems are one of the main symptoms o f ADHD, and people with ADHD have been 
shown to have difficulties both in the ability to maintain attention to stimuli that are 
widely spaced in time (i.e. sustained attention) (Johansen, Aase, Meyer and 
Sagvolden, 2002), as well as in the ability to maintain attention on a stimulus in the 
face o f other (irrelevant) distracting stimuli (i.e. selective attention) (Gomarus, Wijers, 
Minderaa and Althous, 2009). In the present study however, 7g/2-P0 KO mice 
displayed evidence o f improvements in aspects of attentional function during the 5- 
CSRTT; this was not the case during the simplified 1-CSRTT. The differential results 
obtained between the two versions of this task, might infer that this improvement of 
attentional function is confined to aspects of selective attention (i.e. attention over 
space), rather than sustained attention (i.e. attention over time). Conversely, the more 
circumstantial improvement in accuracy, noted during both 5-CSRTT and 1-CSRTT 
in 7g/2-Null KO mice, could possibly be related to more general improvement o f 
attentional aspects. Although a heightened motivational level could in general 
contribute to improvements to some of the aspects of performance on the 5-CSRTT, 
such as higher response accuracy, a greater number of trials initiated or a reduction in 
omission rate, it highly unlikely that this is the case for the Igf2-KO mice. The 7g/2-P0 
KO mice did not display differences for any of the motivational-related indices. 
Firstly, there was no difference observed in the volume of reinforcer consumed during 
the reinforcer habituation between the Igf2-?0 KO mice and WT controls, and 
secondly, the number o f trials initiated throughout the 5-CSRTT did not vary between 
the Igf2-P0 KO mice and WT-controls, and the latencies of stimulus response and 
collection o f reinforcer were also equivalent. Moreover, the 7g/2-Null KO mice 
displayed, in fact, evidence of less motivational level during the both the 5-CSRTT 
and the 1 -CSRTT, as indicated by fewer number of trials intitiated.
Even though impulsive behaviour is another one of the hallmark traits of 
ADHD, impulsivity is generally conceived to comprise a variety of different (but 
related) cognitive/behavioural properties, rather than being a unitary construct 
(Winstanley et al., 2006). A variety of behavioural paradigms have been devised in 
effort to assay these different aspects o f impulsivity. While the 5-CSRTT provides a 
measurement of a certain aspect of response inhibition that entails a cognitive
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component (i.e. impulse control) as the subject is required to make a decision of 
response, another behavioural paradigm known as the Stop signal serial reaction time 
task (SSRTT) indices an aspect o f response inhibition that relies heavily on motor 
components (response control) since in this task the subject is required to abort an 
ongoing prepotent response (Logan and Cowan, 1984). One of the concerns which the 
findings o f present study raise, is whether the reduction of premature nose-pokes 
observed among Igf2-PO KO mice solely reflects a confined improvement of impulse 
control, or if it represents a greater behavioural inhibition on a broader scale that 
might involve improved response control in addition. This issue will be addressed in 
the next chapter (Chapter VI), by testing the Ig/2-KO mice along with their WT- 
littermate controls on the SSRTT.
The discrepancy observed between the results of the current study and findings 
from the literature on ADHD, especially in terms of IUGR, is not necessarily 
paradoxical, but rather highlights the importance to draw a twofold distinction in this 
line of research. Firstly, brain development in rodents, as well as humans, progresses 
in region-specific manner, thus different brain regions undergo critical periods of 
development at varying time points (e.g., caudal parts of the brain develop generally 
earlier than rostral parts, and subcortical structures mature earlier than cortical). 
Therefore, it is pivotal that researchers do not premise that a certain environmental 
stimulus occurring in foetal life will give rise to the same or even similar central 
nervous system profile, in terms of neurobiology, cognition or behaviour, as that 
environmental insult would when acting in early postnatal life. Secondly, instead of 
merely examining the association between IUGR and adult mental health as much of 
the previous research has focused on, it is imperative the future research concentrates 
on how the different causal agents of IUGR impact neurodevelopment, cognition and 
behaviour in later life.
In recent years, a number of lesion studies have managed to unveil some of the 
neural mechanisms that are critically involved in 5-CSRTT performance. The link 
between lesions to the medial parts of the prefrontal cortex and striatum on one hand, 
and significant deficits in response accuracy on the other (Muir, Robbins and Everitt, 
1996; Rogers, Baunez, Everitt and Robbins, 2001), implicates the importance of these 
cerebral regions in modulating attentional functions. There is also evidence indicating 
that the medial striatum might play a key role in response inhibition, as reflected by a 
heightened number o f premature nose-pokes following lesions to this region (Rogers
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et al., 2001). Further to this, studies using neuropharmacological manipulations, have 
implicated many o f the main neurotransmitter systems in 5-CSRTT performance in 
rodents. In fact, cholinergic, catecholaminergic (i.e. dopamine and noradrenaline) and 
serotonergic systems have all been attributed a role in response accuracy on the 5- 
CSRTT (see Robbins, 2002). For instance, agonists of excitatory cholinergic and 
catecholaminergic receptor subtypes have been shown to improve choice accuracy 
(Muir, Robbins and Everitt, 1995; Puumala, Riekkinen and Sirvio, 1997; Granon et al, 
2000), whereas administrations o f excitotoxins or antagonist of these neurotransmitter 
receptors have produced in deficits on attentional performance (Muir, Robbins and 
Everitt, 1994; Jones, Barnes, Kirkby and Higgins, 1995; Puumala et al., 1997; Granon 
et al., 2000). On the other hand, the involvement of the 5-HT system in 5-CSRTT 
performance has primarily been investigated in relation to impulse control; despite 
some evidence of a role for 5-HT in response accuracy also (Harrison, Everitt and 
Robbins, 1997a; Jakala et al., 1992). Although some of the research for the regulatory 
role o f 5-HT in impulsivity has produced contradicting findings, depletion of 5-HT in 
the forebrain has been demonstrated to increase premature responses on the 5-CSRTT 
(Harrison, Everitt and Robbins, 1997b). Similar effects were noticed in the 5-CSRTT, 
following administration of 8-OH-DAT, an agonist of the inhibitory 5-HTia receptor 
(Carli and Samanin, 2000) or administration of SB242084, a 5-HT2C specific 
antagonist, but an administration of a 5-HT2A specific antagonist resulted in the 
opposite (Winstanley, Theobald, Dailey, Glennon and Robbins, 2004).
In light of the above findings, it is conceivable that the malnutrition-induced 
IUGR, could possibly have re-programmed the developmental trajectories o f the 
prefrontal cortex and/or the striatum (as well as other brain regions), affecting one or 
possibly more of these neurostransmitter pathways. Such developmental alterations, 
might in turn, have entailed lasting morphological and neurophsysiological changes at 
these cerebral loci, which underpin the enhanced attentional functions and impulse 
control observed in mice of the Igf2-?0 KO line. It is of paramount importance 
however that further research is carried out to investigate differences in cerebral 
morphology and/or functions of neurotransmitter pathways, between the Igf2-?0 KO 
mice (and possibly the 7g/2-Null KO mice) and their WT-littermate controls. This 
research effort could encompass; histological examination o f region-specific neuronal 
integrity, measurements o f regional neurotransmitter levels, as well as confined 
exploration of gene expression. The outcome of such research could provide
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important insight into how brain development is compromised by placental deficiency
in intrauterine life, as well as give rise to a greater clarity of the behavioural profile
exhibited by the Igf2-P0 KO mice. This issue will be addressed in Chapter VIII.
5.4.1 Summary o f  key results from Chapter V
• 7g/2-P0 KO mice displayed a significantly improved discriminative response 
accuracy in during both the acquisition of the 5-CSRTT and at baseline, 
relative to WT controls.
• 7g/2-P0 KO mice showed also better response accuracy than WT controls 
under task conditions where the ITI was increased and were less distracted by 
the induction of an auditory stimulus coincident with stimulus presentation.
• 7g/2-P0 KO mice made fewer premature nose-pokes than WT controls in the 
5-CSRTT, at baseline and during sessions of increased ITI.
• 7g/2-Null KO mice showed improved response accuracy relative to WT 
controls under condition where the ITI was increased, during both the 5- 
CSRTT and the simplified 1 -CSRTT.
• There was a reduction in rate o f omission among 7g/2-Null KO mice in 
sessions in which the SD was shortened, and response accuracy was 
heightened under conditions of white noise distraction during the 1-CSRTT 
(data not shown).
• 7g/2-Null KO mice initiated fewer trials and showed greater reaction time 
during the acquisition of the 5-CSRTT, and greater latency to collect the 
reinforcer at baseline.
• During the 1-CSRTT, Zg/2-Null KO mice intitiated fewer number of trials, 
made fewer premature nose-pokes, and showed higher rates o f omissions at 
baseline.
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Chapter VI
Further Investigation of Behavioural Inhibition in Igf2-P0 
and Igf2-Null Knockout Mice: The Stop-Signal Reaction Time 
Task
6.1 Introduction
One of the main results in the 5-CSRTT, discussed in the previous chapter, was an 
enhanced behavioural inhibition in mice of the growth restricted Igf2-PO KO line 
relative to /g/2-Null KO mice and wild-type (WT) controls. These results were 
unexpected, with regard to previous epidemiological studies which have consistently 
reported inverse correlations between intrauterine growth retardation (IUGR) and 
measures o f impulsivity in childhood, and similarly the risk of attention 
deficit/hyperactivity disorder (ADHD) (Breslau, 1995; Hack et al., 1992; Pharoah, 
Stevenson, Cooke and Stevenson, 1994; Wichers et al., 2002). Therefore, the purpose 
of the current chapter was to further investigate the response control o f 7g/2-KO mice 
relative to their WT littermates to shed light on the scope of the improved behavioural 
inhibition, previously noted among the Igf2-PO KO mice.
Impulsivity has been highlighted as one of the most fundamental clinical 
symptoms of ADHD, along with inattention and hyperactivity (DSM-IV-TR, 2000). 
Impulsivity refers to lack of behavioural inhibition, including actions that are poorly 
conceived, premature, unnecessarily risky or contextually inappropriate and 
frequently result in an unfavourable outcome (Evenden, 1999a). Current theoretical 
frameworks of behavioural inhibition propose that a lack of impulse control arises as 
the consequence of an underactive inhibitory system which fails to provide transient 
suppression o f conditioned responses and reflexes that would enable slower cognitive 
processes to regulate behaviour (Winstanley, Eagle and Robbins, 2006). However, on 
the basis of the diversity o f behaviour which impulsivity encompasses there is good 
reason to consider it to be a heterogeneous aspect of behaviour possibly involving 
several different neurobiological substrates rather than a unitary construct (Evenden, 
1999b). Nevertheless, by focusing on certain circumscribed behavioural aspects of 
impulsivity, a variety of behavioural paradigms have been successfully established, in
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order to measure impulsivity in both human and non-humans subjects (Winstanley et 
al., 2006).
Laboratory measurements of impulsivity have been primarily based on two 
animal models (Swann, Bjork, Moeller and Dougherty, 2002). The first model 
measures impulsive choice, in terms of the inability of subjects to delay a reward, 
leading to an increased tendency to choose immediate small rewards over larger 
delayed one (Monterosso and Ainslie, 1999). The second model on the other hand, 
examines the inability to inhibit a prepotent response, leading to errors of 
commissions (Evenden, 1999c). One o f the tasks that make use of the latter 
measurement to study response control is the Stop signal reaction time task (SSRTT, 
Logan, Cowan and Davis, 1984), where the subject is required to perform speeded 
respond when cued to do so by a “Go” signal (Go-trials). However, on a subset of 
trials the subject is required to inhibit responding when the “Go” signal is briefly 
followed by the presentation o f a “Stop” signal (Stop-trials). By outnumbering the 
Stop-trials considerably with Go-trials, responding rather than inhibiting is made pre­
potent. The closer the Stop signal is presented in time relative to the moment of 
responding (i.e. “goings”), the more difficult it is for the subject to inhibit their 
behaviour. Many o f the current theoretical models of ADHD have highlighted the 
importance of the ability o f individuals to stop an ongoing response (Alderson, 
Rapport and Kofler, 2007), and research using the SSRTT has repeatedly revealed 
that children and adults with ADHD tend to have longer Stop signal reaction times 
relative to normal controls (see Winstanley et al, 2006 and Lijffijt, Kenemans, 
Verbaten and van-Engeland, 2005 for review). Therefore, the Stop signal paradigm 
has been widely adopted for ADHD research, due to it exceptional ability to assay 
theoretically important cognitive processes by means of the Stop signal reaction time 
metric.
As mentioned, Igf2-?0 KO mice showed reductions in premature nose-pokes 
at baseline conditions and during manipulation of inter-trial interval length in the 5- 
CSRTT suggesting improved behavioural inhibition. Although both the 5-CSRTT and 
the SSRTT provide quantifiable indices o f behavioural inhibition, these behavioural 
tasks assay different aspects o f inhibitory (or impulsive) behaviour (see Nigg, 2000 
for discussion). While the 5-CSRTT task assesses impulse control, i.e. the ability o f a 
subject to inhibit a pre-potent response in anticipation of food reward, the SSRTT 
examines response control or the ability o f subjects to inhibit an ongoing pre-potent
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response. Comparisons in measures o f response control between the two tasks in 
rodents is not straightforward as few studies have been reported for the SSRTT to 
date, whereas 5-CSRTT performance has been more extensively studied (see Robbins,
2002). In terms of the major forebrain neurotransmitter systems, evidence from the 
SSRTT has demonstrated improvements in impulse control after the administration of 
methylphenidate and atomoxetine, reuptake inhibitors for dopamine and 
noradrenaline, respectively (Eagle, Tufft, Goodchild and Robbins, 2007; Turner, 
Clark, Dowson, Robbins and Sahakian, 2004; Chamberlain et al., 2009; Robinson et 
al., 2008, respectively), whereas selective 5-HT reuptake inhibitors show little 
behavioural effects (Chamberlain et al., 2006; Clark et al., 2005; Eagle et al., 2009). 
This is in contrast to the 5-CSRTT, where manipulations of the 5-HT system have 
profound effects on the main measures of impulse control (see Robbins, 2002). Where 
the same pharmacological agent (D-amphetamine) has been used in both tasks, 
differential effects have been found whereby impulsivity is increased in the 5-CSRTT 
(Robbins, 2002) but no effect on impulse control is found in the SSRTT (Eagle and 
Robbins, 2003). Thus the differences in the nature of response control are also 
reflected by differential effects of pharmacological manipulations, suggesting that 
different brain mechanisms/systems may be involved in the control of responding in 
each task. If the Ig/2-PO KO mice do not show any evidence of improvement response 
control during the SSRTT, it could be hypothesized that the enhanced behavioural 
inhibition (as observed during the 5-CSRTT) is somewhat restricted to improved 
cognitive control. On the other hand, improved response control in the SSRTT could 
signify that Igf2-P0 KO mice show a broader impulsivity-related phenotype.
6.2. Materials and Methods
Full methodological descriptions can be found in the relevant sub-sections of 
the General Methods Chapter (Chapter II).
6.2.1 Subjects and animal husbandry
The SSRTT task was carried out on a total number o f 75 male mice (aged 16- 
18 months at the onset of experiment) generated in the Behavioural Neuroscience 
Laboratory at Cardiff University (see table 6.1). The subjects were derived from a
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crossbreeding o f  background strain o f C57BL/6*129 (carrying either the mutant lgf2- 
PO allele or the /g/2-Null allele) with CD1 females, as previously described in Chapter 
II.
Table 6.1: The sample size and genotype o f  the total litter cohort w hich began 
and completed the SSRTT.
Genotype and sample size (h )
Status
Number of subjects to 
begin the SSRTT 29 16
41
(20/21)
Number of subjects to 
complete the SSRTT 16 8
30
(12/18)
The mice were housed in littermates groups o f two to five animals per cage, 
under temperature- and humidity-controlled conditions, with a 12-hour light: 12-hour 
dark cycle (lights on at 07:30 hours). Mice were 8 weeks old at the onset o f the 
experiment, and had access to standard laboratory chow and water ad libitum, but 
restricted to 2-hours access per day when behavioural experiments commenced, as 
described previously 2.4.4. The body weight o f each mouse was monitored regularly 
for indication o f  health status (see Chapter II, section 2.4.2). All experimental 
procedures were conducted under licenses issued by the Home Office (U.K.) in 
compliance with the Animals (Scientific Procedures) Act 1986 and local ethics 
committee.
6.2.2 Behavioural methods
6.2.2.1 Habituation to the reinforcer
Once body weight had stabilised under the water restriction schedule, the 
habituation/preference testing o f the condensed milk reinforcer was established. 
Testing was carried out as previously described (Chapter II, section 2.4.5), with the 
main index o f preference being the amount o f reinforcer (in terms o f percentage o f 
total fluid consumption) consumed on the final day of testing.
6.2.2.2 The Stop signal reaction time task
In the SSRT task, an occasional presentation o f a Stop signal indicates a 
pending ‘Go’ response to be cancelled and provides an estimation o f the time needed 
to withdraw the response (see Figure 6.1). The Stop signal reaction time (SSRT) was 
determined by measurable parameters: the distribution o f the Go-trial reaction time 
(Go-RT) and the accuracy o f stopping during Stop trials. The testing took place in 
nine-aperture operant chambers previously modified for use in mice (Humby et al., 
1999), with seven o f  the nine apertures in the response array covered. The mice 
performed one 20-minute session per day with a maximum o f 100 trials per session.
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Figure 6.1: The SSR TT procedure. A stimulus light presented in an aperture on the 
left side o f  the response array signals the beginning o f the trial (A). A nose-poke in 
the illuminated aperture on Go-trials (B) initiates the a stimulus light presented in an 
aperture on the right side o f  the response array (C). A nose-poke in the right aperture 
results in the delivery o f  the liquid reinforcer (D). On Stop-trials, a burst o f white 
noise is presented following a nose-poke in the left aperture which requires the 
subject to refrain from  responding to the right stimulus light (E). Incorrect responses 
(failure to nose-poke in both apertures on Go-trials or a nose-poke in right aperture 
on stop trials) results in a time-out period.
6.2.2.2.1 Initial behavioural training
The mice were subjected to training sessions on a daily basis that were 
scheduled at the same time o f the day and with each mouse consistently allocated to
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the same operant chamber. Shaping was carried out over five consecutive sessions. In 
the first three sessions, mice were habituated to the operant chamber and trained to 
press the magazine panel, in order to get an access to the liquid reinforcer. In these 
sessions, 40//.1 of the liquid reinforcer was delivered into the food magazine every 30 
seconds throughout the session, indicated by the illumination of the tray light 
coincident to the food delivery. The panel of the food magazine was wedged open, 
allowing easy access to the reinforcer, while the apertures in the response array were 
blocked with a transparent plastic film. During the final two sessions o f shaping, the 
panel o f the food magazine was not wedged open, constraining the mice into learning 
to push the panel (i.e. ‘panel-push’) in order to gain access to the reinforcer. Mice that 
failed to panel-push, were given additional training session to overcome this problem. 
Once, the mice had learned to panel-push they were tested on the SSRTT.
6.2.2.2.2 Acquisition o f the single nose-poke training phase
In the first phase o f the SSRT task, mice were trained to make a single nose- 
poke response; ‘the initiation nose-poke’. Each session began with 40/tl o f the liquid 
reinforcer dispensed in the food magazine. Trials were initiated with a light stimulus 
(INIT-signal) presented in an aperture located left of centre in the 9-aperture array 
(aperture 3 when counted from left). When a nose-poke response was made in the 
illuminated aperture, the light stimulus was extinguished and liquid reinforcer was 
dispensed in the food magazine. The following trial was initiated by a push of the 
magazine panel during the collection of the liquid reinforcer. The duration of the 
initiation stimulus was initially set at 30 seconds but was automatically reduced to 10 
seconds in 5-sec decrements in accordance to the performance of the mice (on five 
consecutive correct trials). If the mice failed to make nose-poke response during the 
stimulus presentation, the mice received a time-out period of 5 seconds, and the trials 
was recorded as non-started. On reaching a stable performance with an initiation 
stimulus duration of 10 seconds and completion of <70% of trials (out of 100 trials), 
the mice were moved to the double nose-poke stage.
6.2.2.23 Acquisition o f double nose-poke training phase (Go trials)
Mice were trained to perform a rapid reaction time response (e.g. double nose- 
poke) from the left initiation aperture to the right ‘Go’ aperture, termed a “Go-
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response”. The session began with the delivery of the liquid reinforcer. A light 
stimulus was presented immediately in the initiation aperture on the left side of the 
response array and in this phase, the initiation stimulus was fixed at 10 seconds. When 
the mice made a nose-poke response in the illuminated aperture, the light stimulus 
was extinguished and a second light stimulus was presented in an aperture located on 
the right side o f the response array (aperture 6 when counted from left). If another 
nose-poke response was then made to illuminated aperture on the right side, the light 
stimulus extinguished and the liquid reinforcer was delivered. The limited hold of the 
second light stimulus (Go-LH) was initially set at 60 seconds and decreased to a Go- 
LH duration equivalent to the mean Go reaction time (mean Go-RT, mGo-RT) for 
each subject with the addition o f 0.3 second, allowing individual differences to be 
taken into account. Decrements in Go-LH were in 5-sec intervals, following five 
consecutive trials. Once the mice had performed two sessions at their own 
individually fixed Go-LH duration, while completing >70% of the trials, they were 
moved on to the next stage.
6.2.2.2.4 Introduction o f the Stop signal trials
At this phase o f the experiment, Stop signals were presented pseudo-randomly 
on 20% of the trials during each session, thus the Stop signal delay (SSD) was zero 
(0%). The Stop signal was presented as a burst of white noise (65dB for 0.3 second), 
at a time coincident with completion o f the initiation nose-poke response (which 
indicated that the subjects had to withhold their second nose-poke response (i.e. 
stopping) in order for the liquid reinforcer to be delivered). The time duration for 
which the mice had to withhold their response (Stop-LH), was initially set at 0.35 
second, a period slightly longer than the duration of the white noise burst, thus 
enabling the mice to hear the delivery of the liquid reinforcer. The Stop-LH was then 
increased as performance improved in 0.1-sec intervals for every five consecutive 
correct trials to a value ranging between 0.7-sec to 1.1-sec, depending on the 
performance of each individual subjects. In order to reach the baseline performance 
criteria, subjects needed to; initiate more than 70% of the trials, correctly stopping 
(withholding response) at least 65% of the time with a minimum Stop-LH of 0.7 
second, have greater than 70% accuracy in Go-responses, and less than 50% omission.
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6.2.2.2.4 The signal delay phase
Once a stable baseline performance was reached following the initial training, 
the response control capability o f the mice was investigated by varying the SSD. Each 
experimental set was implemented following a single baseline session with criteria 
performance, and the introduction of the SSD occurred at several different temporal 
locations that varied between sessions. In baseline sessions the Stop signal was 
presented at a time coincident with the initiation nose-poke (i.e. 0% with respect to 
the mGo-Rt for each subject, thus SSD=0%). The present SSRTT study utilized a 
programme that provided an on-line monitoring of the Go-response reaction time (Go- 
RT) for each mouse and calculated the SSD as a percentage of the on-going Go-RT 
for each individual subject. As the individual session progressed onwards, the mean 
average Go-RT for every subject was based on an increasing number of Go-RT from 
the previous Go-trials of that same session. The SSDs were presented in the following 
order; SSD=70% of mGo-RT (i.e. mean Go RT*0.7), SSD=10% of mGo-RT, 
SSD=90% of mGo-RT, SSD=30% of mGo-RT, SSD=50% of mGo-RT, SSD=80% of 
mGo-RT, SSD=60% of mGo-RT, SSD=20% of mGo-RT and SSD=40% of mGo-RT.
6.2.23 Calculating the Stop-signal reaction time
SSRT represents a ‘virtual’ measures of the latency to stop a response and as 
such cannot be measured directly, thus it was determined by key task parameters (the 
distribution o f the Go-RT and the accuracy of stopping during Stop trials) according 
to the protocol previously described by Logan (1994), and adapted for experiments in 
rats (Eagles and Robbins, 2003). Therefore, to calculate the SSRT, Go-RTs were first 
rank ordered from shortest to longest and the nth Go-RT was then found, where n was 
obtained by multiplying the number of RTs in the distribution by the probability of 
stopping correctly. The n value provides an estimate of the time point at which the 
stopping response finished comparative to the onset of the Go signal. The SSRT 
estimation, i.e. the time point at which the stopping response finished, relative to the 
Stop signal, was acquired by subtracting the SSD from the n value, where SSD was 
calculated as the mGo-RT for that session * SSD value as a percentage. This was 
repeated for each subject for each delay, and the resulting mean was obtained for all 
genotype groups.
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6.2.2.4 Behavioural measures
Task acquisition of the SSRTT was determined by the number of sessions 
required for each subject to reach SSRTT baseline performance, and the number of 
sessions needed to complete each of SSRTT acquisition phases. A number of 
different behavioural measures were recorded for each session, in order to establish a 
relatively broad behavioural profile o f the Ig/2-KO lines. The primary indices of 
aspects of response control were the percentage of response accuracy at Stop-trials 
(i.e. correct Stop responses/(correct Stop-responses + incorrect Stop-responses) and 
the reaction time of correct Stop-responses (SSRT), during the acquisition of Stop 
signal trials, at baseline performance and sessions of varying SSDs. Response 
accuracy and reaction time o f correct responses during Go-trials (Go reaction time) 
were also registered from the Go-trial acquisition phase and onwards. While recording 
response accuracy during Go-trials, provided a measurement of attentional function, it 
also enabled examination o f response pattern among the subjects in order to detect 
potential response bias (i.e. tendency of a subject to solely make either Stop- or Go- 
responses). Other measures of interest included: number of trials initiated (reflecting 
overall performance of subjects), percentage of trials completed (indexing levels of 
motivation), the number of INIT nose-pokes, Go nose-pokes, total nose-pokes and 
panel-pushes, per trial.
6.2.3 Statistical analysis
The behavioural data were subjected to ANOVA by either using a one-way 
design to determine between-subjects effect or general linear design to allow for 
examination within-group effect. The genotype of subjects was primarily defined as 
the between-subject factor throughout the study. However, the order of session (i.e. 
first session vs. last session) within an acquisition phase was defined as the within- 
subject factor during SSRTT acquisition, while the location of the SSD within the Go- 
reaction time of subjects was assigned as the within-subject parameter during the 
SSRTT.
Data from the separate WT lines were clustered together for analysis in order 
to increase the statistical power and for other reasons previously mentioned in Chapter 
II, section 2.4.7. However, every analysis o f SSRTT performance during task 
acquisition, baseline and SSD alteration, was conducted separately for the WT-PO and
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WT-Null mice to ensure behavioural homogeneity between the two WT lines. 
Independent T-tests were used to examine possible genotype difference, whereas a 
repeated measures analysis was used to test for any interactions. The results of these 
analyses are presented in Appendix VI, unless otherwise stated.
6.3. Results
6.3.1 Reinforcer habituation and preference testing
The analysis o f the milk reinforcer preference and total volume consumption 
was conducted on mice that completed the SSRTT. The preference for the condensed 
milk reinforcer increased rapidly across the four habituation sessions (Figure 6.2A, 
within-subject test; F2,io4= 93.71, /?<0.001), but there was no difference observed 
across genotypes (between-subject test; F2,5i= 0.51, n.s.). By the final habituation 
session, mice of all three genotypes had displayed a strong preference for the 
condensed milk reinforcer (7g/2-P0 KO: M= 92%, SE= 0.65, t(15)= 62.99, p< 0.001, 
r= 0.996; Ig/2-Null KO: M= 89%, SE= 2.54, t(7)= 15.49, p< 0.001, r= 0.99; WT 
controls: M= 89%, SE= 2.33, t(29)= 17.04, p< 0.001, r= 0.91) with over 85% 
preference on average. A one-way ANOVA at day six, did not reveal any difference 
in reinforcer preference between genotypes (F2,5i= 0.54, n.s.).
Moreover, a steady rise in the total volume of liquid consumed over the course 
of the reinforcer habituation was noted among all subjects (Figure 6.2B, within- 
subject test; F4,i94= 49.76, p< 0.001). In contrast, the total volume of liquid consumed 
in the final session of the reinforcer habituation, was significantly reduced among 
mice o f the 7g/2-Null KO line relative to 7g/2-P0 KO mice and WT-littermate controls 
(one-way ANOVA; F2,5i= 5.56, /?<0.01). However, this difference did not persist 
following a statistical-correction for body weight (one-way ANOVA; F2,5i= 2.27, 
n.s.). Comparison between the WT-littermate controls of the two mutant lines (i.e. 
WT-P0 littermates and WT-Null littermates), did not reveal any difference in the 
preference for the milk reinforcer or in the overall volume of liquid consumed 
(Appendix 4.1).
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Figure 6.2: Reinforcer habituation. Subjects were only presented with water during 
the first two days o f  reinforcer habituation, but in the following four days an option 
between water and condensed milk (10%) was present. (A) Subjects established a 
relatively strong preference fo r  the condensed milk reinforcer by day four, reaching 
levels >85%. (B) Total liquid consumption (water and condensed milk combined), 
normalised fo r  body weight o f  the subjects, gradually increased over the course o f  the 
reinforcer habituation sessions. For subject N  see methods section 6.2.1. Data are 
presented as mean±SEM.
6.3.2 Acquisition o f the SSRTT
O f the cohort o f 75 subjects that commenced the SSRTT, 54 subjects 
managed to reach baseline and complete all task manipulations within 125 sessions 
(see Table 6.1). There was no difference observed between genotype in SSRTT 
acquisition, in terms o f the number o f sessions required to reach baseline performance 
(lgf2-PO KO: 64.56 ± 3.93 day, /g/2-Null KO: 59.5 ± 3.0 day, WT controls: 57.00 ± 
2.27 day, F2,5i= 0.58, n.s.).
6.3.2.1 Acquisition o f the single nose-poke training phase
In the single nose-poke training phase o f the SSRTT, a single nose-poke to an 
illuminated aperture located on the left side (INIT-signal) was rewarded with a 
delivery o f the reinforcer. All subjects completed the single nose-poke phase o f the 
SSRTT acquisition on average by Session 46, with no significant difference observed 
between genotype (one-way ANOVA; F2,5i= 0.08, n.s.). Similarly, no difference was 
noted between the WT controls o f the separate mutant lines in the acquisition of this
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training phase (see Appendix 4.2). The overall percentage o f trials that were 
completed by subjects, increased by more than 20% on average between first and last 
session o f the single nose-poke phase o f the SSRTT (Figure 6.3A, within-subject test; 
F i ,5i =  20.60, p< 0.001). By contrast, there was no difference found in the percentage 
o f trials completed by the subjects between genotypes (Figure 6.3B, between-subject 
test; F2,5i= 0.49, n.s.). A considerable decrease was however noted for Igf2-Null KO 
mice in the overall number o f  trials initiated (one-way ANOVA; F2,5i= 3.54, p< 0.05), 
relative to Igf2-P0 KO mice (post hoc test: Fi,22= 5.85, p< 0.05) and WT controls 
(post hoc test: Fi,36= 6.33,p< 0.05).
WT-littermates 
tgf2-P0 KO 
Igf2-Null KO
Figure 6.3: Acquisition o f  the single nose-poke phase. The performance o f  subjects 
during at the first and final sessions o f  the single nose-poke phase o f  the SSRTT 
acquisition, in regards o f  the percentage o f  trials completed by the subjects (A) and the 
total number o f trials initiated (B). Data are presented as mean±SEM.
*Significant at p  <0.05.
Furthermore, a significant interaction between genotype and session suggested 
that while the total number o f trials initiated increased from the first to the last session 
for Igf2-P0 KO mice and WT controls, the /g/2-Null KO mice displayed a reduction 
( F 2,5 i=  5 .94, p< 0.01). There was an overall increase between the first and the last 
session o f the single nose-poke phase in the number o f nose-pokes emitted in response 
to the initiation stimulus, per trial (within-subject test; Fi^i= 14.50, p< 0.001) and a 
significant interaction between the genotype group and session suggested that the 
number o f  initiation nose-pokes was greater by /g/2-Null KO mice than among 
subjects o f the other genotypes during the last session (F2,si= 4.53, p< 0.05). 
However, a repeated-measures analysis did not report any differences in the number
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panel-pushes made per trial between the first and last session of the single nose-poke 
phase (within-subject test; F2,5i= 0.51, n.s.) and no differences were shown in the 
number o f panel-pushes per trial between genotype (between-subject test; F2,5i= 0.23, 
n.s.). Finally, although no difference was observed between WT-littermate controls on 
most of the main parameters, the WT controls of the /g/2-Null line did exhibit 
relatively higher number of INIT nose-pokes and panel-pushes per trial than WT 
controls of the Igf2-P0 line. Further, this was particularly noticeable during the final 
session (see Appendix 4.3).
6.3.2.2 Acquisition o f the Go signal trial phase
During sessions where Go signal trials were introduced, mice were only 
rewarded with a delivery o f the reinforcer when they made a correct nose-poke to the 
light stimulus presented in the aperture on the right side of the response array 
following a correct response to the initiation stimulus. The duration of the Go signal 
(Go-LH) was initially set at 60 sec, but was decreased as the mice progressed through 
this acquisition phase independently for each individual subject. Mice of all genotypes 
progressed through the training phase within 25 sessions on average, and no 
significant difference was noted between genotypes (between-subject test; F2,5i= 2 .68 , 
n.s.).
There was no difference found in the percentage of correct response to the Go 
signal (Go-Correct %) between the first and the last session of the double nose-poke 
acquisition phase (Figure 6.4A, within-subject test; Fi,5i= 0.07, n.s.), nor was there 
any difference found between mice o f different genotypes (F2,5i= 1.80, n.s.). On the 
other hand, there was a significant reduction in the correct response reaction time 
(Go-Correct RT) between the first (M= 2.51 sec) and the last session (M= 0.70 sec) o f 
the double nose-poke phase (Figure 6.4B, within-subject test; Fi,5i= 41.37, p< 0.001), 
although no difference was observed between genotypes (F2,5i= 0.29, n.s.). The 
overall percentage o f trials completed by subjects did not differ between the sessions 
(within-subject test; Fi,5i= 0.18, n.s.) or between genotypes (between-subject test; 
F2,51= 0 . 89, n.s.), however there was a significant increase noted in the number of 
trials initiated in the final session relative* to the first session (within-subject test; 
Fi,5i= 2.06, n.s.). No difference was found in the number of either INIT nose- 
pokes/per trial (within-subject test; Fi,51= 0.07, n.s.), Go nose-pokes/per trial (within-
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subject test; Fi,5i= 0.41, n.s.), total nose-pokes/ per trial (Fi,5i= 0.65, n.s.) or panel- 
pushes/per trial (within-subject test; Fi,5i= 0.13, n.s.) across sessions. Similarly, there 
was no effect o f genotype for any o f the above parameters; (between-subject test) 
initiation nose-pokes/per trial (between-subject test): F2,5i= 0.53, n.s., Go nose- 
pokes/per trial (between-subject test): F2,5i= 2.72, n.s., total number o f nose-pokes 
(between-subject test): F2,5i= 1.54, n.s., and panel-pushes/per trial (between-subject 
test): F2,si= 0.58, n.s., respectively. No difference was noted between the separate 
WT-control littermates o f the two mutant lines, summary of these results is shown in 
Appendix 4.4.
WT-littermates 
Igf2-P0 KO 
Igf2-Null KO
First se ss io n  R nal se ss io n
Figure 6.4: Acquisition o f  the Go-trial phase. The performance o f subjects during at the 
first and final sessions o f  the acquisition o f  the Go-trials, in regards o f  response accuracy 
(A) and reaction time (B). Data are presented as mean±SEM.
6.3.2.3 Acquisition o f the Stop signal trials phase
Once the mice had acquired the double nose-poke training phase o f the 
SSRTT, they progressed to the next stage o f the task acquisition where a burst o f 
white noise representing the stop signal tone, was introduced. At this stage, the Stop- 
LH was set shorter than the Go-LH, but was increased in stages o f 0.1 -sec as the 
subjects progressed onwards. All subjects acquired the Stop signal trial training phase 
in 10 sessions, although no difference was found in the number o f sessions required 
for the acquisition o f this training phase between genotypes (between-subject test); 
F2,51=  0- 14, n.s.). A significant reduction was noted in both the percentage o f correct 
stops (Stop-correct %) (Figure 6.5A, within-subject test; Fi,5i= 9.00, p< 0.005) as well 
as in the reaction time o f stopping (SSRT) (Figure 6.5B, within-subject test; Fi,si=
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31.57, p< 0.001), from the first session to the last session, as the Stop-LH, the time the 
mice had to wait for reward delivery, increased. However, no difference was found 
between genotypes on either measure (between-subject tests; Stop-correct %: F2,si= 
0.24, n.s.; SSRT: F2,5i= 0.13, n.s.). Furthermore, there was no difference in the % Go- 
Correct (within-subject test; Fi>5i= 1.92, n.s.) or in Go-correct RT (within-subject test; 
Fi,5i= 0.06, n.s.) between the first and final session o f the Stop signal trials. In similar 
vein, both the Go-correct % and Go-correct RT measures were equivalent across 
different genotype (between-subject tests; Go-correct %: F2,5i= 0.29, n.s.; Go-RT: 
F2,5i= 0.18, n.s.).
WT-littermates 
Igf2-P0 KO 
Igf2-Null KO
Figure 6.5: Acquisition o f  the Stop signal trial phase. The performance o f  subjects 
during at the first and final sessions o f  the acquisition o f the stop signal trials, in regard 
o f response accuracy (A) and reaction time o f  correct Go-responses (B). Data are 
presented as mean values along with SEM.
The percentage o f trials completed by subjects did not differ between the first 
and final session o f the Stop signal trial stage o f the SSRTT acquisition phase (within- 
subject test; Fi,5i= 1.33, n.s.), however there was a significant reduction in total 
number o f trials initiated (within-subject test; Fi,5i= 5.79, p< 0.05), but trial numbers 
for all genotypes still remained >80 out of possible 100/per session. No differences 
were observed on these measures between genotypes (between-subject tests; % trials- 
completed: F2,5i= 0.56, n.s.; trials-initiated: F2,5i= 1.41, n.s.). Moreover, while there 
was no difference found between sessions in the number o f initiation nose-pokes 
emitted per trial (within-subject test; Fi,5i= 1.97, n.s.), there was a significant increase 
with regard to the number Go nose-pokes made per trial (within-subject test; Fi,51= 
4.48, p< 0.05). In contrast, there was no difference in the total number o f nose-pokes
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emitted per trial (within-subject test; Fi)5i= 1.63, n.s.) or the number o f panel-pushes 
(within-subject test; Fij5i= 1.04, n.s.), and performance on all o f these measures was 
equivalent between genotypes; INIT nose-poke/per trials (between-subject test): 
F2,5i= 1.37, n.s., Go nose-pokes/per trial (between-subject test): F2,si= 1.47, n.s., total 
nose-pokes/per trial (between-subject test): F2,5i= 3.52, n.s. and panel-pushes/per trial 
(between-subject test): F2,5i= 1.07, n.s.. Finally, there was no difference found on any 
the measures between the separate mutant line WT controls (Appendix 4.5).
6.3.3 SSRTT performance at baseline
Once the mice had attained a stable baseline performance with greater than 
70% response accuracy on both Go and Stop trials, the Go-LH and Stop-LH were 
fixed (see Table 6.2). A one-way ANOVA did not show any genotype difference in 
either the Go-LH (F2,5i= 0.36, n.s.) or in the Stop-LH (F2,5i= 0.33, n.s.) and the 
durations o f the final Go-LH and Stop-LH were also the same for the WT-control 
littermates o f the different mutant lines, as shown in Appendix 4.6.
Table 6.2: SSRTT baseline performance. The results o f  a one-way ANOVA 
o f  several behavioural measures at SSRTT baseline performance, between 
mice o f different genotypes. No significant difference was found on any o f  
the measures at p<0.05.
P o p o m A f n p c
M e a n  ±  S E Imnsm
G o -L H  (sec ) 0.92 ± 0.03 0.94 ± 0.05 a ^ 4 ± O 0 2 ^
S to p -L H  (sec ) 0.72 ± 0.02 0.71 ± 0.04 0.73 ± 0.01
T r ia ls  c o m p le te d  % 73.2 ± 1.2 70.3 ± 3.3 72.4 ±1.8
N o  o f  tr ia ls  in it ia te d 97.2 ± 0.9 94.4 ±3.1 98.9 ±0.4
IN IT  n o se -p o k e s /p e r  tr ia l 0.84 ±0.02 0.81 ±0.04 0.87± 0.02
G o  n o se -p o k e s /p e r  tr ia l 0.75 ± 0.02 0.66 ± 0.04 0.74 ± 0.03
T o ta l n o se -p o k e s /p e r  tr ia l 1.60 ±0.04 1.47 ±0.07 1.61 ±0.04
P a n e l-p u sh e s /p e r  tr ia l 0.88 ± 0.04 0.82 ± 0.06 0.80 ±0.2
Baseline performance was calculated by averaging parameter values across all 
sessions which preceeded each o f the SSD manipulation session. The results did not 
show any differences between genotypes in the percentage o f correct Stop-trials 
executed (Figure 6.6A, one-way ANOVA; F2,5i= 0.50, n.s.) or in the length o f the 
SSRT (figure 6.6B, one-way ANOVA; F2,5i= 0.13, n.s.). Further, neither response
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accuracy (one-way ANOVA; F2,5i= 0.02, n.s.) nor correct-RT (one-way ANOVA; 
F2,5i= 0.30, n.s.) during Go signal trials varied between subjects of different genotypes 
at baseline performance (as shown in figures 6 .6A and 6 .6B). Interestingly however, 
the reaction time o f an incorrect Go-response during Stop signal trials was 
significantly lower than the reaction time o f a correct Go-response during Go signal 
trials (within-subject test; Fi,51= 50.52, p< 0.001). This acceleration in response time 
could possibly reflect a reduction in impulse control when making an erroneous 
response (see Logan, 1984). Equivalent performance was also observed in the 
percentage o f trials completed by subjects (one-way ANOVA; F2,5i= 0.27, n.s.), as 
well as in the overall number o f trials initiated (one-way ANOVA; F2,5i= 0.27, n.s.). 
As shown in Table 6.2, mice o f different genotypes did not display any behavioural 
difference in terms of; number o f INIT nose-pokes, Go nose-pokes or total nose- 
pokes, per trial at baseline performance. In addition, there was no difference in the 
number o f  panel-pushes emitted per trial between subjects of different genotypes. A 
separate analysis which was carried out on these measures, between the separate 
mutant lines WT-controls did not show any difference, as summarized in Appendix 
4.7.
WT-littemnates 
Igf2-P0 KO 
Igf2-Null KO
Figure 6.6: SSRTT baseline performance. The performance o f subjects at SSRT baseline 
level, in terms o f  response accuracy (A) and reaction time (B). at both Go trials and Stop 
signal trials. Data are presented as mean values along with SEM.
There were no significant effects o f genotype on magazine latency (one-way 
ANOVA; F2,5i= 3.16, n.s.) or eating duration (one-way ANOVA; F2,5i= 0.01, n.s). 
The latency to respond to the initiation signal was also the same between mice o f
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different genotypes (F2,5i= 3.16, n.s.). Finally, no difference was found on the 
magazine or eating duration parameters (see Appendix 4.8), between the separate 
mutant line WT controls In common, there was no difference in the initiation response 
latency between the WT controls o f the separate mutant lines (Fj^8= 0.03, n.s.).
6.3.4 The effects o f varying the Stop signal delay on SSRTT performance
Once a stable baseline performance was reached, the response control 
capability o f the subjects was further investigated by varying the position o f the SSD. 
The subjects completed the SSRTT within 40 sessions from reaching baseline 
performance, and the number sessions required to complete the SSRTT was 
equivalent across genotypes (one-way ANOVA;F2,5i= 0.35, n.s.). Increasing the SSD 
resulted in a decline in the accuracy o f the stopping response (Figure 6.7A, within- 
subject test; F2,i0 2 = 6 7 . 56, p< 0.001), as well as a reduction in the SSRT (Figure 6.7B, 
within-subject test; F 2 , i o 2 = 6 7 . 5 6 , / ? <  0.001).
WT-mterrnates 
Igf2-P0 KO 
Igf2-Null KO
10%30%  40% 60%  70% 00%10%-30% 40°/<r60% 70%Q0%
Step signal delay
(percertage i nto the wean Go-Correct reaction time)
Figure 6. 7: Stop-performanc at varying SSD. The effects o f varying the Stop signal 
delay (from 10% o f mean Go-RT to 90% o f Go-RT) during Stop signal trials on 
response accuracy (A) and SSRT (B), across genotypes. Data are presented as 
mean values with SEM.
A one-way ANOVA did not report any difference between genotypes on either 
the percentage o f correct Stop responses (F2,5i= 0.33, n.s.) or for SSRT (F2,si= 0.56, 
n.s.), when the Stop signal was presented midway in the mean Go reaction time, a 
point where the capacity for response inhibition would have been most susceptible. In
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sessions where the Stop signal was implemented earlier or later during the Go LH, the 
results showed no difference at either Go or Stop trials (see Appendix 4.9). Altering 
the SSD did not affect the percentage o f correct Go-responses (Figure 6.8A, within- 
subject test; F2,io2= 0.43, n.s.) or the reaction time o f correct Go-responses (Figure 
6.8B, F2,io2= 0.08, n.s.) and there were no significant genotype differences found in 
response accuracy at Go-trials (between-subject test; F2,si= 1.96, n.s.) or in the 
reaction time o f the Go-response (between-subject test; F2,5i= 0.49, n.s.). The 
percentage o f trials completed by subjects did not differ between mice o f different 
genotypes (between-subject; F2,5i= 0.53, n.s.), and the overall number o f trials 
initiated was also equivalent (between-subject test; F2,5i= 0.28, n.s.). Also, on a 
separate analysis o f the effects o f varying the SSD on the main SSRTT parameters 
between WT-control littermates o f different lines, results did not show any difference 
as shown in Appendix 4.10.
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Figure 6.8: Go-perjormance at varying SDD. The performance o f  subjects with 
varying the Stop signal delay (from 10% o f mean Go RT to 90% o f  Go RT) on 
response accuracy on Go-trials (A) and Go reaction time o f  correct responses (B) 
on the SSRTT, across genotypes. Data are presented as mean values with STM.
6.4. Discussion
The SSRTT was successfully carried out on mice o f the foetally growth 
deficient Igf2-KO lines and their WT-littermate controls. The majority o f subjects 
showed a steady progress throughout task acquisition and completed the SSRTT 
within the predetermined time window (i.e. 125 sessions). The relatively large decline
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in response accuracy during Stop signal trials along with the lowered reaction time of 
correct responses during both Go- and Stop-trials reflects the relative sensitivity of the 
performance of subjects to the dependency of the SSD. The main findings of the 
present study showed that there was no noticeable difference detected on the measure 
of response accuracy among Igf2-KO mice, in either Go- or Stop-responses, in 
comparison to the WT littermates. Moreover, the results demonstrated an equivalent 
SSRT (and Go reaction time for that matter) across mice of different genotypes. The 
Igf2-KO mice acquired the SSRTT at similar rate as their WT-littermate controls, and 
did not differ on any of the other behavioural measures. Of notice, during the single 
nose-poke phase o f the SSRTT acquisition, the WT littermates of the 7g/2-Null KO 
line made fewer nose-pokes in response to the initiation signal per trial, as well panel- 
pushes, relative to the WT controls of the Igf2-PO KO line. However, since both of 
these behavioural measures rely heavily on locomotor ability, this difference could 
likely be accounted for by the difference in body weight (and size) that was 
previously reported between the WT-control lines in Chapter III, rather than being due 
to some cognitive or emotional aspects.
The findings o f this study suggest that intrauterine malnutrition and/or foetal 
growth retardation does not impact on murine measures of response control in later 
postnatal life. The results are not necessarily surprising even though they do not add 
to the previous 5-CSRRT data (see Chapter V, sections 5.4), which showed enhanced 
response inhibition among the growth restricted mice of the Igf2-P0 KO line. As 
mentioned previously (section 6.1), while impulse- and response control are both 
critical components o f behavioural inhibition (albeit unlikely to be the only ones) and 
have both been strongly associated with a diagnosis of ADHD (Winstanley et al., 
2006), the behavioural phenotypes of the two inhibitory mechanisms are quite 
distinct; in terms that one involves cognitive inhibition whereas the other relies more 
on motor inhibition (Logan and Cowan, 1984).
Furthermore, as previously mentioned in the introduction of this chapter, there 
is no reason to assume that both impulse- and response control are modulated by the 
same neurobio logical substrates, even if they are likely to overlap to some extent. In 
fact, while cat echo laminergic (noradrenaline and dopamine) and serotonergic (5-HT) 
neurotransmitter systems have been demonstrated to play a critical role in the 
functions of behavioural inhibition in the 5-CSRTT (see Robbins, 2002 for review), 
the evidence suggests that the serotonergic influence on SSRTT performance is only
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slight (Robbins, 2007). For instance, numerous studies have reported an increase in 
the number of premature nose-pokes performed in the 5-CSRTT following 5-HT 
depletion (Carli and Samanin, 2000; Harrison, Everitt and Robbins, 1997; Koskinen et 
al. 2000; Koskinen and Sirvio, 2000), whereas studies using selective 5-HT re-uptake 
inhibitors and tryptophan depletion have only reported minor if any effects on 
response control in the SSRTT (Chamberlain et al., 2006; Clark et al., 2005; Eagle et 
al., 2009). However, numerous studies have shown that the dopaminergic and 
noradrenergic systems may play significant roles in controlling SSRTT performance 
(Eagle et al., 2007; Turner et al., 2004; Chamberlain et al., 2009; Robinson et al., 
2008), as might be expected in a task sensitive to ADHD (Prince, 2008). In context of 
this pharmacological data and the results from the current study, it could be proposed 
that early programming by intrauterine under-nutrition might have either directly or 
indirectly, influenced the developmental trajectory of a brain system particularly 
important for mediating impulse control in the 5-CSRTT (the 5-HT system for 
example) and resulted in altered neurochemical functions in the 5-HT pathways in 
later postnatal life. These changes could in turn have improved the impulse inhibition 
of the 7g/2-PO-KO mice without affecting SSRTT performance. Still, despite the 
feasibility o f this account based on the dissociation of the two response inhibition 
phenotypes observed, further research into the multiple 5-HT neurobiological 
substrates that might modulate impulse inhibition (i.e. 5-HT biosynthesis, -reuptake 
mechanisms, receptor subtype expression etc.) is warranted in order to provide more 
conclusive evidence for this possibility.
In conclusion, there were no significant differences observed among the Ig/2- 
KO mice and WT-controls on SSRTT performance. The SSRTT assays a different 
form of behavioural inhibition than the 5-CSRTT, and highlights the possibility that 
the changes shown in the Igf2-?0 KO mouse model are particular to cognitive 
inhibition, rather than broader behavioural inhibition. As such, these differences in 
behavioural phenotypes in Igf2-?0 KO mice could stem from an early developmental 
reprogramming of the 5-HT system, although changes in noradrenergic and/or 
dopaminergic transmissions is also a possibility.
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6.4,1 Summary o f  key results from Chapter VI
• Igf2-KO mice did not show any differences from WT controls in either Go- or 
Stop-response accuracy during the SSRTT.
• The SSRT was indistinguishable between lgf2-KO mice and WT control at 
baseline and under conditions of varying SSD.
• Igf2-KO mice acquired the SSRTT at similar rate as their WT controls, and 
did not differ on any of the other behavioural measures.
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Chapter VII
Investigating the Molecular Substrates of the Heightened 
Stress/Anxiety-Related Phenotypes and Impulse Control 
among Mice of the Igf2-P0 Knockout Mice: A Role for 
Hippocampal GABAergic and Serotonergic Systems
7.1 Introduction
Among the main findings from the series of behavioural experiments reported 
in the preceding chapters was that the Igf2-P0 KO mice exhibited heightened stress 
response and anxiety-related phenotypes, in comparison to wild-type (WT) control 
littermates. The increased stress response among Igf2-PO KO mice was indicated by a 
significantly greater whole body startle reaction to acoustic stimuli, whilst an increase 
in anxiety-related behaviours was observed across a number of ethological based 
conflict tests in this group. The aim of this chapter is to assay the expression of key 
neural/molecular substrates known to be vulnerable to early environmental insults, 
and which have been demonstrated to have a role in stress/anxiety-related behaviour 
with a view to beginning to understand the molecular mechanisms underlying the 
behavioural differences reported in previous chapters.
The hippocampal circuitry plays an integral part in stress/anxiety responses 
(Chapter IV, section 4.1), predominantly via the neurotransmitters GAB A and 
serotonin (5-HT) and their different receptor subtypes (Kim and Gorman, 2005; 
Millan, 2003). Accordingly, stress- and/or anxiety-related psychiatric disorders are 
frequently characterized by dysfunctions of the GAB A- and 5-HTergic systems 
(Millan, 2003; Graeff, Guimaraes, De Andrade and Deakin, 1996; Kalueff and Nutt, 
2006, respectively), and these neurotransmitter systems have also been found to be 
affected by the activity of the hypothalamic-pituitary-adrenal (HP A) axis (Kirby et al, 
2008; Leonard, 2005). Furthermore, in parallel to the aforementioned findings of a 
marked hippocampal susceptibility to nutritional programming during early 
development (see Chapter I, section 1.3.2), there is a strong body of evidence that 
GAB A- and 5-HTergic neurotransmission is attenuated by poor intrauterine nutrient 
availability (Steiger, Alexander, Galler, Farb, and Russek 2003; Fiacco, Fitzgerald,
144
Blatt, Rosene, and Galler, 1998; Mokler, Galler and Morgane, 2003; Mokler, 
Bronzino, Galler and Morgane, 1999).
GABA is the major inhibitory neurotransmitter of the central nervous system 
(CNS) and is therefore involved in a number of different physiological actions. The 
usage of anxiolytic drugs, such as the benzodiazepines, which modulate GABA 
function, have suggested a key role for the GABAergic system in the control of 
anxiety-related behaviours. Benzodiazepines act to potentiate the inhibitory effects of 
GABA via modulation of the GABAa receptor by binding at different molecular sites 
in the receptor complex. The benzodiazepine (BZ) type-I receptor site (containing the 
GABA*# receptor subunit) has been suggested to be involved in sedation but the BZ 
type-2 receptor site which encompasses the GABA*# and GABA*# subunits, has been 
found to play a key role in modulating anxiety (Atack, 2005), and moreover the 
expression o f these receptor subunits is highly enriched in the hippocampus (Mohler, 
Fritschy and Rudolph, 2002). The expression of GABA*# and GABA*# receptor 
subunits has previously been shown to be influenced by intrauterine nutrition in a rat 
model (Steiger, Galler, Farb and Russek, 2002), implicating them as candidate 
molecular mediators for the previously described behavioural effects.
In terms o f the serotonergic system, the 5-HT ia and 5-HT2A receptor subtypes 
have been shown to play a pivotal role in modulating anxiety-related behaviour, 
although the manner in which these receptors function in stress and anxiety remains 
obscure. For example, down-regulated expression of the 5-HTia receptor subtype has 
repeatedly been noted in stress-and/or anxiety-related disorders in both humans 
(Mann, 1999; Lopez., Chalmers, Little and Watson, 1998) and animals (Lopez et al., 
1998; Flugge, 1995; McKittrick, Blanchard, Blanchard, McEwen, and Sakai, 1995), 
and gene deletion of the 5-HT ia receptor in mice leads to a robust anxiogenic 
phenotype, exemplified by heightened levels of avoidance to a novel unfamiliar 
environment and related increase in stress response (Toth, 2003). Moreover, a large 
number of studies have described anxiolytic effects in humans and rodents, following 
administration 5-HTia partial or full agonists (De Vry, 1995; Schreiber and De Vry, 
1993 and 1992; Higgins, Jones, and Oakley, 1992). There is less of a consensus for 
the role that the 5-HT2A receptor may have in anxiety-related behaviours. In contrast 
to the effects of 5-HT i a gene deletion, a 5-HT2A receptor knockout mouse model has 
recently been reported to suppress avoidant behaviour in a range of approach- 
avoidance conflict paradigms (Weisstaub et al., 2006). There are discrepancies in the
145
results of work using 5-HT2A receptor agonist agents which describe anxiogenic 
effects on rodent behaviour (see Griebel, 1996 for review), whereas other more recent 
studies demonstrate the reverse (Masse, Aine, Dhonnchadha, Hascoet and Bourin, 
2007; Ripoll, Hascoet and Bourin, 2005; Dhonnchadha, Hascoet, Jolliet and Bourin,
2003). The differential results o f 5-HT2A receptor agonist studies most probably stem 
from regionally-specific effects of the 5-HT2A receptor in anxiety-related behaviour. 
In support of this notion, localized micro-infusion in either the amygdala or 
periaqueductal gray o f the 5-HT2A receptor agonist DOI ((±)-l-(2,5-dimethoxy-4- 
iodophenyl)-2-aminopropane) has been shown to cause an increase in anxiety-related 
behaviour (Masse, Petit-Demouliere, Dubois, Hascoet, and Bourin, 2008), whereas 
infusion into the dorsal hippocampus has evoked profound anxiolytic effects. Of 
particular relevance to this thesis, malnutrition during intrauterine life in rats has been 
shown to down-regulate 5-HTia receptor subtype brain expression (Blatt, Chen, 
Rosene, Volicer and Galler, 1994); however, to the author’s knowledge, the same has 
not been demonstrated for the 5-HT2A receptor. On the basis of this evidence it is 
reasonable to assume that the heightened stress- and anxiety-related phenotypes of 
Igf2-P0 KO mice might stem from reduced expression of GABAergic and/or 5- 
HTergic receptors in the hippocampus.
Another key finding in Igf2-?0 KO mice was enhanced impulse control in the 
5-choice serial reaction time task (5-CSRTT), as indexed by the significantly reduced 
number of premature nose-pokes performed at baseline and during the session in 
which the inter-trial interval was lengthened (see Chapter V). This result is of 
considerable interest, as there is evidence for greater behavioural inhibition associated 
with anxiety disorders in humans (see Colder and O’Connor, 2004; Turner, Beidel 
and Wolff, 1996 for review). However, similar findings have not been reported in any 
of the previous animal models o f intrauterine under-nutrition. In fact, studies have 
noted a decrease in response inhibition among intrauterine malnourished rats during a 
simple reward-conditioning paradigm (Tonkiss et al., 1990b; Smart et al., 1973). 
Nevertheless, it is feasible that the improved impulse control of Igf2-P0 KO mice 
might originate as a result of the increase in anxiety and there is a substantial amount 
of both behavioural and biological data supportive of such a relationship, see section
8.2 for discussion.
The 5-HT system has been strongly implicated in behavioural inhibition in 
both humans and animals (Winstanley et al., 2006). Numerous animal studies have
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underlined the importance of 5-HT for impulse control in the 5-CSRTT (Robbins, 
2002) where attenuations in 5-HT by global forebrain lesion (Harrison et al., 1997a) 
or agonism of the 5-HT ia receptor (which reduces 5-HT release, Carli and Samanin, 
2000) increase the number of premature nose-pokes on the 5-CSRTT. Moreover, 5- 
HT efflux, as measured in the medial prefrontal cortex using in vivo microdialysis 
during the 5-CSRTT, was shown to be increased in situations where greater 
impulsivity was induced (Dailey, Theobald, Eagle, Passetti and Robbins, 2002) 
further indicating the link between 5-HT and impulsivity in the 5-CSRTT. The 
complexity o f the 5-HT system, which includes over 15 different types of receptors in 
the mammalian system (Robinson et al., 2008), means that it can exert both excitatory 
and inhibitory actions on serotonergic neurons, and on their dopamingergic and 
glutamatergic targets. For example, a recent study demonstrated a significant 
reduction in premature responding on the 5-CSRTT following microinfusion of the 5- 
HT2A antagonist M l00907 into the ventral striatum (i.e. nucleus accumbens), whereas 
infusion of SB242084, a 5-HT2c receptor subtype antagonist, heightened this 
parameter o f impulse control (Robinson et al., 2008). Conversely, administration of 
either SB242084 or Ml 00907 in the medial prefrontal cortex (i.e. prelimbic cortex) 
did not produce any effect on impulse control during the 5-CSRTT, highlighting the 
functional importance of the striatum for behavioural inhibition and regional 
specificity o f this response. In addition, this functional dissociation between 5-HT2 
receptor subtypes has been demonstrated in previous studies (Higgins, Enderlin, 
Haman and Fletcher, 2003; Winstanley et al., 2003). Hence, the enhanced impulse 
control displayed by the Igf2-?0 KO mice during the 5-CRSTT could be due to 
alterations in the expression of these 5-HT receptor subtypes in specific regions o f the 
brain, most notably the striatum.
In the present study, a quantitative real-time polymerase chain reaction 
(qPCR) analysis was performed to investigate expression levels of several of the 
target receptor subtypes which have been implicated with anxiogenic behaviour and 
impulse control. In relation to the heightened levels of stress response and anxiety- 
related behaviour in the Igf2-P0 KO mice, the expression of GABA^, GABA^, and 
5 -H T ia  and 5-HT2A receptor subtypes was examined in the hippocampal region, 
whereas striatal expression of 5-HT2A and 5-HT2c receptor subtypes was examined for 
potential involvement in the enhanced impulse control observed during 5-CSRTT. 
Additionally, the expression of the two different splice variants of the 5HT2c receptor
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(see Hannon and Hoyer, 2008), the functional 5-HT2CLong and nonfunctional 5- 
HT2cshort> and their ratio, were examined. As the major behavioural effects that have 
been found so far (see Chapters III-VI) relate to the 7g/2-P0 KO mice, analysis was 
limited to these mice and their own WT-littermate controls (i.e. WT-PO littermates).
7.2 Material and Method
7.2.1 Real-time qPCR
Cerebral tissue was collected from a total of 16 mice from different litters of 
Igf2-P0 KO and their WT-control littermates; consisting of eight subjects in each 
genotype group. All subjects (6-8 months old, age-matched between genotypes) were 
culled by cervical dislocation and the brain rapidly removed, The cerebral structures 
dissected and obtained for the purpose of present investigation included; the 
hippocampus, hypothalamus and striatum (see Chapter II, section 2.7). RNA was 
extracted from both hemispheres and prepared in accordance to the protocol 
previously described in Chapter II (section 2.8). Total extracted RNA was synthesized
TPli
into cDNA using a Sprint RT Complete Products Kit (Clontech, Mountain View, 
CA) along with the accompanying Poly-dT protocol (as outlined in Chapter II, section 
2.8.5). Real-time qPCR analysis was carried out on the cDNA samples in order to 
determine level o f gene expression in the aforementioned brain structures (see 
Chapter II, section 2.8.7). All of the reactions were arranged in triplicate (in effort to 
minimize pipetting errors) and a Corbett CAS-1200 robotic bench top instrument 
(Corbett Life Science) enabled automated PCR setup. All primer concentrations were 
optimized before use (see Chapter II, section 2.8.6). The qPCR was run on a Rotor- 
Gene™6000 cycler machine.
The assessment of GABA^, GABA^, 5-HTiAand 5-HT 2a subunit expression 
in the hippocampus was of particular importance for the purpose of examining 
potential molecular targets underlying the stress/anxiety-related phenotypes observed 
in the 7g/2-P0 KO mice (Chapter IV). In relation to the heightened impulse control 
observed among the Igf2-P0 KO mice (Chapter V), expression of the 5-HT2A receptor 
and 5-HT2C receptor subunit variants; 5-HT2c-iong and 5-HT2c-short, was examined in 
the striatum, as well as the expression ratio between the two variants as an index of 
alternative splicing (calculated as 5-HT2c-iong / 5-HT2c-short). Expression of the
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housekeeping gene 18S, was also determined in each brain region as a control for 
RNA concentrations (see section 7.2.2.1).
7.2.2 Real-time PCR analysis: the Z AAa method
Since gene expression was compared between mutant mice and their WT- 
littermate controls, a relative quantification method was selected as the appropriate 
method of analysing the data. Furthermore, the 2"AACt method was used to calculate 
relative changes in gene expression determined from real-time quantitative PCR 
experiments. Derivation of the 2'AACt equation, including assumptions, experimental 
design and validation tests have been previously described by VanGuilder et al. 
(2008), and Livak and Schmittgen (2001).
7.2.2.1 Selection o f internal control and calibrator fo r the 2'AACt method
Due to the fact that samples vary in size, and thus the amount of RNA 
obtained, false expression data could be produced by the varying concentration of 
extracted RNA, or the converted cDNA. Therefore, in order to normalise the PCR 
reactions for the amount o f RNA added to the reverse transcription reaction, an 
internal gene (otherwise known as house-keeping gene), was required to establish a 
control. Importantly, the expression of the house-keeping gene needs to be abundant 
and unaffected by genetic abnormalities or chemical treatments. For these reasons, 
18S RNA was selected as a suitable control for the real-time qPCR analysis. The 
selection of calibrator for the 2‘AACt method was based on the kind of gene expression 
analysis, and for the current study the most basic design, the untreated control, was 
used. While using the 2"AACt method, the data was presented as fold change in gene 
expression, normalised to the endogenous house-keeping gene and relative to the WT 
controls. In case of the o f the WT control, the AACt equals 0 and 2° equals 1, whereby 
the fold change in gene expression relative to the WT controls equals 1, by definition. 
On the other hand, in case o f the mutant sample evaluation of the 2_AACt indicates the 
fold change in gene expression relative to the WT control.
7.2.2.2 Data analysing using the 2'AACt method
The Ct values obtained from the Rotor-Gene™6000 cycler software were 
imported into Microsoft Excel, which enabled descriptive analysis of the data. The Ct
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values for the 18s and the target gene rRNAs were averaged across the triplicates for 
each sample, prior to performance of the ACt calculation. Next, the ACt value was 
calculated by subtracting average Ct values of the target genes from the average Ct 
values of the 18S. The estimated variance from the replicate Ct values is used in the 
final calculation o f relative quantities using standard propagation of error methods. 
However, due to the fact that the Ct value is exponentially related to the number o f 
copies, for the final calculations the error was estimated by evaluating the 2"AACtterm 
using the adding/subtracting o f the standard deviation to/from the AACt values. This 
results in a range o f values that are asymmetrically distributed relative to the average 
value, as the asymmetric distribution is consequence of converting the results of an 
exponential process into a linear comparison of amounts. These values are then 
combined with the values o f relative change in the expression of the target gene 
between the comparison groups and presented as a graph.
7.2.23 Statistical analysis o f the real-time PCR data
The final stage o f the real-time qPCR analysis is to determine the threshold 
cycle or the Ct value. The Ct value is derived from a log-linear plot of the PCR signal 
against the cycle number, which depicts the Ct value as an exponential instead o f 
linear term Hence, the data was converted to a linear form using TACt, which then 
demonstrated the individual variation among replicates with further accuracy. The 
data obtained was statistically analysed using a one-tailed independent T-test, while a 
Benjamini Hochberg false discovery rate correction testing (Benjamini and Hochberg, 
1995) was used to adjust /7-values for false positives, due to multiple testing. The 2‘ 
AACt relative method was applied to graphically present the gene expression data, but 
this method was designed to assess gene expression in a set of samples relative to the 
expression o f the same genes in a control (i.e. wild-type) set o f samples.
7,3 Results
73.1 Hippocampal expression of GABA- and 5-HTergic receptor subtypes
Expression of GABA and 5-HT receptor mRNA in the hippocampus and 
hypothalamus was measured to determine if changes in these neurotransmitter 
systems might account for the increased stress/anxiety effects observed in Igf2-P0 KO
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mice (see Chapter IV). Real-time qPCR data revealed a significant -35%  down- 
regulation o f the GABA^ subunit expression in the hippocampus of/g/2-P0 KO mice 
in comparison to their own WT-control littermates (Figure 7.1 A, /(14)=-3.15, /?<0.01, 
significant following Benjamini-Hochberg adjustment), whereas no apparent 
difference was detected in the expression o f  GABA^ in this brain region (t(\4)= 0.13, 
n.s.). Moreover, there was no variation in GABA^ expression observed in the 
hypothalamus (/(l 4)= 0.93, n.s.). These data suggest regional specificity in the 
alteration o f GAB A«3 expression in Igf2-?0 KO mice.
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Figure 7.1: Expression o f  certain GABA and 5-HT receptor subtypes, implicated with 
anxiety-related behaviour in the hippocampus and control brain regions (i.e. 
hypothalamus and striatum). (A) The expression o f GABA02 and GABAa} receptor 
subunits in hippocampal and hypothalamic brain regions, between Igf2-P() KO mice 
and their WT-littermates. (B) The expression o f 5-HT)A and 5-HT2A receptor subtypes 
in hippocampal and striatal regions, between Igf2-P0 KO mice and their WT- 
littermates. Data are presented as mean±SEM.
*Signijicant at p  <0. 05 following a Benjamini Hochberg correction fo r  multiple
testing.
A similar pattern o f effects was observed when gene expression o f the 5-HT ia 
and 5-HT2A receptors was assayed. There was a significant -24% reduction in 5-HT2A 
receptor subunit expression in the hippocampus of Igf2-?0 KO mice (Figure 7.IB, 
t( 14)=-2.64, /7<0.01, significant following Benjamini Hochberg adjustment). In 
contrast, gene expression o f the 5-HTjA receptor in the hippocampus (f(14)=-0.55, 
n.s.), and the 5-HT2A receptor in the striatum (/(l4)= 0.03, n.s.) did not differ between 
Igf2-?0 KO mice and their WT littermates. Thus, consistent with the previous results, 
these data further highlight possible dysfunction in the hippocampus as a neural
151
mechanism that might underlie the altered stress/anxiety behaviour o f Igf2-P0 KO 
mice.
7.3.2 Striatal expression o f 5-HT2 receptors
In the context o f the heightened impulse control exhibited by the Igf2-PO KO 
mice (Chapter V), striatal mRNA expression o f the 5-HT2A and 5-HT2C receptor 
subtypes was assayed. No difference was noted in expression of the 5-HT2A receptor 
subtype in the striatum (see Figure 7.1 A above, f(14)= 1.61, n.s.), which in 
comparison with the reduced expression in the hippocampus suggests that the 
alteration in 5-HT2A expression was relatively localized. The 5-HT2C receptor subtype 
undergoes alternate splicing during transcription, and thus produces a truncated non­
functional variant (5-HT2c-short) in addition to the functional version (5-HT2c-iong)- 
Therefore, it was important to examine the relative expression of both splice variants 
(Figure 7.2. A) and also the ratio between them (Figure 7.2B).
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Figure 7.2: Expression o f  5-HT2C receptor variants and expression ratio o f  variants. 
(A) Striatal expression o f  5-HT2A, 5-HT2c -long und 5-HT2C -short receptor variants, in 
Igf2-P0 KO mice and their WT-littermates. (B) The striatal expression ratio o f  the 5- 
HT2C-Umg receptor variant relative to the short non-functional 5-HT2c-shorb in Igf2- PO 
mice and their WT-littermates. Data are presented as mean values along with SEM.
*Significant at p  <0.05.
There were no differences in the relative expression between the Igf2-PO KO 
mice and their WT-littermate controls o f either the functional variant o f the 5-HT2C 
receptor subtype (5-HT2c-iong, t{ 14)= 0.84, n.s.), or for the non-functional variants (5-
HT2c-shoit, t{ 14)= 0.03, n.s.). However, calculation of the ratio of expression for the 
two transcription variants revealed a significant alteration in the splicing of 5-HT2C 
transcripts between the 7g/2-P0 KO mice and their WT controls (Figure 7.2B, t( 14)= 
2.00, p<0.05). This increased ratio in 7g/2-P0 KO mice suggests a shift towards 
greater expression of the functional 5-HT2c-iong transcript and may represent an overall 
increase in 5-HT2C receptor functionality in the striatum, which in turn may underlie 
the altered impulse control shown by Igf2-?0 KO mice.
7.4 Discussion
Previous research in the field of foetal programming, as a result of altered in 
utero nutrition, has demonstrated the involvement of aberrant alterations in the 
physiological feedback circuitry o f GABA and 5-HT systems, in the pathogenesis of 
later stress/anxiety-related disorders and there is substantial evidence implicating links 
between the 5-HT-ergic system and impulse control (see section 7.1). Moreover, 
alterations in these neurotransmitter systems have shown regional specificity, 
highlighted by dysfunction in the hippocampus and striatum, respectively (Robinson 
et al., 2008). Thus, the present study aimed to investigate whether developmental 
alterations in the hippocampal and striatal expression of key GABA and 5-HT 
receptor subtypes might underlie the differences in stress/anxiety and impulse control 
observed in 7g/2-P0 KO mice. As mice of the full Igf2 KO line did not show such 
pronounced alterations on these behavioural parameters relative to WT-controls, only 
tissue from the Igf2-?0 KO mice was analysed.
In terms of the heightened levels of stress reactivity and anxiety-related 
behaviour, observed among mice exposed to placental deficiency and foetal growth 
restriction (i.e. the 7g/2-P0 KO line), the developmental alteration in the hippocampal 
expression of key GABA and 5-HT receptor subtypes was investigated. Findings from 
the real-time qPCR analysis revealed a significant reduction in the expression of 
GABAo? receptor subunit in the hippocampus, although no difference was noted in 
GABAo2 mRNA levels. Moreover, the fact that the reduction in GABA^ expression 
was absent in the hypothalamus, supports the idea that nutritional insults in early life 
might exert region-specific effects on gene expression in the brain. This reduction in 
GABAoj expression is in line with previous work, indicating the susceptibility of 
GABAa receptor expression to early malnutrition (Steiger et al., 2002). A regionally-
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specific decrease was also observed in the expression of the 5-HT2A receptor subtype 
in the hippocampus, whereas expression of the 5-HTia receptor subtype was found to 
be intact. This result was particularly interesting, on the basis that only the 5-HT ia 
expression (not 5-HT2a) to the author’s knowledge, has previously been shown to be 
altered by intrauterine malnutrition (Blatt et al., 1994). Moreover, the overall pattern 
of expression (GABA^ GABA^ 5-HT ia and 5-HT2a) suggests quite a specific range 
of altered gene expression rather than a general non-specific alteration in hippocampal 
integrity.
Evidence from numerous studies has implicated a strong functional 
relationship between GABA and 5-HT systems in the pathogenesis of anxiety (see 
section 7.1), although, as mentioned, there has been particular focus on the 5-H Tia  
receptor in terms on this relationship. Indeed, reduced 5-HT transmission (mainly via 
the 5-H T ia receptor), which in turn diminishes GABAa receptor expression and 
increases anxiety and benzodiazepine insensitivity in knockout mice deficient of 5- 
H Tia receptor expression, (Bailey and Toth, 2004), and transient postnatal 
pharmacological blockade of the 5-H T ia receptor has been shown to produce a long­
term increase in anxiety and reduced benzodiazepine sensitivity, but also heightened 
expression of GABAa receptor subunits in the prefrontal cortex and the hippocampus 
(Vinkers, Oosting, van Bogaert, Olivier and Groenink, 2010). However, the major 
5HTergic difference observed was in terms of reduced 5-HT2A gene expression in the 
hippocampus, which has not been previously linked with intrauterine growth 
restriction (IUGR) but a relationship has been found between the hippocampal 
function of this receptor and anxiety (Leonard, 2005). As mentioned previously (see 
section 7.1), there is not a consensus for the effects of manipulations of the 5-HT2A 
receptor on anxiety where both anxiogenic and anxiolytic behaviours have been 
observed. The 5-HT2A receptor is widely distributed in the brain (Xu and Pandey, 
2000; Burnet, Eastwood, Lacey and Harrison, 1995) and regional-specificity may 
account for these discrepant results. Thus, the current findings of increased 
stress/anxiety in Igf2-P0 KO mice may well be accounted for by the decreased 
hippocampal gene expression of the 5-HT2A receptor, but with the contribution of the 
reduction in GABA^ expression.
Also noteworthy is the fact that in addition to being strongly implicated with 
stress-related psychiatric disorders, both the GABA- and 5-HT-ergic systems have 
been found to be affected by increased HPA axis activity. Secretion of the stress-
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regulating corticotropin releasing hormone (CRH) has, for instance, been 
demonstrated to modulate the transmission o f dorsal Raphe 5-HT neurons directly 
through the CRHr2 receptor, as well as indirectly via presynaptic GABA activity 
(Kirby et al., 2008). In addition, administration of either dexamethasone or natural 
glucocorticoids has also been found to modulate 5 -H T ia  and 5-HT2A receptor 
expression, via glucocorticoid receptors (Leonard, 2005). However, in context of the 
findings from current study, it should be considered whether this modulating 
influence of HPA axis function upon the reciprocal interactions of the GABA and 5- 
HT systems in the dorsal Raphe nuclei, could be broadened to other brain regions 
(such as the hippocampus) and include other receptor subtypes of these 
neurotransmitters.
In relation to the heightened impulse control observed in the Igf2-PO KO mice 
(Chapter V), real-time qPCR analysis did not reveal any difference in the expression 
level o f 5-HT2A receptor subtype in the striatum and although no difference was noted 
in the striatal expression of either splice variant of the 5-HT2C receptor subtype (i.e. 
the 5 -H T 2 c -io n g and 5 -H T 2 c -sh o it) , between the Igf2-?0 KO mice and their WT- 
littermate controls, the results did reveal an alteration in post-transcriptional 
modification of the 5-HT2C receptor. This was demonstrated by a significant increase 
in the expression ratio, in terms that the balance between the splice variants was 
shifted towards the functional 5 -H T 2 c -io n g variant in the Igf2-?0 KO mice and away 
from the truncated, non-functional shorter transcript. That the IUGR Igf2-PO KO 
mice show an altered pattern of 5-HT2C editing is consistent with a previous study 
where early life stress was also found to lead to altered RNA editing of the 5-HT2C 
receptor in later life (Bhansali, Dunning, Singer, David, and Schmauss, 2007), and 
moreover, there is evidence that growth retardation by deletion of an imprinted gene 
control region (Prader-Willi syndrome, PWS-IC17' mice) also leads to aberrant editing 
patterns of 5-HT2C via a snoRNA mediated pathway (Doe et al., 2009). Furthermore, 
when assessed in the 5-CSRTT, PWS-IC+/‘ mice were found have attenuated 5-HT2C 
receptor-mediated impulse control following administration of the specific 5-HT2C 
antagonist, SB242084, suggesting that altered editing of this receptor has significant 
functional consequences.
As mentioned previously, there is considerable evidence linking the 5- 
HTergic system and impulsive behaviour, especially in terms of 5-CSRTT 
performance. Global forebrain depletion of 5-HT leads to an increase in premature
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responding (Harrison et al., 1997a), as does selective depletion of 5-HT in the dorsal 
Raphe nuclei, which primarily project to the striatum and neocortex (Harrison et al., 
1997b). Moreover, administration of SB242084, a specific 5-HT2C antagonist, also 
increases impulsivity in this task (Winstanley et al., 2003; Doe et al., 2009) suggesting 
that 5-HT may act via this receptor to control this form of behaviour, possibly by 
inhibitory modulation of dopamine release from both striatal and ventral tegmental 
area neurons (Bubar and Cunningham, 2006; Porras et al., 2002; Di Matteo, Blasi, Di 
Giulio and Esposito, 2001; Gobert and Millan, 1999). Indeed, decreased dopamine 
levels have repeatedly been reported to attenuate impulse control during the 5-CSRTT 
(see Robbins, 2002 for review). For example, a dose-dependent increase in impulsive 
responding (i.e. premature nose-pokes) is noted following striatal infusion of the drug 
D-amphetamine (Cole and Robbins, 1987), whereas dopamine depletion in the 
nucleus accumbens o f the striatum seems to attenuate this effect (Cole and Robbins, 
1989). The pattern of effects observed in Ig/2-PO mice of increased response control 
(decreased impulsivity) and it is highly probable that an increase in the functional 
form o f the 5-HT2C receptor could increase the binding efficacy of 5-HT, suppress 
forebrain dopamine release, and in turn improve impulse control.
Intriguingly, in recent years there has been accumulating body of work for the 
differential splicing of the 5-HT2C receptor RNA in various psychiatric disorders, 
including schizophrenia (Sodhi, Burnet, Makoff, Kerwin, and Harrison, 2001), 
depression (Dracheva, Chin and Haroutunian, 2007; Iwamoto, Nakatani, Bundo, 
Yoshikawa and Kato, 2005) and in people of increased risk of suicide (Gurevich et al., 
2002; Dracheva et al., 2008), conditions with a high risk of altered response control. 
Furthermore, while there have still not been any studies directly showing alternate 
splicing o f the 5-HT2C receptor variants in stress- or anxiety-related disorders 
(although the links with depression and suicide are quite persuasive in terms of 
increased neuroticism in these conditions), differences in post-transcriptional 5-HT2C 
editing have been described between anxiogenic rat strains (i.e. BALB/cJ and 
DBA/2J) and a non-anxiogenic strain (i.e. C57BL/6J, Hackler, Airey, Shannon, Sodhi, 
and Sanders-Bush, 2006), suggesting that this altered editing may also underlie some 
of the stress/anxiety phenotypes demonstrated by Igf2-P0 KO mice.
Thus, the findings from the present study demonstrated for the first time the 
long-term effects of foetal exposure to placental deficiency and growth restriction on 
gene expression in the brain, by using targeted knockout of the promoters of the
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imprinted Igf2 gene. These findings shed an important light on exactly how the 
developmental trajectories of the CNS are affected by early life nutrition, as well as its 
implication for later behaviour. However, in the absence of evidence to show altered 
concentrations of the proteins derived from the mRNA extrapolation of these results 
needs to be cautionary at this stage. Future analysis of tissue samples by Western 
blotting techniques, in situ hybridisation or immunohistochemistry would demonstrate 
the true effect of these data. Moreover, many studies use multiple housekeeping 
genes in their analyses, so the addition of one or more to this data set could 
significantly improve the validity o f control data.
In the view o f aforementioned research, one possible interpretation of these 
findings is that the differences found in the behavioural phenotypes in Ig/2-PO KO 
mice are modulated by dysregulation of central 5-HT function, derived by a 
hyperactive HPA axis. This dysfunction of the 5-HT system might in turn act to; a) 
increase stress responses and anxiety among the Igf2-PO KO mice by down-regulating 
GABAa receptor expression, and, in parallel b) affect facets of working memory 
function (i.e. attentional function and impulse control) via altering prefrontal and 
striatal dopamine release. In order to provide stronger support for this proposal, a 
further expression analysis o f genes involved in dopamine function (e.g. dopamine 
receptors DI and D2 etc.), would be required. Additional work of fundamental 
importance, would be to demonstrate that the differences in GABA and 5-HT systems 
observed in the Igf2-P0 KO mice are absent in /g/2-Null KO mice, in order to ensure 
that these changes in receptor-gene expression underlie the behavioural differences 
among the Igf2-KO mice, rather than being non-related alterations in neural substrates 
as a results of early growth retardation.
Possible future work might also include pharmacological manipulations of 
GABA- and 5-HTergic systems in Igf2-PO KO mice to try and normalise behaviour. 
Such experiment would show conclusively whether it is alterations in these systems 
that are giving rise to the aberrant behavioural phenotypes in your mutant mice.
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7.4.1 Summary o f  key results from Chapter VII
• A significant reduction was found in hippocampal expression of the GABA^ 
receptor subunit in the Igf2-¥0 KO mice when compared to their WT 
littermates, however no difference was observed in GABAqz receptor subunit 
expression or in GABA^ receptor subunit expression in the hypothalamus.
• In the Ig£2-P0 KO mice, there was a significant reduction in the expression of 
5-HT2A receptor subtype in the hippocampus relative to their WT littermates, 
although no difference was found in hippocampal 5-HTia receptor expression.
• There was no difference found in the expression of 5-HT2A or 5-HT2C receptor 
subtypes in the striatum, between Ig£2-P0 KO mice and their WT littermates.
• A significantly greater splicing of the non-truncated functional variant of the 
5-HT2C receptor was found in the striatal tissue of the Igf2-¥0 KO mice when 
compared to that of their own WT littermates
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Chapter VIII
General Discussion
Nutrition is the major intrauterine environmental influence that alters expression of 
the foetal genome and can have deleterious and lasting consequences for mental 
health in later life. In fact, there is evidence that the intrauterine environment of the 
individual foetus may be of at least equal importance in the aetiology of chronic 
disease in adults as the genome of the foetus (Wu et al., 2004). The scope of the 
present thesis was to investigate how compromised nutrient availability, via placental 
deficiency and growth retardation in intrauterine life, might act upon brain 
development and behavioural phenotypes in later life. This was achieved by 
comparing performance of two different Igf2 imprinted gene knockout (KO) models 
(i.e. the 7g/2-P0 KO and 7g/2-Null KO lines) to wild-type (WT) littermate controls, on 
a wide range of behavioural tests. Furthermore, a preliminary examination of changes 
in gene expression was also carried out, to dissociate some of the conceivable neural 
substrates that may underlie the observed behavioural phenotypes.
8.1 Main findings
The generation of the growth deficient Igf2 KO mouse models was successful 
with relatively low neonatal mortality. Mice of both 7g/2-P0 and 7g/2-Null KO lines 
showed considerable intrauterine growth retardation (IUGR) as indicated by the 
lowered birth weight, although this growth deficiency was found to be more severe in 
7g/2-Null KO mice. The weight of Igf2-?0 KO mice was -75% that of WT controls at 
birth, but these mice showed a considerable compensatory weight gain during early 
postnatal life and were found to have equivalent body weight to their own littermate- 
controls (i.e. WT-PO controls) in adulthood (Chapter III). In addition, early somatic 
development did not seem to be affected in Igf2-?0 KO mice. In comparison, the birth 
weight of the Tg/2-Null KO mice was only -55% of their WT-littermate weight. 
Moreover, while the 7g/2-Null KO mice showed a transient growth spurt in the first 
few days following birth, these mice were delayed on all measurements of somatic
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development (i.e. unfolding o f ear-pinna, incisor eruption, fur growth and eye 
opening) and remained growth impaired throughout life.
8. L I Behavioural findings
In general, the /g/2-P0 KO mice selectively showed a marked increase in 
stress reactivity and anxiety-related behaviour, across a number of ethologically based 
behavioural batteries that are sensitive for traits of anxiety in rodents (Chapter IV and 
see Table 8.1). The Igf2-PO KO mice displayed a heightened startle response to 
acoustic stimuli, greater neophobic reactivity to a novel food, spent proportionally less 
time on the open arms o f the elevated plus-maze (EPM) and showed a greater latency 
to ambulate into the exposed open region of the open field (OF) arena. Moreover, 
Igf2-PO KO mice spent less time in the novel compartment and were more reluctant to 
enter the distal part o f the novel compartment, in the free exploratory paradigm 
(FEB). The presumption that these changes in behaviour reflected heightened stress 
and anxiety was further validated by the fact that the Igf2-?0 KO mice were found to 
be indistinguishable from WT controls on every parameter of locomotor competence 
when assessed in these paradigms (i.e. ambulatory velocity, duration of ambulation 
and distance ambulated). Furthermore, no differences in motor ability were found 
between the Igf2-PO KO mice and WT controls when assessed in the locomotor 
activity (LMA) chambers or on the rotarod apparatus. Conversely, /g/2-Null KO mice 
did not display any evidence o f increased stress or anxiety phenotypes, but instead 
showed a significant reduction in ambulation during the LMA chambers, as well as an 
overall improvement in motor co-ordination and balance on the rotarod apparatus 
(indicated by greater latency to fall from the rod and a greater rotation velocity at the 
time of fall). Although the improvements in rotarod performance of the Tg/2-Null KO 
mice could readily be accounted by their relatively smaller body size, the reasons 
behind the reduction in LMA is less clear. In terms of sensory-motor gating, the Igf2- 
PO KO mice displayed a mild impairment in prepulse inhibition (PPI), relative to WT- 
control mice; however Igf2-Null KO mice did not differ from WT controls on this 
measure.
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Table 8.1: Main findings of the behavioural differences observed among the Igf2-KO 
mouse models (relative to WT-controls), in the present research.
B e h a v io u r a l test: P a r a m e te r /c o n s tr u c t Ig f2 -P 0  K O Ig f2 -N u ll K O
L M A  c h a m b e r s Ambulation No difference L o w e red
R o ta ro d
a p p a r a tu s
Motor balance and 
coordination No difference H eig h te n e d
A c c o u s t ic  s ta r t le  
an d  P PI
Stress response H eig h te n e d No difference
Sensory motor gating L o w ered No difference
E P M Anxiety-related behaviour H eig h te n e d No difference
O F Anxiety-related behaviour H eig h ten ed No difference
F E P Anxiety-related behaviour H eig h te n e d No difference
5 -C S R T T
Attention H eig h te n e d H e ig h te n e d
Impulse control H eig h te n e d No difference
Motivation No difference L o w e red
S S R T T
Go responses No difference No difference
Stop responses No difference No difference
Heightened attentional performance was observed for both Igf2-PO and Igf2- 
Null KO mice during the 5-CSRTT relative to WT controls, as indexed by greater 
discriminative response accuracy (Chapter V). This improvement in response 
accuracy was observed in lg f2-PO KO mice during task acquisition, at baseline, and 
during task-manipulations which increased attentional demand (i.e. at increased ITI 
and white-noise distraction). Similarly, the response accuracy of Igf2-Null KO mice 
was noted to be significantly improved at baseline, during sessions where the 
temporal predictability o f  the stimuli was absent and under specific task- 
manipulations during the 1-choice serial reaction time task (1-CSRTT, i.e. at 
increased ITI, and white noise distraction, data not shown). Moreover, Igf2-PO KO 
mice showed greater impulse control during the 5-CSRTT, indexed by reduced 
numbers o f premature nose-pokes, relative to WT controls, both at baseline and in 
sessions when the ITI duration was pseudorandomly extended. As expected, the 
number o f trials initiated during the 5-CSRTT was considerably reduced for 7g/2-Null 
KO mice as these mice are likely to become sated much earlier during each session 
relative to Igf2-?0 KO and WT controls, as a result of their lower body weights (and 
size). Importantly, since no differences were found between the lgf2-PO KO mice and 
the WT controls in the Stop signal serial reaction time task (SSRTT, Chapter VI), it is
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feasible that increased behavioural inhibition among the Igf2-PO KO mice stems from 
aspects of cognitive inhibition rather motoric inhibition.
8.1.2 Consistency o f behavioural findings across different WT-control lines.
In addition to the behavioural differences that were demonstrated between the 
IUGR Igf2-K.O mouse models and the WT-control group, some notable variations 
were also found between the WT littermates o f the Igf2-PO and 7g/2-Null mutant lines 
(i.e. the WT-PO and WT-Null controls). The greatest differences were observed on 
parameters of somatic developmental and postnatal growth; however several 
variations were also noted in behavioural measures which could be accounted for by 
the increased body size and mass o f the /g/2-Null derived WT controls. Thus, the 
heightened startle response of the WT-PO controls where body mass may influence 
the sensitivity of the startle measurement, and the improved rotarod performance due 
to lower body/rod size ratio among WT-PO controls, may be explained in terms of 
different body size/weight. However, other differences, such as the increased activity 
level o f WT-Null controls during the EPM and the increased number of nose-pokes 
and panel-pushes during the early acquisition of the SSRTT could not be attributed 
solely to body size/weight differences, and suggest that some other factors may 
contribute to these differences. Nevertheless, it is highly unlikely that the variations 
between the two WT-control groups has had much of an effect on interpretation of the 
observed behavioural differences between the Igf2-P0 KO and Zg/2-Null KO mice, 
and the collective WT-control group, since no difference was ever found on any of the 
relevant behavioural parameters between the segregated WT-PO and WT-Null 
controls.
Furthermore, in order to further ensure that the main behavioural differences 
observed between the Igf2-PO KO mice and the combined WT-control group was not 
produced (or exacerbated) by discrepancy in performance of either individual WT- 
control group, additional statistical comparisons were carried out between Igf2-PO KO 
mice and each o f the segregated WT-control groups on the main behavioural 
parameters (see appendices 8.1 and 8.2). In short, the heightened stress- and anxiety- 
related behaviour of /g/2-P0 KO mice remained significant when compared to both 
WT-PO and WT-Null controls for the relevant parameters of the acoustic startle and 
PPI paradigm (i.e. the increased startle response), food neophobia assessment (i.e. the
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lowered consumption of novel food-substance) and the OF test (i.e. the increased 
latency o f first entry to central region). The lowered exploratory behaviour of/g/2-PO 
KO mice on the open arms o f the EPM was only found to be significant when 
compared to behaviour of their own WT-littermate controls, whereas the anxiogenic 
effects noted on the FEP parameters only yielded significance relative to WT-control 
mice of the 7g/2-Null line. Similar patterns were found following separate comparison 
between the Igf2-KO mice and both WT-control groups with regard to the improved 
5-CSRTT performance. Taken together, these findings provide further evidence that 
the main behavioural findings were not misconstrued due to heterogeneity between 
the WT-control groups of different mutant lines.
8.1.3 Molecular findings
A preliminary molecular analysis was carried out between the mice of the 
7g/2-P0 KO mice and their own respective WT-littermate controls, using real-time 
qPCR for specific gene candidates related to the main behavioural differences found 
(Chapter VII). Receptor subtype-specific alterations were found in gene expression 
for GABA03 and 5-HT2A receptor subunits, suggestive of irregular GAB A and 5-HT 
transmission function in the hippocampus. Furthermore, there was significantly 
greater splicing of the non-truncated functional variant of the 5-HT2C receptor found 
in the striatal tissue of the Igf2-P0 KO mice when compared to that of their own WT 
littermates, evidence of altered post-transcriptional modification of the 5-HT2C 
receptor. Unfortunately, an equivalent comparison of gene expression could not be 
carried out between KO mice and WT littermates of the 7g/2-Null line, due to both 
temporal and financial constraints, but would be useful as these mice did not show 
anxiogenic behaviours but were IUGR. Therefore, such further examination would 
establish a stronger functional linkage between the observed alterations in gene 
expression and the behavioural phenotypes in 7g/2-P0 KO mice.
8.2 Relationship between behavioural phenotypes
The co-occurrence o f heightened stress/anxiety-related phenotypes in the Igf2- 
PO KO mice, together with elevated attentional-fiinction and impulse control as 
displayed on the 5-CSRTT, is particularly interesting given the fact that anxious 
individuals frequently tend to experience increased arousal, behavioural inhibition,
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and heightened awareness o f their surroundings (Enoch, White, Waheed and 
Goldman, 2008). Moreover, behavioural inhibition during early childhood, frequently 
highlighted by heightened withdrawal and vigilance towards novel people, objects and 
environment, has been implicated as a risk factor in the development of anxiety 
disorders (Hirschfeld-Becker, Micco, Henin, Bloomfield, Biederman and Rosenbaum, 
2008; Perez-Edgar and Fox, 2005; Gray and McNaughton, 2000). In fact, the 
physiology of behaviourally inhibited children has been shown to be paralleled by 
activation of the physiological systems that are affiliated with increased stress and 
anxiety (Fox, Henderson, Marshall, Nicholsand Ghera, 2005). For example, children 
showing high levels of behavioural inhibition show significant increases in heart rate 
and higher basal cortisol levels after presentation of a stressor (Schmidt et al., 1997; 
Kagan et al., 1988; Kagan et al., 1987). Nevertheless, the extent to which these 
symptoms o f behavioural inhibition in humans are akin to the impulse control 
observed in rodents during the 5-CSRTT, would be a subject of debate.
Despite the large amount of research that has been dedicated to the area of 
selective attention (or attentional bias) towards aversive stimuli in cases of anxiety 
disorders (e.g. Cisler and Koster, 2010; Rinck, Becker, Kellerman and Toth, 2003; 
Mathews, Mackintosh and Fulcher, 1997), at present very few studies have more 
generally focused on the relationship between anxiety and attentional competence per 
se (Castaneda, Tuulio-Henriksson, Marttunen, Suvisaari and Lonnqvist, 2008). 
However, in a recent study individuals with a life long diagnosis of noncomorbid 
anxiety disorders were found to have significantly elevated auditory P300 potential 
(an event related voltage considered to index attentional allocation) and improved 
performance on the Wechsler Adult Intelligence Scale-Revised (WAIS-R, Wechsler, 
1981) digit symbol subtest, when compared to either individuals of comorbid anxiety 
disorders (i.e. major depression and alcohol use disorder) or nonpsychiatric controls 
(Enoch, White, Waheed and Goldman, 2008). Also of considerable importance, a 
Vall58Met polymorphism o f the catechol-O-methyltransferase (COMT), a dopamine- 
degrading enzyme, has been implicated with patterns of cognitive function and 
emotionality similar to that observed in the Igf2-?0 KO mice (Enoch et al., 2008). In 
particular, individuals with the Met 158 allele, which leads to reduced COMT activity, 
have been found to perform better on tests of working memory and executive 
function, (Enoch, Waheed, Harris, Albaugh and Goldman, 2009; Barnett, Jones, 
Robbins and Muller, 2007; Egan et al., 2001), but have a greater risk of developing
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anxiety-related behaviours (Hetttema, et al., 2008; Olsson et al., 2005; Enoch, Xu, 
Ferro, Hams and Goldman, 2003). Consistent with this, COMT inhibitors have been 
found to improve working memory and attention (Apud et al., 2007; Tunbridge, 
Hamson and Weinberger, 2006). Based on these findings, it is possible that altered 
function of dopaminergic pathways might be among the key neural substrates that 
underlie the behavioural phenotypes 7g/2-P0 KO mice.
8.3 Nutritional deficiency or intrauterine growth restriction?
The observation that only Igf2-P0 KO mice (and not the Ig£2-Null KO mice) 
showed heightened stress reactivity, anxiety-related behaviour and greater impulse 
control, raises the question o f whether these particular differences in behavioural 
phenotypes (see Table 8.1) might be particular sequelae of foetal nutritional 
deficiency, as opposed to a result o f IUGR per se. The key difference between the 
Igf2-KO mouse models lies in the pattern of deletion of Igf2, where foetal expression 
was intact in Igf2-P0 KO mice but not 7g/2-Null KO mice, whilst both Ig/2-KO mice 
had no placental Igf2 expression, and it has been proposed that a mismatch between 
foetal and placental Igf2 expression will affect the relative demand and transmission 
of nutrition (see Angiolini et al., 2006 and Reik et al., 2003). Thus Igf2-?0 KO mice 
will have high demand (intact foetal Igf2) but a reduced placental capacity and may 
therefore have been more severely affected by nutritional deficiency than mice of the 
7g/2-Null KO model. In contrast, as the ablation of Igf2 expression from the foetal 
tissue of 7g/2-Null mice exerts limitations on the their intrinsic growth trajectory, it is 
plausible that the nutrient demand o f the foetus was at least, to some extent, reduced 
in parallel with the reduced placental supply of vital nutrients; thus these mice were 
not as nutritionally constrained despite their IUGR.
Interestingly, recent data on the 7g/2-P0 KO model illustrated an up-regulation 
of glucose and System A amino acid transport of the placenta at E l6 (Coan, 
Angiolini, Sandovici, Burton, Constancia and Fowden, 2008; Constancia et. al.,
2005). However, this up-regulation was decreased at E l9 in correlation with 
reductions in foetal weight (relative to wild-type weight) and thus failed to rescue the 
foetus from IUGR, whereas such up-regulation of glucose and amino acids has 
previously been found to be absent in the placentas of 7g/2-Null KO mice (Angiolini 
et al., 2006). In agreement with these studies, inverse correlations have been noted
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between System A amino acid transporter activity and birth size and weight in babies 
across the range of normal birth weight and size (Godfrey et a l, 1998). One 
interpretation of these findings is that a placental adaptation occurs in response to 
signals from foetal tissue still expressing Ig/2, in terms of up-regulation of glucose 
and System A amino acid transport from the placenta, in effort to retain normal foetal 
growth (Constancia et al., 2005). However, because of failure to maintain this up- 
regulation (along with the decreased placental permeability), foetal growth restriction 
ensues during late gestation. In comparison, a reduced (or absent) nutrient demand 
signal from the foetus of the 7g/2-Null KO model would require smaller placental 
supply of nutrients to support the lower growth rate, and placental glucose and amino 
acid transport activity is therefore lowered accordingly.
However, since heightened attentional function was observed across both Igf2- 
KO mouse models, it is possible that the neuronal substrates that underlie this 
behavioural difference are either more susceptible to early nutritional deficiency than 
the heightened stress/anxiety and impulse control (assuming that the 7g/2-Null KO 
mice were exposed to at least a mild malnutrition), or more likely to result from IUGR 
(at least to a greater degree) rather than nutritional deficiency.
8.4 Implications of early postnatal compensatory growth
One of the main developmental differences between the Igf2-KO mouse 
models was their distinct postnatal growth pattern (Chapter III) where mice of both 
Igf2 KO models displayed some degree of accelerated postnatal weight gain during 
early life. However, only 7g/2-P0 KO mice showed a complete compensatory (or 
‘catch-up’) growth, as indicated by an equivalent body weight to their own WT 
littermates at day 100. In comparison, 7g/2-Null mice showed only a brief growth 
spurt during the first few days post partum and remained growth retarded throughout 
life. Therefore, it could be argued that behavioural differences between Igf2-?0 and 
7g/2-Null mice might be due to the variation in early postnatal growth rather than 
differences in nutritional supply during intrauterine life. Such an interpretation could 
be considered in line with the findings of significantly greater body weight at day 100 
of the WT littermates o f the 7g/2-Null mutant line (relative to littermates of the Igf2- 
P0 control line), suggesting that the 7g/2-Null KO mice might possibly have gained 
less nutrient access to their mother during lactation. However, this is unlikely to have
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been the case since litter size, in terms o f the number of WT littermates, did not 
significantly affect the body weight (or size) o f 7g/2-Null KO mice at postnatal day 
100. Thus it is more probable that the lasting growth impairment of 7g/2-Null KO 
mice stems from a genetically intrinsic limitation in growth potential due to the 
ablation of foetal Igf2 expression, rather than due to poor nutrient access in early 
postnatal life.
One of the prominent theoretical paradigms in the research of foetal 
programming, known as the ‘thrifty phenotype hypothesis’ (Hales and Ozanne, 2003), 
highlights the importance of the interaction between intrauterine and postnatal growth 
for later disease susceptibility. As such, the foetal endocrine system undergoes 
adaptive change in response to a poor nutrient environment, in an attempt to divert the 
limited nutrient supply to maintain survival and development of vital organs (e.g. the 
brain), at the expense of overall growth leading to reduced birth sizes of the organism 
(Cianfarani, Germani and Branca, 1999). Nevertheless, while this adaptive response 
might have significant survival advantages under conditions where nutrition is 
intermittent or poor, these same physical adaptations could become detrimental in a 
postnatal environment where nutrition is abundant. This hypothesis has gained 
considerable support from a number of epidemiological studies which suggest that 
individuals that have undergone IUGR but exhibited early postnatal compensatory 
weight gain (‘catch-up growth’) and have above average body weight (or size), are at 
greater risk for metabolic (Forsen et al., 2000; Ong et al., 2000) and cardiovascular 
diseases (Eriksson et al., 1999; Leon et al., 1996). However, many other studies have 
failed to replicate these findings (Martin, McCarthy, Smith, Davies and Ben-Schlomo, 
2003; Law et al., 2002) and in terms o f neurological or psychological disorders, there 
has not been any evidence indicating such effects on neurodevelopment or behaviour.
One of the major challenges to the thrifty phenotype hypothesis is in regard to 
the vague definition of ‘catch-up’ growth. This term usually refers to the realignment 
of the genetic growth potential of the individual and can refer to the first 6-12  months 
of life or to as late as two years after birth (Simmons, 2005). However, considering 
the fact that approximately 90% of IUGR infants display some catch-up growth 
within the first six months o f life (McMillen and Robinson, 2005), it is reasonable to 
assume that this early postnatal weight gain might simply represent a normal 
physiological response to the foetal growth deficiency rather than being an indicator 
of an aberrant adaptation due to nutritional imbalance. As such, these studies are
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compromised by an inability to dissociate the extent of in utero growth deficiency 
between children showing catch-up growth and those which do not. Therefore, it is 
possible that the early catch-up growth displayed by the Igf2-PO KO mice might 
merely reflect a normal physiological response to suboptimal nutrition in early life 
and the /g/2-Null KO mice however, did not show catch-up growth as they were 
malnourished to a lesser degree in utero. Another critical shortcoming of such an 
interpretation of the thrifty phenotype hypothesis involves the lack of evidence that 
catch-up growth does in fact mirror nutritional imbalance rather than the influences of 
other environmental or non-environmental factors. For example, children o f low birth 
weight which show postnatal catch-up growth are more likely to have been subjected 
to maternal smoking during foetal life (Ong et al., 2000). Perhaps more 
fundamentally, the thrifty phenotype hypothesis also does not address the possibility 
that the postnatal growth rate o f these presumably catch-up and noncatch-up growth 
children might not reflect a qualitative difference in postnatal environment (such as 
varying nutrient availability), but merely constitute the opposite tails of the normal 
distribution of postnatal growth rate.
8.5 A role for dvsregulated imprinted gene expression in foetal development and 
adult brain function
During gestation and early postnatal life in particular, the developmental 
trajectories o f neurons are determined by a complex series of epigenetically-mediated 
processes. Furthermore, there has been increasing body of work implicating that 
environmental factors can act to alter these trajectories via modulating histone 
modifications and DNA methylation. In fact, the notion that epigenetic dysregulation 
of imprinted gene expression might play a paramount role in modulating the effects of 
early life adversities on adulthood disease susceptibility has gained substantial support 
among researchers (Lim and Ferguson-Smith, 2010; Dolinoy, Das, Weidmand and 
Jirtle, 2007; Waterland and Michels, 2007; Gallou-Kabani and Junien, 2005; Abel,
2004). As imprinted genes are functionally haploid and expression is tightly 
epigenetically regulated, they may be particularly susceptible to 
environmental/nutritional insults (Thompson, Konfortova, Gregory, Reik, Dean and 
Feil, 2001), for example by a lack of dietary methyl donors and co factors owing to the 
lack of compensative protection that diploid expression usually provides (Jirtle and
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Skinner, 2007; Waterland and Jirtle, 2004; Vand den Veyver, 2002). Moreover, as 
imprinted genes are important in fundamental foetal growth and development 
processes, any maternal diet-induced dysregulation of imprinted gene expression in 
the embryo/foetus, may have severe adverse consequences for foetal development. In 
agreement with this, in vitro studies have described altered expression of the 
imprinted H19 and Igf2 genes following modification of the external nutrient supply 
(Doherty, Mann, Tremblay, Bartolomei and Schultz, 2000; Khosla, Dean, Reik, and 
Feil, 2001), whilst exposure to a nutrient-restricted diet during early postnatal life was 
associated with developmental relaxation o f Igf2 imprinting in mice (Waterland et al., 
2006). Furthermore, in a recent study o f the Dutch Hunger Winter cohort, subjects 
that were exposed to the famine during gestation were found to have a persistent and 
significant reduction in methylation at the IGF2 locus (Heijmans et al., 2008). 
However, the extent to which these epigenetic changes may confer vulnerability to 
later mental illness remains to be empirically tested.
Besides affecting imprinted gene expression in the foetus directly, nutritional 
and other environmental insults also influence foetal development indirectly via 
effects on imprinted genes expressed in the placenta. Many placentally expressed 
imprinted genes identified to date are known to be involved in regulating and 
allocating maternal nutrient resources to the foetus; hence any perturbation o f their 
function could potentially impair placental efficiency and reduce the supply of 
nutrients (possibly via amino acid transport system A) and oxygen to key organs, 
including the embryonic brain. Several human studies have described altered placental 
expression of imprinted genes in IUGR or small for gestational age (SGA) 
pregnancies, including enhanced expression of the maternally expressed gene 
PHLDA2 and suppression of the IGF2 (Apostolidou et al, 2007; Diplas et al, 2009; 
McMinn et al, 2006). Consistent with this finding, a recent study employing genome- 
wide methylation analysis has revealed a significant hypo methylation of the 
H19HGF2 imprinting control region, in IUGR placentas (Bourque, Avila, 
Penaherrera, von Dadelszen and Robinson, 2010).
8.6 The advantages and limitations of animal models
A range of different animal species have been used as models of intrauterine 
nutritional deficiency and foetal growth restriction as the majority of the important
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experimental research cannot be adequately undertaken in humans for both ethical and 
practical reasons. Moreover, because the mammalian systems o f rodents share 
embryo logical, anatomical and physiological homology with humans, studies using 
rodent models have provided valuable translational insights into the genetic, 
molecular and cellular events that underlie the foetal programming of later health 
vulnerability in humans (Vuguin, 2007). However, caution must be exercised when 
making inferences about the developmental implications of early life adversities from 
animal models to human conditions. One o f the major caveats of using animal models 
to emulate foetal programming in humans is the fact that the ontogeny of central 
nervous system (CNS) in rodents deviates markedly from humans such that the 
critical periods for neural development in rodents extends into early postnatal life, 
whereas the majority of the maturation of the human brain has largely taken place by 
the time of birth (Rice and Baron Jr., 2000), although there are regionally specific 
trajectories in the development of some brain structures that are not complete by 
adulthood (e.g. prefrontal cortex, see Diamond, 2002). Nevertheless, despite the fact 
that animal models will probably never be totally satisfactory in mimicking the 
condition and consequences of human pregnancy and development these models have 
proven to be effective and valuable tools to further our understanding of the basic 
mechanisms underlying foetal growth and programming and are necessary for the 
advancement o f this field of research.
8.6.1 The advantages and limitations of the Igf2-KO models
The application of the Igf2 KO mouse lines provides an effective approach to 
model and investigate the relationship between foetal life and later health. The 
targeted deletions o f the imprinted Igf2 gene in these models are particularly 
appropriate to assay nutritional programming given the fact that the foetal IGF axis 
has been shown to be regulated by nutrition (see Chapter I, section 1.4.1.2), and also 
in light o f accumulating evidence for the role of placentally expressed imprinted gene 
in IUGR in humans (see section 8.7). While established rodent models have in general 
been considered to be beneficial for developmental research due to their short 
generation time and life span and the ability to produce large litters (Carter, 2007), the 
Igf2-KO mouse models extend several other advantages over previous animal models 
of early life nutrition. For instance, the fact that the lgf2-P0 and Null deletions inhibit
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the genetic growth potential o f the placenta intrinsically, no imposition of food 
deprivation or malnutrition is required and thus maternal distress is minimized among 
the dams, reducing potentially confounding maternal effects on postnatal development 
and behaviour (see Chapter I, section 1.5.2). Also importantly, since the 7g/2-P0 and 
Null mutations are only passed down to ~50% of offspring these genetic mouse 
models allows the foetally growth deficient Ig/2-KO mice to be directly compared 
with their own WT littermates; therefore ensuring greater homogeneity of the 
postnatal environment between experimental and control groups.
However, there are some issues in the use of the Igf2-KO models that require 
discussion. For example, while compromised placental efficiency will give rise to a 
reduction in placental transport o f nutrients to the foetus (i.e. glucose, lactate and 
amino acids), other critical functions o f the placenta are likely to be affected as well, 
such as oxygen delivery and regulation o f hormonal balance (see Barry, Rozance and 
Anthony, 2008 and McMillen and Robinson, 2005 for review). Therefore, the 
possibility that, for example, either foetal hypoxia and/or over exposure of 
glucocorticoids, could have played contributing roles to the brain and behavioural 
phenotypes o f the Igf2-KO mice in adult life cannot be dismissed. In fact, KO mice 
deficient for the placentally-expressed 11 /?-hydroxysteroid dehydrogenase type 2 gene 
(1 l/3-HSD2-Null), a catalyst o f glucocorticoid synthesis, have been found to be 
foetally growth retarded and exhibit heightened anxiety in later life (Holmes et al.,
2006). Evidently, these phenotypic similarities between the 11 /3-HSD2-Null mice and 
the 7g/2-P0 KO mice highlight the developmental susceptibility o f the stress/anxiety 
neural circuitry to foetal programming. However, on the basis that several studies 
have indicated placental deficiency in cases o f foetal growth deficiency in humans 
(see section 8.5 above), it is reasonable to assume that changes in oxygen delivery and 
hormonal exposure may be inevitable physiological consequences o f malnutrition in 
early life.
Furthermore, while animal models such as the Igf2-KO lines provide a 
relatively high degree o f experimental control over confounding variables, it is 
difficult, if not impossible, to exclude subtle early postnatal life confounds such as; 
differential mother-pup or pup-pup interactions, as results of any of the physiological 
or behavioural variations across genotypes, but these should be reduced in comparison 
to models o f maternal malnourishment. Another general disadvantage of using a 
mouse model for a functional study is the relatively small size of mice (Carter, 2007),
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which severely affects the quality o f spatial resolution in any morphological or 
neurochemical assay. However, this limitation is being addressed by the ongoing 
development o f sophisticated techniques for neuronal and molecular imaging.
8.7 Implications of present work and future directions
This thesis introduced, for the first time, a genetic model to investigate the 
lasting impact of adverse nutritional environment upon brain development and 
behaviour in later life. The experiments reported here provide converging lines of 
evidence, both behavioural and molecular, that are consistent with the view that 
nutrient deficiency arising from compromised placental function affects expression of 
the foetal genome, which in turn leads to lasting changes in both brain and 
behavioural phenotypes. Furthermore, although there has been significant discussion 
on the possible role o f imprinted genes in mediating the relationship between the 
foetal environment and later mental health (Kopsida, Mikaelsson and Davies, 2010; 
Lim and Ferguson-Smith, 2009; Dolinoy et al, 2007; Gallou-Kabani and Junien, 2005; 
Abel, 2004), the present research is the first to provide direct evidence for this link. 
The behavioural findings o f heightened stress and anxiety in the Igf2-P0 KO mice 
substantiate earlier work from humans and animals on early life nutrition (see Chapter 
IV), and is also in accordance with work describing increased HPA activity in cases of 
IUGR (see Chapter VI, section 4.4.). However the evidence suggesting improved 
executive function (i.e. better discriminative response accuracy and greater impulse 
control during the 5-CSRTT) is entirely novel and are particularly intriguing given the 
previous epidemiological studies indicating a higher risk o f attention-deficit 
hyperactivity disorder (ADHD) in children bom IUGR (see Breslau et al., 1996 for 
review). These findings could suggest that other environmental factors (besides poor 
nutrition) which are known to affect foetal growth might underlie the relationship 
between IUGR and ADHD risk (see Chapter V, section 5.1). However, it could also 
be argued these findings highlight the susceptibility o f the neurobio logical substrates 
of attention and behavioural inhibition to foetal programming by early nutritional 
deficiency, and that the differential behavioural manifestations of this compromised 
neural circuitry reflects between-species variation.
The work in this thesis provides only a snap-shot view o f the mechanisms and 
consequences of nutritional programming, and raises a number of important questions
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that need to be addressed with further research. For example, while Ig/2-PO KO mice 
repeatedly displayed evidence of heightened anxiety towards a potentially aversive 
environment during the approach-avoidance conflict tests, it remains unknown how 
Igf2-P0 KO mice would react to the presentation of an aversive stimulus (i.e. fear 
reactivity). Although the differences between the behavioural responses to a potential 
(i.e. anxiety) and a present threat (i.e. fear) may appear to be only subtle, there is some 
evidence that these behavioural constructs rely on the involvement of distinct brain 
regions (Barkus et al., 2010; Bannerman et al., 2004). As such, the hippocampus has 
been more strongly implicated in anxiety-related behaviours such as observed during 
ethological conflict tests (i.e. context based response), whereas fear reactivity during a 
fear conditioning paradigm (i.e. cue based response) has been shown to rely to a 
greater degree the amygdala (see Bannerman et al., 2004 for review). Therefore, a 
further assessment o f fear expression and learning during a fear conditioning 
paradigm (see Ehrlich et al., 2009), would provide a greater clarity o f the scope of the 
heightened emotionality o f Igf2-P0 KO mice, and dissociate the roles o f the 
hippocampus and the amygdala, in these stress- and anxiety phenotypes. To further 
corroborate this dissociation, gene expression analysis of key anxiety-related targets 
in the amygdala could also be investigated in Igf2-P0 KO and WT-littermate mice 
(see Chapter VII).
Furthermore, in light of the large amount of research that has highlighted the 
developmental susceptibility o f the hippocampus (see Chapter I, section 1.3) and the 
indications o f altered neurotransmitter functionality in this brain region of Igf2-KO 
mice (Chapter VII), memory function should be also be assessed, as it has been shown 
to depend heavily on the integrity o f the hippocampus (e.g. Bannerman et al., 2004). 
Therefore further behavioural characterization of the Igf2-KO mice should include 
assessments of this cognitive ability. Such an investigation would also be of particular 
relevance, considering the fact that epidemiological studies have indicated that IUGR 
children are at higher risk of memory impairments in later life (Geva, Eshel, Leitner, 
Fattal-Valevski and Harel, 2006; Vicari et al., 2004). However, the experimental 
design should minimize the involvement of high levels o f visuospatial processing (in 
light of the heightened attentional performance o f lgf2-P0 KO mice) and a test such as 
the Social Transfer o f Food Preference (STFP, see Wrenn, Harris, Saavedra, and 
Crawley, 2003) should be used, in which memory function is examined via olfactory 
functioning of subjects.
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Another important line o f future research, would be to follow-up on the 
findings of the improved attentional function and impulse control during the 5- 
CSRTT (Chapter V). For instance, it would be interesting to examine 7g/2-P0 KO 
mice on tasks o f cognitive flexibility (i.e. the ability to spontaneously withhold, 
modify or sustain adaptive behaviour in response to changing situational demand), 
since findings from recent work by Robbins and colleagues (2008) have raised the 
possibility o f a functional dissociation between impulse control and cognitive 
flexibility. In previous work, systemic striatal administration of the specific 5-HT2C 
receptor antagonist SB242084, has been shown to increase impulsive behaviour of 
mice on the 5-CSRTT, however in a subsequent study, the administration of 
SB242084 was also found to improve spatial reversal learning in mice (Boulougouris, 
Glennon and Robbins, 2008). The reverse effects were observed following 
administration of Ml 00907, a specific 5-HT2A antagonist (Boulougouris et al., 2008). 
Hence, in context o f the evidence of altered 5-HT2C receptor splicing in 7g/2-P0 KO 
mice (Chapter VII), it is highly relevant that an assessment o f cognitive flexibility is 
performed, using a number o f the tasks that have been developed to assay such frontal 
cortical functions, such as the attentional set shifting paradigm (formally equivalent to 
the human Wisconsin card sorting test, Colacicco et al., 2002) and serial spatial 
reversal learning (Boulougouis et al., 2008).
The preliminary work presented here revealed evidence of altered GABA and 
5-HT function (i.e. reduced GABA^ and 5-HT2A receptor expression) in Zg/2-PO KO 
mice as result of compromised nutrient access and growth in foetal life. However, 
while the differences in the GABA- and 5-HTergic receptor expression of/g/2-P0 KO 
mice were predominantly in line with their behavioural phenotypes, it is difficult to 
conclude a functional linkage between these behavioural and molecular aspects 
without further research. As mentioned previously (Chapter VII), it is of fundamental 
importance to establish that the differences in gene expression in Igf2-?0 KO mice are 
absent in mice o f the 7g/2-Null KO line, as these molecular changes could relate to 
IUGR without having any modulating involvement for the behavioural phenotypes of 
Igf2-?0 KO mice. It is also apparent, that further evidence o f altered GABA and 5-HT 
function is required as these changes in receptor expression could have occurred as an 
adaptive intracellular response, to counter extracellular neurochemical changes of 
opposing effects. As such, the reduced expression GABAq3 and/or 5-HT2A receptors 
could have been post-synaptic responses to excessive pre-synaptic GABA and/or 5-
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HT release. In order to address this issue, further research could use in vivo 
microdialysis to obtain indices o f GABA and 5-HT flux in specific brain regions (e.g. 
hippocampus, striatum and preffontal cortex). Another important area for future 
research would entail providing further support for the involvement GABA and 5-HT 
receptors in the behavioural phenotypes displayed by 7g/2-P0 KO mice by examining 
whether the behavioural differences observed between 7g/2-P0 KO mice and their 
respective WT littermates could be reduced or eliminated, with the use of the relevant 
pharmacological manipulations. Such work could involve local (hippocampal) 
administration of benzodiazepine drugs or 5-HT2A agonists prior to testing on the 
ethological tests o f anxiety, or administration of a specific 5-HT2C antagonist (e.g. 
SB242084) during the 5-CSRTT.
Based on the current findings and previous research, it was hypothesized that 
the early nutritional insult which the /g/2-P0 KO mice were exposed to (due to the 
placental deficiency), might have caused hyperactivation of the HPA-axis. This, in 
turn led to a dysregulation of the central 5-HT system (leading to greater impulse 
control) and induced heightened stress/anxiety through hippocampal GABA circuitry, 
and altered attentional function via the frontal dopaminergic (and or noradrenergic) 
pathways. However, although this conjecture may be reasonable in light of the 
evidence reviewed in this thesis, there is a great deal of further research required to 
provide more solid support for this notion. For instance, while altered HPA function 
has been consistently reported in different animal models o f early malnutrition and 
growth retardation, such endocrine changes need to be established in the Igf2-?0 KO 
model (and the ig/2-Null KO model), by either measuring basal levels of 
glucocorticoids (as well as ACTH, or CRH levels), or by examining 
glucocorticoid/mineralocorticoid receptor expression in the hippocampus.
Furthermore, it may be interesting to investigate the potential involvement of 
dopamine in mediating the altered attentional function of the Igf2-KO mice, by using 
either in vivo microdialysis to assess dopamine transmission in the forebrain, or real­
time qPCR to examine expression level in the preffontal cortex of genes involved in 
either function, such as the dopamine receptors D1 and £>2, the TH gene (encodes the 
enzyme tyrosine hydroxylase, the rate-limiting enzyme in dopamine biosynthesis), the 
dopamine transporter gene (DAT) and the cat echo 1- O- methy 1 transferase (COMT, a 
dopamine degrading enzyme) gene.
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The use o f Igf2 deletion models was particularly relevant for the purposes of 
this research (in light of the central role for the IGF axis in mediating developmental 
programming), there are a number of other placental gene deletion models that could 
be of utility in examining the long-term effects o f compromised nutrient transfer in 
intrauterine life, such as the Pegl, Peg3 and Slc38a4 gene deletion models. 
Alternatively, genetic models using over expression of growth inhibiting imprinted 
genes could also be adopted for this purpose. For example, over-expression of the 
imprinted Phlda2 gene (due to loss o f imprinting), results in foetal and placental 
growth retardation and, similar to Igf2-PO KO mice, low birth weight and an 
accelerated postnatal weight gain (Salas et al., 2004). Finally, since environmental 
factors can alter the epigenome, their ability to influence disease risk might involve 
epigenetic transgenerational inheritance (Jirtle and Skinner, 2007). Studies in rodents 
have demonstrated that nutritional deficiency during gestation could affect the 
incidence of diabetes and growth defects in second (F2) generation animals 
(Zambrano et al., 2005; Cesani et al., 2003). Hence, it would be particularly 
interesting to investigate whether the heightened stress/anxiety and impulse inhibition 
phenotypes observed in Igf2-P0 KO mice (presumably as a result of compromised 
placental function), could be propagated to the their own offspring (i.e. F2 
generation). Such work could be carried out by comparing the behaviour of WT- 
offspring of the Igf2-P0 KO mice, to that of WT-offspring of the WT-littermates of 
the Igf2-?0 mutant line, in some or all the behavioural tests used in this thesis. Finally, 
it would also be o f interest to investigate the long-term effects lgf2 gene manipulation 
in female mice, as marked gender-specific differences have been noted in the 
development o f the CNS (see de Vrie and Sodersten, 2009 for review), and the work 
in this thesis made use of only male subjects.
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Appendices:
Appendix I
Parameters of early postnatal growth Independent T-test:
Weight at birth t(75)= -1.95, n.s.
Weight at postnatal day 100 *t(75)= -5.27, p= 0.001
Postnatal growth rate: Day 1 -25 *t(76)= -3.75, p= 0.001
Postnatal growth rate: Day 25-50 *t(76)= 4.02, p= 0.001
Postnatal growth rate: Day 50-75 t{76)= -0.77, n.s.
Postnatal growth rate: Day 75-100 t(76)= -0.48, n.s.
Overall postnatal growth rate: Day 1-100 t(76)= -1.06, n.s.
Parameters of somatic/ 
neurological development Independent T-test:
Ear opening *f(75)= -2.26, p= 0.05
Incisor eruption *t(75)= -3.07, p= 0.005
Fur growth /(75)= 0.00, n.s.
Eye opening /(75)= -1.26, n.s.
Parameters of somatic/ 
neurological development Independent T-test:
Beam-breaks at Session 1 r(30)= 1.04, n.s.
Beam-breaks at Session 2 t{30)= 0.69, n.s.
Beam-breaks at Session 3 t(30)= 0.69, n.s.
Runs at Session 1 r(30)= 0.19, n.s.
Runs at Session 2 t(30)= 0.33, n.s.
Runs at Session 3 /(30)= 0.00, n.s.
Between subjects test: Interaction:
Beam-breaks across sessions F i ,30= 1.03, n.s. F2,60= 0.07, n.s.
Run across sessions Fi,3o= 0.01, n.s. F2,60= 0.08, n.s.
215
Parameters of balance and 
motor control Between subject test: Interaction:
Latency to fall o f rod Fi,35= 2.27, n.s. *F3,ii3= 2.97, p= 0.05
Velocity level at time o f fall F u 5= 2.22, n.s. *F4,i40= 2.61, p= 0.05
Independent T-test:
Latency to fall o f rod at 35rpm *t(35)= 2.80, p= 0.01
Latency to fall o f rod at 45rpm */(35)= 2.38, p= 0.05
Startle response and prepulse 
inhibition parameters Independent T-test:
Startle response to acoustic 
stimulus *t(46)= -2.02,/?= 0.05
Performance across trials of 
varying prepulse sound levels Between subject test: Interaction:
Startle response Fi,46= 3. 73, n.s. F2,77= 2. 15, n.s.
Prepulse inhibition Fi,46= 1. 34, n.s. F3,138= 0.67, n.s.
Pa remeters Between subject test: Interaction:
Total liquid consumption 
across sessions Fi,65= 0. 44, n.s. F4^ 79= 1.36, n.s.
Condensed milk 
preference at: Independent T-test:
Session 3 t(65)= -0.55, n.s.
Session 4 t(65)= -0.61, n.s.
Session 5 t(65)= -1.85, n.s.
Session 6 /(65)= -0.96, n.s.
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Appendix II
Behavioural Measures Independent T-test:WT-PO controls/WT-Null controls
Percentage of time spent on 
open arms ^
t(42)= -1.31, n.s.
Frequency of open arm entries /(42)= 1.78, n.s.
Latency of first entry onto an 
open arm /(42)= 0.64, n.s.
Rearing /(42)= 1.82, n.s.
Head dips /(42)= 0.13, n.s.
Stretch attends t{42)= -0.48, n.s.
Total distance moved *f( 42)= -3.31 ,p= 0.005
Amount of time spent moving *t{42)= -3.35,/?= 0.005
Average velocity *t(42)= -3.12, p= 0.005
Behavioural Measures Independent T-test:WT-PO controls/WT-Null controls
Percentage of time spent in the 
inner-stjuare f(40)=-1.29, n.s.
Percentage of time spent in the 
middle-square f(40)=-0.43, n.s.
Frequency of inner-square 
entries j(40)=-0.07, n.s.
Frequency of middle-square 
entries /(40)=-1.31, n.s.
Latency of first entry into the 
inner square /(40)= 0.40, n.s.
Total distance moved £(40)= 0.41, n.s.
Amount of time spent moving £(40)= 1.56 n.s.
Average velocity £(40)= 1.41, n.s.
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Behavioural Measures Independent T-test:WT-PO controls/WT-Null controls
Percentage of time spent in the 
novel compartment t(38)= 1.20, n.s.
Percentage of time spent in the 
distal part of the novel 
compartment
438)= -1.46, n.s.
Frequency of entries into the 
novel compartment f(38)= 1.80, n.s.
Frequency of entries into the 
distal part of the novel 
compartment
438)= 0.03, n.s.
Latency of first entry into the 
novel compartment 438)= 0.19, n.s.
Latency of first entry into the 
distal part of novel compartment 438)= - 0.42, n.s.
Total distance moved 438)= 0.67, n.s.
Amount of time spent moving 438)= 0.56, n.s.
Average velocity 438)= -0.60, n.s.
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Appendix III
Statistical analysis Test of between subject: GENOTYPE
Condensed milk preference t(35)= 0.89, n.s.
Total volume consumption /(35)= 1.05, n. s.
Behavioural Measures
Repeated-measures analysis of 5-CSRTT acquisition |
Test of between-subject: 
GENOTYPE
Test of within-subject: 
INTERACTION
T rials Fi^5= 0.00, n.s. F6,214= 0.87, n.s.
Accuracy F u 5= 0.36, n.s. Fjo,350= 1-26, n.s.
Omissions Fi,35= 2.28, n.s. F4, 152= 1.42, n.s.
Correct RT F i,35= 1-39, n.s. F2,52= 0.96, n.s.
Behavioural Measures Independent T-test:WT-PO controls/WT-Null controls
Trials /(35)=-0.74, n.s.
Accuracy (%) f(35)=- 1.35, n.s.
Omissions (%) f(35)=- 0.12, n.s.
Correct reaction time (sec) /(35)= 0.01, n.s.
Magazine latency H\= 3.18, n.s.
Eating duration /(35)= .00, n.s.
Premature nose-pokes /(35)=- 0.23, n.s.
Nose-pokes per trial f(35)= 0.51, n.s.
Panel-pushes per trial f(35)= 1.55, n.s.
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Behavioural Measures
Spatial location of light stimulus presentation
Test of between-subject: WT 
CONTROL
Test of within-subject: 
INTERACTION
Accuracy Fi,35= 0 .02 , n.s. F3, io6=  2.03, n.s.
Omissions Fi,35= 0.53, n.s. F4, mo=  2.21, n.s.
Correct RT Fi,35= 0.03, n.s. F2,77= 0.15, n.s.
Behavioural Measures
Test of between-subject: 
GENOTYPE
Test of within-subject: 
INTERACTION
Accuracy F1,35— 0.03, n.s. F2,79= 1-88, n.s.
Omission Fi,35= 0.63, n.s. F2,82=1.25, n.s.
Correct RT Fi,35= 0.00, n.s. F2,82= 0.32, n.s.
Premature nose-pokes F1,35= 0.72, n.s. F2,67= 0.79, n.s.
Trials F3 35= 2.44, n.s. F3, io5= 0.92, n.s.
Accuracy Fi,35= 0.50, n.s. F3, 105= 0.70, n.s.
Omission Fi,35= 0.63, n.s. F2,82=1.12, n.s.
Correct RT Fi,35= 0.03, n.s. F2,56= 1.99, n.s.
Premature nose-pokes Fj 35=0 .60, n.s. F3. 105= 1-40, n.s.
T rials Fi,35= 0.32, n.s. F3,89= 2.84, n.s.
Behavioural Measures
Test of between-subject: 
GENOTYPE
Test of within-subject: 
INTERACTION
Accuracy Fi,35= 0.17, n.s. F2,75= 1.11, n.s.
Omission Fi,35= 1.52, n.s. F3. i o 5=2 .57 , n.s.
Correct RT Fi,35= 0.00, n.s. F2r77= 2.26, n.s.
Premature nose-pokes Fi.35= 0.93, n.s. F 3 .105= 0.23, n.s.
Trial F i,35~  0.07, n.s. | F 3 ,105- 0.24, n.s.
Accuracy Fi,35_  0.83, n.s. Fi,5i= 0.80, n.s.
Omission F1,35= 0.14, n.s. F3, 105= -46, n.s.
Correct RT Fi,35=  0.01, n.s. F 3 ,105= 0.10, n.s.
Premature nose-pokes Fi,35= 0.00, n.s. F 3 ,105= 0.86, n.s.
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Appendix 3.6: continued (see above)
I Trial | Fi,3 5 =  0.45, n.s. | F2,7i= 0.24, n.s. |
Behavioural Measures
Test of between-subject: 
GENOTYPE
Test of within-subject: 
INTERACTION
T rials Fi,35= 0.00, n.s. Fi,35= 0.14, n.s.
Accuracy Fi,35= 0.15, n.s. Fi,35= 0.43, n.s.
Omissions F1,35= 1.41, n.s. Fi,35= 1.44, n.s.
Correct RT Fi,35= 0.04, n.s. Fi,3s= 2.10, n.s.
Behavioural Measures
Test of between-subject: 
GENOTYPE
Test of within-subject: 
INTERACTION
Trial Fi?35= 0.04, n.s. F3, io5= 1-05, n.s.
Accuracy Fi,35= 0.62, n.s. F3, 105= 0.62, n.s.
Omissions Fi,35= 0.01, n.s. F2,7i= 0.62, n.s.
Correct RT Fi,35= 0.09, n.s. F2,7i= 0.67, n.s.
Behavioural Measures 1-CSRTT Independent T-test
5-CSRTT/l-CSRTT  
Test of within-subject: 
INTERACTION
T rials f(35)=-0.29, n.s. Fi,35= 0.02, n.s.
Accuracy (%) /(35)=-1.06, n.s. Fi,35= 0.01, n.s.
Omissions (%) f(35)=-1.02, n.s. Fi,35= -57, n.s.
Correct RT (sec) t(35)= 1.35, n.s. F1,35= 1.26, n.s.
Premature nose-pokes f(35)=-1.43, n.s. F1,35= 0.18, n.s.
Magazine latency Hi= .42, n.s.
Eating duration f(35)=-0.47, n.s.
Nose-pokes per trial f(35)=-0.98, n.s.
Panel-pushes per trial t(35)= 0.57, n.s.
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Appendix IV
Statistical analysis Test of between subject: GENOTYPE
Condensed milk preference t(28)= -0.24, n.s.
Total volume consumption 428)= -0.74, n.s.
Statistical analysis Test of between subject: GENOTYPE
Single nose-poke training phase 428)= 0.78, n.s.
Go trial training phase 428)= 1.30, n.s.
Stop signal trial training phase 428)= -0.90, n.s.
SSRTT 428)= 3.83, n.s.
Behavioural Measures
Repeated-measures analysis
Test of between-subject: 
GENOTYPE
Test of within-subject: 
INTERACTION
Trials completed % Fu 8= 1.64, n.s. Fi,28= 0.35, n.s.
Number of trials 
initiated Fi^g= 0.40, n.s. Fi,28= 0.06, n.s.
INIT NPs/per trial *F!,28= 9.95, p= 0.005 *Fi,28= 6.01, p= 0.05
Panel-pushes/per trial F i^8= 2.38, n.s. *F,,28= 7.09, p= 0.05
Behavioural Measures
Repeated-measures analysis
Test of between-subject: 
GENOTYPE
Test of within-subject: 
INTERACTION
% Go-correct Fi.28= 2.27, a s . Fi,28= 1-77, n.s.
Go-correct RT Fi,28= 0.61, n.s. Fi,28= 0.77, n.s.
% trials completed Fi,28= 0.45, n.s. F i,28= 0.65, n.s.
Number of trials init. Fi>28= 0.07, n.s. Fi,28= 0.01, n.s.
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INIT NPs/per trial Fi,28~ 0.18, n.s. Fi,28= 1.41, n.s.
Go NPs/per trial Fi,28= 0.08, n.s. Fi,28= 0.38, n.s.
Total NPs/per trial Fu 8= 0.01, n.s. Fi.28= 0.99, n.s.
Panel-pushes/per trial F i^8= 0.00, n.s. Fi,28= 0.12, n.s.
Repeated-measures analysis
Behavioural Measures Test of between-subject: Test of within-subject:
GENOTYPE INTERACTION
% Stop-correct Fi,28= 0.11, n.s. Fi,28= 2.40 n.s.
SSRT Fi,28= 0.07, n.s. Fi.28= 1.26, n.s.
% Go-correct Fi.28= 1.21, n.s. Fi,28= 1-53, n.s.
Go-correct RT Fi.28= 0.36, n.s. Fi,28= 0.59, n.s.
% trials completed Fi28= 0.36, n.s. Fi.28= 0.35, n.s.
Number of trials 
initiated Fi^s= 1.96, n.s. Fi,28= 0.43, n.s.
INIT NPs/per trial Fij28= 0.94, n.s. Fit28= 1.88, n.s.
Go NPs/per trial F i^8= 0.08, n.s. Fi.28= 3.25, n.s.
Total NPs/per trial Fir28= 0.46, n.s. Fi,28= 2.86, n.s.
Panel-pushes/per trial Fi^8= 0 .1 2 , n.s. Fi^S”  0.08, n.s.
LH measure Test of between subject: GENOTYPE
Go signal LH f(28)=-0.11, n.s.
Stop signal LH /(28)=-0.15, n.s.
Behavioural measures Test of between subject: GENOTYPE
% Stop-correct /(28)= 1.71, n.s.
SSRT t{28)=-0.94, n.s.
% Go-correct f(28)= 0.90, n.s.
Go-correct RT t(28)=-0.36, n.s.
% trials completed t(2S)= -1.44, n.s.
Number of trials 
initiated /(28)= 1.02, n.s.
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I N IT  N P s /p e r  tr ia l j(28)=-0.40, n.s.
G o  N P s /p e r  tr ia l f(28)=-0.09, n.s.
T o t a l  N P s /p e r  tr ia l f(28)=-0.25, n.s.
P a n e l-p u s h e s /p e r  tr ia l /(28)= -1.37, n.s.
B e h a v io u r a l  M e a s u r e s
R e p e a te d -m e a su r e s  a n a ly s is
Test of between-subject: 
GENOTYPE
Test of within-subject: 
INTERACTION
M a g a z in e  la te n c y Fi,28= 0.03, n.s. Fi,28= 1-53, n.s.
E a t in g  d u r a tio n Fi,28= 0.16, n.s. Fi,28= 0.54, n.s.
B e h a v io u r a l M e a su r e s
O n e -w a y  A N O V A : T e st o f  b e tw e e n -s u b je c t  e ffe c t
Stop signal: 10-30% of mean 
Go RT
Stop signal: 70-90% of mean 
Go RT
%  S to p -c o r r e c t F2,51= 1.19, n.s. F2.51= 0.24, n.s.
S S R T F2,5i= 0.83, n.s. F2,51=0.32, n.s.
%  G o -c o r r e c t F2,5i= 0.10, n.s. F2,5i=0 .53, n.s.
G o -c o r r e c t  R T F2,51= 0.20, n.s. F2,51= 0.17, n.s.
%  tr ia ls  c o m p le te d F2,51= 0.77, n.s. F2,5i= 0.22, n.s.
N u m b e r  o f  tr ia ls  
in it ia te d F2,51= 0.78, n.s. F2,51= 1.74, n.s.
B e h a v io u r a l
M e a s u r e s
O n e -w a y  A N C 1VA: T e st  o f  b e tw e e n -s u b je c t  e ffe c t
Stop signal: 10-30% of 
mean Go RT
Stop signal: 40-60% 
of mean Go RT
Stop signal: 70-90% of 
mean Go RT
%  S to p -c o r r e c t /(28)= 1.15, n.s. £(28)= 0.78, n.s. £(28)= -0.32, n.s.
S S R T /(28)= 0.74, n.s. £(28)= 0.84, n.s. £(28)= -0.36, n.s.
%  G o -c o r r e c t £(28)=-0.56, n.s. £(28)= 0.95, n.s. r(28)= -0.10, n.s.
G o -c o r r e c t  R T £(28)= 0.25, n.s. £(2 8)= 0.37, n.s. t(28)= -0.03, n.s.
%  tr ia ls  
c o m p le te d t(28)= 1.85, n.s. £(28)= 1.88, n.s. ^(28)= 1.37, n.s.
N u m b e r  o f  
tr ia ls  in it ia te d t(28)=-0.66, n.s. £(28)=-1.00, n.s. t(28)= 0.17, n.s.
224
Appendix V
Appendix 5.1: The results from a one-way ANOVA comparative analyses (o f all four  
genotype groups) o f  performance between the lgf2- PO KO mice to each o f the two 
WT-littermate control groups, on various behavioural batteries where significant 
results were obtained using a collective WT-control group.
Behavioural
test:
Behavioural
parameter:
ANOVA
significance
test:
Post hoc comparisons between 
Igf2-P0 knockout and;
WT-PO controls: W-Nullcontrols:
Acoustic 
startle and 
prepulse 
inhibition
Startle response 
at baseline
F 3,80= 7.10,
p< 0.001
F,,56= 12.13, 
p< 0.005
F i ,30= 18.22,
p< 0.001
Test of food- 
neophobia
Novel food­
stuff preference
F3)ii9= 3.82, 
p< 0.05
F3,7i= 8.13, 
p< 0.05
F3,i 19= 8.81, 
p< 0.05
Elevated plus- 
maze
Open-arm
preference
F3,72= 4.51,
p< 0.01
Fi, 38= 12.21, 
p< 0.005
F i ,40= 4.86, 
n.s.
Open field
Latency o f  first 
inner-square 
entry
F3,66= 6.22,
p< 0.001
FU3= 8.90, 
p< 0.05
F 1,39= 8.22, 
p< 0.05
Free
exploratory
paradigm
Novel-
compartment
preference
F3,65= 3.28, 
p< 0.05 Fi ,39= 4.14, n.s.
F ,,35= 7.83, 
p< 0.05
Latency o f first 
distal-novel 
compartment 
entry
F 3,65= 2.80, 
p< 0.05 Fi39= 5.33, n.s.
F,35= 3.33, 
p< 0.05
The 5-CSRTT
Response 
accuracy at 
baseline
F3,68= 5.67, 
p< 0.005
F,,47= 14.67, 
p< 0.005
F i ,30= 1.77, 
n.s.
Response 
accuracy at 
Long ITI
F3,68= 5.00, 
p< 0.005 F],47=  6.47, n.s.
Firj0= 8.42, 
p< 0.05
Response 
accuracy at 
white-noise 
distraction
F3,68= 2.49, 
n.s. - -
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Appendix 5.1 continued: (see above)
The 5-CSRTT
Premature 
nose-pokes at 
baseline
F3,68= 2.99, 
p< 0.05 F i ,47= 5.51, n.s.
F,,30= 4.54, 
n.s.
Premature 
nose-pokes at 
Long ITI
F3,68= 3.92, 
p< 0.05
F i ,47= 7.36, 
p< 0.05
Fi3o= 8.93, 
p< 0.05
Appendix 5.2: The results from a one-way ANOVA comparative analyses (of all four  
genotype groups) of performance between the /g/2-Null KO mice to each o f  the mo 
WT-littermate control groups, on various behavioural batteries where significant 
results were obtained using a collective WT-control group.
Behavioural Behavioural ANOVAcifin l *■ panpo
Post hoc comparisons between 
Igf2-P0 knockout and;
test: parameter: Mj'iiii i i  t im etest: WT-PO
controls:
W-Null
controls:
Response 
accuracy at 
baseline
F3,68= 5.53, 
p< 0.005
FU6= 8.19, 
p< 0.05 F i^3= 1.31, n.s.
The 5-CSRTT Response 
accuracy at 
Long ITI
F3,68= 5.00, 
p< 0.005 Fi36= 6.47, n.s.
FU3=8.51, 
p< 0.05
Omissions at 
Short SD
F3,68= 2.89, 
p< 0.05 Fi,36= 2.96, n.s.
Fi^3= 6 .88, 
p= 0.051
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